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Abstract 
Congenital heart defects are responsible for more neonatal deaths than any 
other birth defect.  Although genetic and environmental factors play an 
important role, either separately or in combination (multifactorial), still the 
cause in most cases remains unknown. 
Changing life styles, e.g. exposure of the mother to excessive alcohol, 
nicotine in tobacco smoke, easily available traditional and, over the counter 
medicines and environmental contaminants could be possible causes of 
congenital malformations.  Maternal diseases like diabetes mellitus are also 
one of the etiological factors for developmental defects.  Several 
developmental genes, for instance connexin 43; one of the key proteins 
involved in cardiovascular development, and endothelin 1; another 
important gene required in many developmental processes, could be 
responsible for developmental anomalies of the heart.  Supplementation 
with micronutrients such as folic acid and Vitamin C during the 
periconceptional period has been shown to prevent some neural tube and 
congenital heart defects. This study was aimed at evaluating the adverse 
effects of ethanol, retinoic acid, nicotine, cadmium chloride, sodium 
fluoride, ginseng and diabetic conditions on chick cardiomyocytes cultured 
in the micromass system, and examining the potential protective effects of 
folic acid and vitamin C.  Also teratogenic effects of some of the 
teratogens, ethanol, nicotine, retinoic acid and diabetic conditions, were 
examined using in ovo culture. 
 Hearts were dissected from 5 day old White Leghorn chick embryos and 
the cells were isolated and cultured.  They were exposed to different 
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concentrations of test chemicals.  Folic acid and vitamin C were added to 
see any protective effects.  Cell viability was assessed using the resazurin 
reduction assay and the kenacid blue assay was performed for determining 
cell number.  For in ovo culture, day 3 chick embryos were injected with 
ethanol, nicotine, retinoic acid or diabetic molecules or a combination of 
teratogenic chemicals and vitamins (folic acid and vitamin C).  
Immunohistochemistry and western blotting were employed to detect the 
expression of connexin 43 and endothelin 1.  Results of micromass culture 
revealed that ethanol, retinoic acid, nicotine, cadmium chloride and 
diabetic conditions dramatically reduced cellular differentiation, cell 
viability and protein content in a dose dependant manner.  However, 
vitamin C (100µM) and folic acid (1mM) administered concurrently with 
these chemicals, except for cadmium chloride, could significantly improve 
all parameters such that the values were comparable with the control.  
Nicotine had no effect on cell viability and protein content, but cell beating 
was significantly affected.  This effect was reversed by the addition of 
Vitamin C and folic acid.  Results of in ovo culture showed that ethanol 
and diabetic conditions caused gross and histological malformations in 
chick embryos.  However their effects were abrogated with supplemental 
folic acid and vitamin C.  Immunohistochemical and western blotting 
results demonstrated a decreased expression of Cx43 and endothelin 1 in 
ethanol, retinoic acid, nicotine and diabetic condition treated cells while 
addition of vitamins restored their expression so they were comparable to 
controls. 
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It may be that environmentally induced teratogenic effects on heart 
development could be prevented by supplementation with Vitamin C and 
folic acid during pregnancy.  
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1. Introduction 
This project is focused around the influence of environmental factors and 
maternal diseases on pregnancy outcome and also the protection of 
embryonic development, which may be brought about by factors such as 
proper nutrition and supplementation with vitamins. 
Congenital anomalies, birth defects and congenital malformations are the 
terms currently used to describe developmental disorders present at birth 
(Moore & Persaud, 1998).  These anomalies are the leading cause of infant 
mortality.  An estimated 495,000 infants die every year worldwide due to 
congenital defects (Rosano et al., 2000; Dolk, 2005). 
Out of all the congenital defects 60-70% are of unknown cause, 20% are 
because of genetic transmission, 3-5% from chromosomal anomalies and 
the remaining 3-4% are due to chemicals and drugs (Giavini et al., 1994).  
However, many common congenital anomalies are thought to be caused by 
genetic and environmental factors adding together as multifactorial 
inheritance (Moore & Persaud, 1998). 
Environmental agents are only responsible for a small group of birth 
defects reported but are also the most amenable to control. For this reason 
much research has been focused on environmental agents as a cause of 
congenital defects (Steel & Copping, 1993). 
Maternal nutrition (both micro and macro nutrients) plays a vital role in 
normal growth and development of the fetus.  These micro and macro 
nutrients are critical for a woman to maintain a normal pregnancy with 
JRRGSUHJQDQF\RXWFRPH $ZRPDQ¶V nutritional status is prejudiced by 
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several factors, including genetics, lifestyle habits, underlying diseases or 
exposure to toxic drugs (Keen CL et al., 2003).   
Various studies around the world show a direct impact of environmental 
insults on the nutritional status of pregnant women.  Studies on the Dutch 
wartime famine showed an increased risk of early abortions and fetal 
miscarriages, intrauterine growth retardations, and congenital 
malformations (Smith, 1947).  Several women of child-bearing age in both 
the developing and developed world do not maintain a healthy diet pre, peri 
and post conceptionally.  There are many reasons for taking in less than the 
recommended diet during pregnancy, and these include lack of knowledge 
or lack of access to a high quality diet (Mehta, 2008).  Moreover, a number 
of studies have also shown that most women of reproductive age are not 
attaining adequate vitamins A, C, B6, and E, folic acid, calcium, iron, zinc, 
and magnesium levels in their diet (de Weerd S et al., 2003; Yang QH et 
al., 2007).  Although the precise mechanisms of how these micronutrients 
can influence pregnancy outcomes are not entirely understood, some of the 
OLNHO\ PHFKDQLVPV LQFOXGH DQ LPSURYHPHQW LQ WKH PRWKHU¶V LPPXQH
system, energy metabolism, anabolic processes, ability to respond to stress, 
and hemoglobin levels etc.  All these effects in turn affect the incidence of 
preterm birth, fetal intrauterine growth restriction, congenital 
malformations and fetal growth retardation (Susser, 1991; Ladipo, 2000; 
Keen CL et al., 2003; Fawzi et al., 2007). 
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1.1. Teratogens and teratology 
A teratogen is any substance, agent or process that induces developmental 
abnormalities in the embryo/fetus as defined by the Oxford Medical 
Dictionary. The effect produced by a teratogen depends on the stage at 
which the embryo/fetus is exposed to it, the most vulnerable period is the 
period of organogenesis (Brown & Fabro, 1983). 
Teratology is the study of abnormal prenatal development and congenital 
malformations induced by exogenous chemicals or physical agents (Bailey 
et al., 2005).  Although only some 10% of all congenital defects are caused 
by teratogens (Brent, 1995), those teratogens compromise the quality of 
life for millions of people worldwide and cost billions of dollars in health 
care every year (Bailey et al., 2005). 
1.2. History and principles of teratology 
It was in the 1920s and 1930s when teratology was born as a science, with 
the birth of malformed piglets, especially with a lack of eyes, from mothers 
fed an experimental diet low in vitamin A and high in fat (Bailey et al., 
2005).  Subsequent evidence came to light over the next two decades with 
the recognition in 1941 of congenital defects in children born to mothers 
who had suffered from rubella virus infection, and a little later with 
environmental contamination with mercury in 1956 (Igata, 1993).  Then in 
1961, thalidomide, a sedative and anti-emetic, was identified as a potent 
teratogen to embryos which caused minimal or no toxicity to adults (Bailey 
et al., 2005). 
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It was following the revelation of thalidomide as a teratogen, that the study 
of teratogens increased and more guidelines were introduced regarding 
environmental agents, considered safe for fetal exposure.   
Since then many other teratogens including drugs, infectious diseases, 
radiation and maternal factors have been identified by various experimental 
studies (Moore & Persaud, 1998). 
A number of basic principles and concepts applicable to teratology 
research have been formulated.  Six main principles have been outlined by 
Wilson on which the study of teratogens should be based (Bailey et al., 
2005).  
1. Susceptibility to teratogenesis depends on the genotype of the 
conceptus and the manner in which it interacts with 
environmental factors. 
2. Susceptibility to teratogenic agents varies with the developmental 
stage at the time of exposure. 
3. Teratogenic agents act in specific mechanisms on developing 
cells and tissues to initiate abnormal embryogenesis. 
4. The final manifestations of abnormal development are 
malformation, growth retardation, death and functional disorder. 
5. The access of adverse environmental influences to developing 
tissues depends on the nature of the influences. 
6. Manifestations of deviant development increase in degree as 
dosage increases from the no effect to totally lethal. 
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1.3. Teratogenicity testing 
Teratogenicity testing of different toxins, chemicals and drugs, which 
pregnant mothers come across in everyday life, is very essential.  Screening 
of new chemicals with potential toxicity would allow medical experts to 
help pregnant women in avoiding direct contact with these potentially 
hazardous substances.  Currently most teratogenicity assays utilize in vivo 
animal studies to attain the goal of detecting chemical hazards (Bailey et 
al., 2005).      
1.3.1. In vivo tests 
In vivo studies give the preliminary guidelines on whether a drug or 
chemical causes any teratogenicity during pregnancy. A range of doses is 
usually administered through the most appropriate route, to pregnant 
animals during the period of organogenesis, and the results compared to 
untreated animals.  The standard sample size in most of the cases is 20 or 
more pregnant females per dose, with a range of doses from highest to 
lowest; in such a way that the highest dose only causes some signs of 
maternal toxicity and lowest dose has no toxicity in mothers.  
The most common species used are rats, mice and rabbits. Although the 
rodents are the species of choice in teratology research, one should 
consider many physiological and biochemical differences between the 
animal species used in teratology research and humans, and it is not 
surprising that no one species can be shown to be the perfect experimental 
animal for developmental toxicity studies. None of the species absorb, 
metabolise and eliminate test substances like humans and none of them 
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have the same placental transfer properties. Despite these liabilities, 
rodents have become the most commonly used species for evaluating 
potential human teratogens.  Because of the intrinsic problems and 
inadequacies of teratology testing with the animals most commonly used 
(mouse, rat, rabbit, hamster, and monkey), scientists have tried to integrate 
more species into their experiments in order to find one that fulfils the 
criteria of an ideal animal. Dogs, cats, pigs and non-human primates were 
tested with a selection of known teratogens, but none of them proved to be 
the appropriate animal for developmental toxicity testing.   
Several inter-species differences including; anatomical differences, 
metabolic variations, response to potential teratogens, sensitivity to 
environmental conditions, route of administration and vehicles used, must 
be considered, when designing animal developmental toxicology studies 
and extrapolating to humans (Pratt et al., 1982).  
1.3.2. In vitro alternatives to animal studies 
In recent years, scientists started using in vitro methods to overcome the 
intrinsic problems and differences in animal teratology studies. These 
methods are now well established and invaluable for conducting these 
studies, and are very useful for the screening of chemicals (Brown et al., 
1995).  The in vitro tests are less expensive, quicker, and much more 
reproducible. There is now an absolute need for alternatives to 
conventional animal-based methods due to the fact that every year 
hundreds of drugs are introduced to the market and pregnant women are 
exposed to thousands of toxic substances in everyday life (Bournias-
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Vardiabasis & Teplitz, 1982).  The European Union (EU) white paper 
published in 2001 suggested the organization of testing requirements for 
approximately 30,000 chemicals marketed before September 1981 
5HJLVWUDWLRQ (YDOXDWLRQ DQG $XWKRUL]DWLRQ RI &KHPLFDOV µ5($&+¶
(Hartung et al., 2003).  If animal-based methodology were applied, this 
attempt would require the use and sacrifice of an estimated 12.8 million 
animals at a cost of 8.68 billion Euros over a period of 45 years (Hartung et 
al., 2003). Therefore, there can no longer be any justified resistance to the 
development and adoption of alternative teratology methods.  A wide range 
RIDOWHUQDWLYHVKDYHEHHQLQYHVWLJDWHGZLWKDSRWHQWLDOWRIROORZWKH³7KUHH
5V´ 5HGXFWLRQ 5HILQHPHQW DQG 5HSODFHment) principle in order to  
minimize and eventually replace animal models with non-animal 
alternatives without compromising high quality science (Russell & Burch, 
1959).  There are many available in vitro tests, e.g. hydra regeneration 
assay, the frog embryo teratogenesis assay (FETAX), drosophila assay, 
which detect the developmental and reproductive toxicity in mammals and 
other primates.  Out of all the in vitro tests, three are validated as embryo 
toxicity assays by the ECVAM advisory committee (ESAC).  These are the 
embryonic stem cell test, the micro mass test and the whole embryo culture 
test (Genschow et al., 2000; Brown, 2002; Genschow et al., 2002). 
1.3.2.1. The Hydra Regeneration Assay 
Johnson and his colleagues proposed an assay using lower organisms such 
as Hydra for the detection of teratogenic substances for the first time.  
Since then these organisms have been used by many scientists in a 
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modified manner to test for potential teratogenic effects (Johnson & Gabel, 
1983).  Hydra are usually 2 to 25 mm in height and live in fresh or salt 
water.  The most common way of reproduction is vegetative, with the 
ability to totally regenerate the body from parts or cells. Hydra attenuata is 
readily available and can be maintained in fresh water in a laboratory.  
Their population doubles every 4 days under favourable temperature 
conditions.  The artificial embryos generated from the budding of adult 
hydra exhibit the same features as mammalian embryos such as 
proliferation and regression of cells, creation of organ fields, initiation of 
competence, pattern configuration, metabolic changes, organogenesis, and 
well-designed ontogeny.   This assay can detect the teratogenic potential of 
many chemicals except those which are water insoluble and contain 
copper.  Also this should not be considered a reliable assay for the 
evaluation of toxicity risk of any compound, due to its single end point 
(Wilby & Tesh, 1990).    
1.3.2.2. The Drosophila Test 
The fruit flies or Drosophila melanogaster, had been employed by 
scientists for mutagenicity studies since many years.  The drosophila is 
also used for detection of possible teratogens.  Initial experiments were 
performed to detect the toxicity of vinblastine, thymidine, deoxycytidine 
and 5-bromodeoxyuridine in the 1970s.  Later on several other chemicals 
were studied by Schular et al.  The male and female adult fruit flies are 
anaesthetized and positioned in vials; containing distilled water and instant 
Drosophila medium. The chemicals to be tested are added to the distilled 
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water, and the medium.  The flies are allowed to mate and lay eggs.  The 
larvae of the eggs are exposed to the maximum tolerated dose of chemicals 
to be tested.   The time required for the adults to hatch from larvae is about 
9 or 10 days.  The adults are then examined within 16 hr of coming out 
from the puparium. The adult flies and independent body parts are 
morphologically examined and scored in terms of shape, colour, body 
alignment, and growth and missing parts.  At least 200 flies per dose level 
are scored.   
The Drosophila system has shown a great degree of similarity not only 
with in vivo animal studies but also with human epidemiological data; 
furthermore, the vast and detailed knowledge of Drosophila molecular 
biology could potentially be of use in the derivation of teratogenic 
mechanisms (Bournias-Vardiabasis et al., 1983).  Although this test is not 
very expensive and time consuming, results of this test rely on 
morphological scoring only, which could be biased and depends on 
expertise (Bournias-Vardiabasis & Teplitz, 1982; Bournais-Vardiabasis, 
1994).  
1.3.2.3. The Frog Embryo Teratogenesis Assay (FETAX) 
Amphibian embryos, for instance toads and frogs, have been utilized in 
developmental toxicity assays since the 1970s. A teratogenic screening 
assay (FETAX), using the South African clawed frog (Xenopus laevis), 
was developed by Dumont and colleagues (Dumont et al., 1982).  FETAX 
is a 96-hour whole embryo in vitro test which is based on the fact that the 
initial 96 hours of Xenopus development are equivalent to many of the 
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major developmental processes of human organogenesis.  ECVAM 
approved this test as the only non-avian (non-mammalian) vertebrate 
system which was worth pursuing for teratogenicity screening. The 
inherent metabolic deficiencies of the frog are overcome by addition of an 
external metabolic activation system.  This would further increase the 
specificity and accuracy of the FETAX system. The principal endpoints 
include mortality, malformations and growth inhibition. Using these 
endpoints to assess the teratogenic effects of up to 90 substances, FETAX 
proved to be more accurate, more specific, and more predictive in terms of 
results when compared to human teratology data than other animal 
teratology data.  Although this method has been used for screening 
hazardous chemicals rather than directly replacing animal teratogenecity 
studies, this method has advantages of being time and cost effective 
(Dawson et al., 1989).  Dawson and his colleagues tested water samples 
from abandoned lead and zinc mines with FETAX. It was concluded that it 
was a good test for screening environmental substances that cause birth 
defects (Dawson et al., 1989). FETAX has shown to be as reproducible and 
reliable an assay for screening of environmental toxins which cause birth 
defects, as many other bioassays (Bantle et al., 1994). Further more in the 
ICCVAM held in May 2000 the FETAX system was particularly discussed. 
The results of this meeting concluded that as a teratogenesis assay, FETAX 
is not sufficiently validated to be used for regulatory applications (FETAX 
Expert Panel Meeting Summary Minutes, 2000). 
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1.3.2.4. Whole Embryo Culture (WEC) 
Whole embryo culture is a teratogen screening assay, utilizing whole 
embryos (mouse, rat, and rabbit) for a short duration from fertilization to 
the end of period of organ formation (Sadler et al., 1982; Schmid, 1985; 
Ninomiya et al., 1993).  Usually the test involves the dissection of embryos 
at the head-fold or early somite stage away from maternal tissue.  The 
embryos are then cultured in an appropriate medium for 1 or 2 days.  This 
test is difficult and lengthy as compared to other validated tests (micromass 
and embryonic stem cells) due to the number of factors involved, which 
need to be considered (Genschow et al., 2002).  This test is advantageous 
due to the fact that it determines potential toxicity of chemicals in embryos 
without any maternal factors and test chemicals can be applied at different 
times during the culture period.  However there are some obstacles to 
undertaking this system; first, at least ten to twelve pregnant mothers are 
required for each time; second, it is also complex and needs technical 
expertise to get reproducible results; third, it is very costly. 
1.3.2.5. Embryonic Stem Cell Test (EST) 
In the Embryonic stem cell test (EST), the teratogenic potential of different 
chemicals is assessed in two permanent murine cell lines embryonic stem 
(ES) cells known as D3 cells represent embryonic tissue, and 3T3 
fibroblast cells represent adult tissue (Spielmann et al., 1997; Scholz et al., 
1998; Genschow et al., 2000).  D3 Embryonic stem cells can differentiate 
into a variety of cell types when cultured in vitro.  The embryonic stem 
cells are maintained in an undifferentiated stage in the presence of 
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leukaemia inhibiting factor (LIF), and in order to differentiate into 
cardiomyocytes these cells must be cultured without LIF. The cultured 
cells are then exposed to a series of different concentrations of the 
potentially embryotoxic substance.  The endpoints are assessed after 10 
days of culture: the inhibition of cell differentiation, the inhibition of cell 
growth.  The results of the values derived from endpoints, at which there is 
inhibition of 50% of differentiation and growth, are then used to classify 
substances as not embryotoxic, weakly embryotoxic, and strongly 
embryotoxic.  This test when applied to detect potential toxicity of 
substances in a validation study proved to be accurate, precise and 
predictable when compared to in vivo studies.  The EST seems to be 
promising, as a pre-screening method and also a useful replacement for 
animal-EDVHG WHFKQLTXHV DV LW KDV DFKLHYHG D µ5V¶ VXFFHVV E\ JUHDWO\
reducing the numbers of animals involved and bypassing a need for the use 
of pregnant animals to provide tissue for in vitro culture, and will still 
provide useful and applicable information for human teratology 
assessments (Spielmann et al., 1997).  
1.3.2.6. The Micro-mass test (MM) 
The Micromass system involves the culture of primary cells, isolated either 
from the mesencephalon, heart or the limb buds of developing embryos, 
plated at high density.  The most important mechanisms of development 
including cell±cell communication, cell proliferation, cell±matrix 
interactions and differentiation, are found in micromass cultures.  Due to 
these reasons, this system has been proposed and prevalidated as a 
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potential screening assay for teratogen detection (Spielmann et al., 2001).  
The basic principle of assay is the potential of teratogens to disrupt normal 
differentiation of primary embryonic cells in vitro. Formation of neuronal 
tissues, chondrocytes or contractile cardiomyocytes is the basis of the 
endpoints used along with cell viability measurements. Several species 
have been used for micromass cultures: rat (Flint & Orton, 1984; Parsons et 
al., 1990; Tsuchiya et al., 1991); mouse (Tsuchiya et al., 1991; Doyle & 
Kapron, 2002), and chick (Wiger et al., 1988; Meyer et al., 2001; 
L'Huillier et al., 2002; Hurst et al., 2007).  The MM rat limb bud test has 
been subjected to extensive validation studies. The outcome of the 
validation study conducting on rat limb bud cells (INVITTOX protocol 
114) demonstrated that results were reproducible and the embryotoxicity 
potential could easily be categorised into non-embryotoxic, weakly 
embryotoxic and strongly embryotoxic (Genschow et al., 2002).  
1.3.2.7. Chick micromass assay    
The chick MM assay utilizes primary cells obtained from midbrain, limbs 
or heart of chick embryos.  This assay is superior to mammalian assays 
because mammalian assays are time consuming, require animal housing 
and maintenance and mating to get the embryos at the required age.  Also 
for the mammalian micromass assay, mothers have to be sacrificed in order 
to remove the embryos and therefore this requires a Home office licence in 
UK.  On the other hand with chick embryos there is no need to sacrifice the 
mother.  Moreover the development of embryos can be postponed by 
storing eggs at 12oC.  In order to assess early developmental defects, and to 
38 
 
get the maximum tissue from each embryo, cells could be collected from 
three different systems, limb bud, mid brain and heart at embryonic day 5.  
The organs at day 5 have still the ability to differentiate and can be clearly 
identified (L'Huillier et al., 2002; Hurst et al., 2007).   Once the cells are 
cultured in high density they can then be exposed to the test chemicals in 
replicates and observed for cytotoxic effects by the use of relevant 
endpoints, i.e. differentiation, and cytotoxicity assays (Atterwill et al., 
1992). 
1.4.  Development of the Human heart 
The heart is the first organ in the human embryo to develop and function as 
a circulating system (Sakabe et al., 2005).  During the third week of 
development, the heart forming mesodermal cells become apparent 
(Moorman et al., 2003).  The heart begins to function at the start of 4th 
week (Moore & Persaud, 1998).  
1.4.1.  Origin of Heart forming cells 
The ovoid human embryonic plate is formed at the union of the yolk sac 
and amniotic cavity.  A streak called the primitive streak, with a node on its 
cranial end, is present in the midline on the dorsal aspect of embryo.  
Through this streak, cells migrate from the outermost layer by the process 
of gastrulation to form the three germ layers of the embryo proper (the 
ectoderm, the mesoderm, and the endoderm).  It is the mesodermal layer 
which gives rise to cardiac cells (Moorman et al., 2003), as shown in fig 
1.1.   
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Fig.1.1. Horseshoe-shaped cluster of angiogenic cells lying lateral and 
anterior to the brain plate 
(http://www.luc.edu/faculty/wwasser/dev/heart.htm). 
1.4.2. Establishment of cardiac fields 
Several studies have shown that the heart forms from two separate heart 
fields, which segregate from a common progenitor at gastrulation.  The 
earliest cardiac progenitors, called the primary heart field, originate in the 
anterior splanchnic mesoderm and give rise to the cardiac crescent that 
ultimately contributes to the left ventricle and atria. An additional source of 
cardiac precursors, the secondary or anterior heart field, is derived from 
pharyngeal mesoderm, located medial to the primary heart field.  Cells 
from the secondary heart field form the right ventricle and outflow tract of 
the heart (Garry & Olson, 2006).   
1.4.3. Formation of Heart tube 
The heart primordium first becomes evident at day 18 of development 
(Moore & Persaud, 1998).  On day 19, paired vascular elements called 
endocardial tubes begin to develop from splanchnic mesoderm in the 
cardiogenic region, which is located cranial and lateral to the neural plate.  
Later the lateral folding of the embryo brings these tubes into the midline, 
where they fuse to form a single heart tube (Larsen, 1997) as shown in fig 
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1.2.  At this stage the heart tube consists of a thin endothelial tube, 
surrounded by cardiac jelly which separates it from the primitive 
myocardium.   
The endothelial tube becomes the future endocardium, whereas primordial 
myocardium becomes myocardium and the epicardium is derived from 
mesothelial cells of the external surface of the sinus venosus.  Beating 
starts at the 22nd-23rd day and blood flows through it during the 4th week 
of development.  With craniocaudal folding of embryo, the heart tube 
moves to lie anterior to the foregut and caudal to the oropharyngeal 
membrane (Moore & 
Persaud, 1998). 
.   
 
 
 
 
Fig.1.2. Showing the two endocardial tubes fuse along the embryonic 
midline, and a single tubular heart, develops many constrictions outlining 
future structures. (http://www.luc.edu/faculty/wwasser/dev/heart.htm). 
1.4.4. Looping of heart tube 
With the addition of new cells to the cranial and caudal poles of the 
primitive heart tube from the secondary heart field and with the 
proliferation of myocardial cells, the heart tube begins to elongate. 
Concurrent to this change the dorsal myocardium, which initially joined the 
left ventricle to the dorsal mediastinum undergoes degeneration and 
liberates a large portion of the tube (Moorman et al., 2003; Dunwoodie, 
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2007).  Once released, the dorsal heart tube bends towards the right side to 
form a d shaped heart.  At this moment the presumptive heart segments 
begin to appear as truncus arteriosus, bulbus cordis, ventricle, atrium and 
sinus venosus (Moore & Persaud, 1998; Sakabe et al., 2005). 
Once the heart segments become specified as shown in fig 1.3, some of the 
endothelial cells in the region of the atrioventricular and outflow tract 
change their phenotype to mesenchymal cells and migrate into the adjacent 
cardiac jelly, where they form the endocardial cushion tissue, primordia of 
valves and septa of the adult heart.  Along with these events, another 
population of mesenchymal cells from the cardiac neural crest cells move 
towards the outflow tract via the pharyngeal arches, where they, along with 
endocardial derived mesenchyme, contribute to outflow tract septation, 
including formation of the conus septum, aorticopulmonary septum and 
semilunar valves (Sakabe et al., 2005).   
 
 
 
 
 
 
 
 
 
 
 
Fig.1.3. The heart tube will bend ventrally, caudally and slightly to the 
right and show various parts 
(http://www.luc.edu/faculty/wwasser/dev/heart.htm). 
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1.4.5. Formation and separation of the cardiac chambers. 
Chamber formation is first evident during looping of the heart tube, as they 
balloon out as discrete portions of the heart tube (Dunwoodie, 2007).   
Partitioning of the primitive atrium, ventricle and atrioventricular (AV) 
canal begins in the middle of the third week and is completed by end of the 
fifth week of development.   
Division of the primary AV canal is facilitated by fusion of the endocardial 
cushions which act as AV valves, while the atrium is divided in to two 
halves by means of two septa, the septum primum and septum secundum.  
Similarly the primordial ventricle is separated into two halves by the 
interventricular septum, which consists of a muscular part, which starts 
near the apex of the ventricle and later is completed by fusion of the 
enlarged medial walls of the ventricle, and a membranous part, which is 
derived from the right side of the endocardial tubes and merges with the 
muscular part.  Until the 7th week of development a crescent shaped defect 
is present between the IV septum and endocardial cushions, which is 
closed by fusion of the right bulbar ridge, left bulbar ridge and endocardial 
cushions. 
With further development of the heart, the sinus venosus which initially 
acts as a separate chamber and opens in to the right atrium, shows 
enormous changes.  Its left horn becomes smaller and forms the coronary 
sinus and its right horn undergoes enormous enlargement and receives all 
the blood from the superior and inferior vena- cavae and is incorporated in 
the wall of the right atrium as mentioned in fig 1.4 and 1.5.  
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The primordial pulmonary vein, which develops as an outgrowth from the 
dorsal wall of the left atrium, forms most of smooth wall, of the left atrium.  
With more development of the atria, the primordial pulmonary vein and its 
main branches are incorporated into the wall of the left atrium, which 
results in the formation of four pulmonary veins (Larsen, 1997; Moore & 
Persaud, 1998).   
 
 
 
 
 
 
 
1.4.6. Conduction system of the heart 
The cardiac conduction system (CCS) is responsible for the generation and 
timely transmission of electrical impulses, necessary for a coordinated 
1. Venous valves 
2. Septum primum 
3. Ostium secundum 
4. Septum secundum 
5. Pulmonary veins 
6. Endocardial cushions 
7. Interventricular foramen 
8. Muscular interventricular septum 
9. Foramen ovale 
Fig.1.4: 
http://embryo.chronolab.com/ 
1. Superior vena cava 
2. Pulmonary veins 
3. Left atrium 
4. Right atrium 
5. Septum primum 
6. Septum secundum 
7. Primitive left atrium 
8. Primitive right atrium 
9. Valve of inferior vena cava 
10. Valve of coronary sinus 
11. Sinus venarum 
Fig.1.5:http://embryo.chronolabc
om/ 
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contraction produced by the myocardium.  This system consists of several 
functional subunits and includes, the sinoatrial node (SA node), which is 
responsible for generating electrical impulses, the AV node, causing a 
delay in the propagation of generated impulses at the atrioventricular 
junction, and the bundle of His (Purkinje system), by which the impulses 
rapidly spread throughout the ventricles. 
When the primitive heart starts beating, all the myocytes have the ability to 
generate impulses which are of the same velocity and transmitted amongst 
them by means of gap junctions.  These impulses propagate through the 
entire heart in a very well organized way, started at posterior wall of right 
atrium and reaching to the outflow tract.   
As the development of the heart progresses, especially when looping 
begins, three main changes become apparent in cardiac electrical activity. 
1. The velocity of the generated impulse becomes significantly slowed at 
the atrioventricular junction. 
2. Any direct electrical coupling through myocyte-myocyte gap junctions is 
disassociated with the formation of the ventricular septum.   
3. During separation of the ventricles, an obvious shift in the direction of 
impulse is observed; the impulse which previously ran from apex to base 
now runs in an opposite direction. 
The above mentioned changes are necessary for effective pumping by the 
heart.  It is evident from several studies that CCS develops from 
myocardium and it has no neurogenic contributions (Gourdie et al., 2003).   
Several signalling and transcriptional factors have been implicated during 
the development of CCS.  Signalling factors include endothelins, 
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neuregulins, Notch and Wnt, while MSX, NKX, Hop, Tbx and GATA gene 
family have been detected as transcriptional factors important during the 
development of CCS (Mikawa & Hurtado, 2007).   
1.4.7.  Molecular cascades during development of heart. 
The fate of cardiac cells depends upon a number of positive and negative 
regulatory signals that are released either from surrounding tissues or from 
the heart forming region itself.  As the cardiac progenitors lie between the 
endoderm anteriorly and the epidermis posterior to it, signals from these 
regions, in conjunction with signals from the anterior lateral mesoderm 
itself, promote cardiac specification, while signals from axial tissues and 
the neural plate repress heart formation in the head region.   
The signalling systems implicated in mammals for cardiac induction 
include, Hedgehog, BMP, FGF, Wnt-JNK as positive influences, while 
inhibitory signals include Wnt ligands expressed in the dorsal neural tube, 
(Wnt-1, Wnt-3a) and anti-BMPs expressed in axial tissues as shown in fig 
1.6. 
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Figure1.6: Development of the components of the heart. (A)  The primary 
myocardium/nodal myocardium is in gray, and the chambers and ventricular 
conduction system are in red and blue, respectively. The mesenchyme at the 
connections between the heart and the body is shown in green. (B) Scheme 
showing the developmental relationships between components of the heart, many 
transcription factors are required to form and pattern the primary myocardium 
and, subsequently, to effect the localized formation of ventricles (cranioventral) 
and atria (dorsocaudal). A subpopulation of the primary myocardium retains its 
phenotype by the action of Tbx2/3/Nkx2-5. Cells of this pool may subsequently 
differentiate to chamber myocardium (*).  The nodal components of the 
conduction system are formed from the primary myocardium, whereas the 
working myocardial chambers and ventricular conduction system are formed from 
the early chamber myocardium. Marker genes expressed in each of the 
components are indicated. avb, atrioventricular bundle; avj, atrioventricular 
junction; avn, atrioventricular node; bb, bundle branches; pvcs, periventricular 
conduction system (Purkinje); san, sinoatrial node; s(i)cv, superior (inferior) caval 
vein (Christoffels et al., 2004), reproduced with permission). 
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The specification of cardiac chambers is expressed using transcriptional 
regulators like Hand1, Cited1, and Irx1/Irx3/Irx5, hormones like atrial 
naturetic factor, conduction proteins of the connexin family and the muscle 
specific cytoskeletal protein, Chisel.  These markers are expressed at the 
outer curvature of the heart tube.  Other factors in chamber specification 
include Tbx5, Tbx20, which promote specification of the chamber 
myocardium, while Tbx2 and Tbx3 act to inhibit these factors in order to 
maintain the non chamber character of the inner curvature of the heart as 
shown in fig 1.7.   
 
Fig.1.7: Model for the mechanism of transcriptional control of chamber and non-
chamber genes. Broadly expressed transcription factors Nkx2-5, Tbx5 and Gata4, 
cooperatively activate gene expression in the chambers. Locally expressed Tbx2 
and Tbx3 compete with Tbx5 for DNA binding, and for Nkx2-5. Complexes 
containing Tbx2/3 will repress gene expression, chamber myocardium will not 
form in these regions, and rather inflow tract, atrioventricular canal, and outflow 
tract will from. Figure from Architectural plan for the heart: early patterning and 
delineation of the chambers and the nodes.(Christoffels et al., 2004; Dunwoodie, 
2007) (reproduced with permission). 
Despite current advances in the detection of molecular factors responsible 
for the development of the heart, a comprehensive understanding of the 
complex molecular interactions is still lacking (Dunwoodie, 2007). 
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1.5. Comparison between human and chick heart 
development 
 
http://www.meddean.luc.edu/lumen/MedEd/GrossAnatomy/thorax0/heartdev/main_fra.html 
The heart 
development 
in humans 
The heart 
development 
in Chicks 
 
Developmental events 
Days Hours/Days  
16/17 12-22 hrs Angiogenic cells align themselves in 
cardiogenic plate 
18-20 23-25 hrs Endocardial tubes are formed and start to 
move towards each other. 
21-22 26-32 hrs Both endocardial tubes fuse with each other 
and move towards thoracic region due to 
folding of embryo (both lateral and cephalic). 
22 33-44 hrs Endocardial tubes completely fuse with each 
other and form a single heart tube.  The Heart 
begins to beat and splanchnic mesoderm 
invests the newly formed heart tube to form 
pericardial sac. 
23 45-46 hrs The heart tube grows rapidly and forcing it to 
fold upon itself 
24 47-48 hrs The shifting of centrally located sinoatrial 
node is obvious. 
25-28 49-56 hrs There is formation of bulboventricular loop.  
The septum primum appears to begin. 
28 52-69 hrs The ventricular septum appears at the floor of 
common ventricles.  The endocardial cushions 
begin to form.  Single pulmonary begins to 
arise from dorsal wall of left ventricle. 
29 70-71 hrs Appearance of truncal swellings is obvious. 
30/31 Day 3-3.5 Perforations appear in septum primum 
32/33 Day 4 The ostium secundum begins to appear near 
the edge of septum primum.  The 
bulboventricular flange begins to shrink. 
35 Day 4 The sinoatrial junction has shifted completely 
towards right side. 
37 Day 4 The free edge of septum secundum forms 
foraman ovale. 
42 Day 5-6 Both superior and inferior endocardial 
cushions fuse completely. 
46 Day 7 The coronary sinus is formed and ventricular 
septum stops to grow further. 
End of 7th Day 8 The interventricular canal is completely 
closed. 
8th week Day 8 The outflow tracts are completely separated 
from each other. 
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(Martinsen, 2005). 
1.6. Environmental teratogens 
1.6.1. Alcohol (Ethanol) 
Ethanol, or alcohol, one of the major environmental toxins, when 
consumed in excess during pregnancy creates wide range of fetal 
dysmorphogenesis (Riley & McGee, 2005).  The fetal alcohol syndrome 
(FAS) is the most familiar form of ethanol teratogenesis and is 
characterized by growth retardation, central nervous system disorders 
particularly mental retardation, and a distinguishing pattern of 
cardiovascular, facial and limb defects.   Data from animal studies show 
features of fetal alcohol syndrome in embryos when treated with high doses 
of ethanol.  There are many possible mechanisms involved in the 
pathogenesis of ethanol toxicity and these include increased oxidative 
stress, mitochondrial damage, interference with growth factor activity, 
effects on cell adhesion, lack of blood supply, oxidative damage and 
nutritional imbalance.  But still the exact molecular pathways which cause 
the FAS are yet to be discovered (Cudd, 2005; Sulik, 2005).  
1.6.2. Nicotine 
Smoking during the early stages of pregnancy, results in abnormal 
development of many vital systems including the central nervous system, 
respiratory system and cardiovascular system (Bauman et al., 1991).  
Vulnerability has been correlated to cardiovascular defects, neural tube 
defects, orofacial clefts, limb defects and kidney malformations (Bertolini 
et al., 1982; DiFranza & Lew, 1995).  The majority of data show the 
50 
 
relation between combustion products in smoke and congenital defects.  
However there are many other substances mainly nicotine, present in 
cigarettes which proved to cause congenital defects in animal studies.  
Nicotine exerts its effects by acting on acetylcholine receptors, which are 
present in even very early brains and might contribute to developmental 
defects.  Also nicotine causes an altered cell function and cell death due to 
generation of many reactive oxygen species with resultant oxidative stress 
(Atluri et al., 2001).  
1.6.3. Cadmium chloride 
Heavy metals, like cadmium, have no biological role and are rather toxic 
even at very low concentrations (Foulkes, 2000).  These metals once they 
enter into cells, cause damage to cellular activities with resultant injury or 
death (Sunda & Huntsman, 1998).  The occurrence of this toxic metal in 
the environment has been increased in recent years due to its large benefits 
in some industrial and agricultural activities (Rule  et al., 2006).  Cadmium 
has well known toxic effects to living creatures: e.g. it shown to have 
teratogenic effects in Xenopus embryos (Mouchet et al., 2006; Mouchet et 
al., 2007) and has also proved to be carcinogenic in hamsters (Waalkes & 
Rehm, 1998).  It exerts its toxic effects by different cellular and molecular 
mechanisms.  Studies on animals suggest that cadmium-induced damage is 
associated with blockage of oxidative phosphorylation, glutathione 
depletion and antioxidant enzymatic activity inhibition, production of ROS, 
DNA damage, and inhibition of relative repair mechanisms, a general 
reduction of protein synthesis coupled to an increase in stress proteins 
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(Ercal et al., 2001; Schröder et al., 2005; Lin  et al., 2007).  Also cadmium 
exposure results in apoptotic events in several cell types (Risso-de 
Faverney et al., 2001; Kim et al., 2002; Agnello et al., 2007).  
 
1.6.4. Sodium fluoride 
Fluoride has been used for the treatment of dental caries for many centuries 
(Sognnaes, 1979).   Water fluoridation is a common practice in many 
countries and nearly 200 million people drink water which is fluoridated 
with hydrofluorosilicic acid, sodium silicofluoride, or sodium fluoride.  
Also an additional 100 million people reside in areas of high natural 
fluoride in water (Sognnaes, 1979).  Apart from used in fluoridation of 
water, sodium fluoride is also utilized in many pesticides, in glass and 
vitreous enamel processing, in frosting glass, as a wood preservative, as a 
steel degassing agent, and in electroplating (Heindel et al., 1996).  The data 
regarding its potential toxic effects in developing embryo are scarce.  Some 
animal studies show its toxic effects on sperms when fluoride is 
administered intraperitoneally to male Swiss mice (Pati & Bhunya, 1987).  
 1.6.5. Ginseng 
Ginseng is one of the most popular herbal remedies taken by many women 
in the western world as a treatment of various diseases, and for daily 
nourishment and health building.  It has been shown to act as an anti-
diabetic, anti-hypertensive, anti stress, antioxidant and anti-tumour agent 
(Jeon et al., 2000; Kaneko & Nakanishi, 2004).  Also it is used for 
increasing memory and as a mood stabilizer (Scholey & Kennedy, 2002; 
Seely et al., 2008).  The active components of ginseng are ginsenosides.  
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Ginsenosides comprise two major groupV¶ SDQD[DGLRO DQG SDQD[DWULRO
Ginsenoside Rb1 (GRb1) is representative of panaxadiol (Attele et al., 
1999).  Rb1 was shown to have teratogenic effects on rat embryos (Chan et 
al., 2003).  Congenital defects were also observed in the mouse when 
embryos were exposed to ginsenoside 1(Rb1) (Liu et al., 2005).   
1.7. Maternal diseases particularly Diabetes Mellitus 
Mothers with Diabetes Mellitus have a high incidence of pregnancy 
complications and fetuses with developmental disorders of the cardio-
vascular system, brain, skeleton and other anomalies compared to non-
diabetic women (Eriksson & Borg, 1993). The rate of maternal and fetal 
complications is inversely proportional to the degree of diabetic control 
(Eriksson et al., 2003). The precise mechanism behind the high rate of 
congenital defects in diabetic pregnancies is presently unknown.  It has 
been proposed that both maternal factors such as hyperglycemia, 
hyperketonemia, disturbed prostaglandin metabolism, as well as the 
embryonic genetic background may be involved. One of the possible 
mechanisms involved is higher generation of ROS (Ornoy, 2007).  Glucose 
at higher concentrations results in non-enzymatic protein glycosylation, 
increased mitochondrial electron transport chain flow, glucose auto-
oxidation and changes in the redox potential.  Also degradation of high 
glucose levels leads to high production of ketone bodies and a further 
increase in the production of ROS.  The resultant oxidative stress in the 
embryonic environment causes massive cell damage, an increase in 
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apoptotic events and defective embryonic development (Zangen et al., 
2002). 
1.8. Vitamins  
1.8.1. Folic acid 
Folic acid is a water soluble vitamin, and it is recommended by many 
countries for all women of child bearing age to take at least 400µg of folic 
acid per day to prevent neural tube defects in their offspring (Botto et al., 
2003).  It is now well established that folic acid when consumed in the 
periconceptional period protects against neural tube defects.  Apart from 
protecting against neural tube defects folic acid has also been shown to 
prevent many birth defects including those of the heart (Shaw et al., 1995; 
Botto et al., 1996) and genito-urinary system (Czeizel et al., 1998), as well 
as cleft lip and palate, and limb reduction defects (Werler et al., 1999).  The 
role of folic acid in avoiding other unfavourable reproductive outcomes 
e.g. early abortions, still births and premature delivery is also obvious in 
many studies.  The other beneficial effects of folic acid in the general 
population include protection against cereberovascular and cardiovascular 
diseases (Lucock, 2000). 
1.8.2. Vitamin C & E 
Vitamin C (ascorbic acid) is a water soluble molecule with the ability to 
scavenge several free radicals.   It is an important micronutrient required 
for normal metabolic functioning of the body (Jaffe, 1984).  It is not 
synthesized in humans and other animals due to the deficiency an enzyme 
required for its biosynthesis (Woodall & Ames, 1997).  Therefore it must 
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be consumed in the diet. The foods which are rich sources of vitamin C 
include fresh fruits, particularly citrus fruits, and vegetables (Levine, 
1986).  Deficiency of vitamin C in the diet causes a disease called scurvy.  
Scurvy is characterized by weakening of collagenous structures, causing 
tooth loss, joint pains, bone and connective tissue disorders, and poor 
wound healing.  Apart from these symptoms scurvy is also characterized 
by mood swings and depression due to the fact that vitamin C also 
functions as a cofactor for catecholamine biosynthesis, in particular the 
conversion of dopamine to norepinephrine, catalyzed by dopamine b-
monooxygenase.  Vitamin C is also implicated in various other metabolic 
activities of the body (Weber et al., 1996).   
9LWDPLQ (¶ LV D FRPPRQ WHUP XVHG IRU DOO FRPSRXQGV WKDW VKRZ WKH
biological activity of Į-tocopherol (Bramley et al., 2000).  The RRR-Į-
tocopherol is the most active form of vitamin E (formerly D-Į-tocopherol), 
which accounts for approximately 90% of the vitamin E found in animal 
tissues (Bjorneboe et al., 1990; Debier & Larondelle, 2005).  The eight 
naturally occurring vitamin E compounds are Į-, ȕ-, Ȗ- and į-tocopherols 
and Į-, ȕ-, Ȗ- and į-tocotrienols,  Vitamin E compounds are water insoluble 
and are soluble in alcohol and other organic solvents (diethyl ether, acetone 
and chloroform) as well as in oils.  Rich sources of vitamin E are 
polyunsaturated vegetable oils, cereal seeds, fish, nuts, eggs, liver, dairy 
products and green vegetables (Bramley et al., 2000). 
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1.8.3. Retinoic acid 
Vitamin A comprises all compounds that demonstrate the same biological 
activities.  These compounds include retinol, retinal, and retinoic acid.  
Vitamin A and its analogues are essential dietary elements required for 
many biological functions including growth, reproduction, vision and 
cellular differentiation etc.  Both deficiency and excess of this vitamin 
result in many pathological conditions in the body.  Many animal studies 
proved it to be essential in reproduction and embryonic development but on 
the other hand its excess dose can be teratogenic.  Pregnant women can be 
exposed to high doses of retinoic acid in several different ways: excess 
intake of those foods which contain high amount of retinoids (e.g. carrots, 
liver, eggs, green leafy vegetables, milk etc.); use of retinoids to treat 
reluctant acne or other skin disorders as well as different kinds of cancers; 
excessive use as nutrient supplement (Soprano & Soprano, 1995).    
1.9. Connexins 
Connexins are highly regulated integral membrane proteins that form 
vertebrate gap junctions. Connexins regulate coordinated contraction of 
excitable cells, tissue homoeostasis and controlled cell growth and 
differentiation and are also thought to regulate embryonic development.  
Disruptions in their expression have been related to numerous diseases 
(Gong et al., 1997; Paznekas et al., 2003), including oculodentodigital 
dysplasia, atrial septal defects and arrhythmias.  Many connexins (i.e. 
Cx31, Cx32, Cx36, Cx37, Cx40, Cx43, Cx45, Cx46, Cx50 and Cx56) have 
been recognized.  Cx43 is the most extensively expressed connexin, being 
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present in at least 34 tissues and 46 cell types (Laird, 2006), and is the 
predominant connexin expressed in most cell lines.  The connexins assist in 
direct contact between adjacent cells by allowing passage of ions and small 
metabolites (Gong et al., 1997; White & Paul, 1999; Saez et al., 2003; Sohl 
& Willecke, 2004).  Because connexins also regulate embryonic 
development and help control cell growth and differentiation, disruption or 
mutations of the connexin gene has effects on development. Extensive 
evidence also indicates that gap junctions play important roles in the 
control of cell growth and inhibit tumour formation (Cronier et al., 2009).  
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1.10. Aims and objectives 
The main aims and objectives of the current study are 
¾ To evaluate chick heart micromass culture for use in teratogenicity 
assays. 
¾ To develop and assess in ovo culture to be used in detection of 
potential developmental toxicity of various environmental agents. 
¾ To determine the efficacy of chick heart micromass in predicting 
potential toxicity of different chemicals.  
¾ To detect possible preventive effects of multi-vitamins on ethanol 
and nicotine (social drugs) induced toxicity in micromass and in 
ovo cultures. 
¾ To assess possible teratogenic effects of diabetic conditions and 
their possible prevention by use of multivitamins utilizing both in 
vitro (micromass) and in ovo cultures. 
¾ To evaluate the effects of different teratogens on connexion 43 and 
endothelin 1 expression. 
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Chapter 2 
Materials and methods 
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2.1. Materials and Methods for micromass culture 
2.1.1 Materials 
2.1.1.1. Eggs 
White Leghorn Fertile chicken eggs Henry Stewart & Co. UK 
2.1.1.2. Tissues and cell culture reagents 
Bovine serum albumin Sigma-Aldrich, UK 
Carbon dioxide British Oxygen Company 
Dimethylsulphoxide (DMSO) Sigma-Aldrich, UK  
Dulbecos modified Eagles medium (1x) Cambrex Biosciences,UK 
Glacial acetic acid BDH, UK 
Horse serum Life technologies, UK 
Hanks Balanced salt solution Sigma-Aldrich, UK 
Heat inactivated fetal bovine serum Autogen Bioclear, UK 
Kenacid blue Sigma-Aldrich, UK 
ES®7X liquid detergent SLS, UK 
L-glutamineCambrex  Biosciences, UK 
Neutral red Sigma-Aldrich, UK 
Paraformaldehyde Sigma-Aldrich, UK 
Penicillin/streptomycin Sigma-Aldrich, UK 
Potassium acetate Fisher scientific, UK 
Resazurin Sigma-Aldrich, UK 
Resorufin (95% dye colour) Sigma-Aldrich, UK 
Trigene Medichem International, UK 
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Trypsin (0.05%) /EDTA (0.02%)     Life technologies, UK 
2.1.1.3. Plastic and Glass ware 
Bijoux bottles(7ml) Bibby Sterilin Ltd, UK 
Cell star tubes (50ml) Greiner Lab technik, 
France 
Chamber slides (8 well) SLS, UK 
Cover slips SLS, UK 
Disposable serological pipettes Corning Incorpated, UK 
Eppendorf tubes (0.5 & 1.5ml) Sterilin, UK 
Pipette tips Starstedt, Germany 
100mm round petridishes Sterilin, UK 
Transfer pipette (3.5ml) Sterilin, UK 
Transfer pipette (3.5ml) Sterilin, UK 
Universal bottles (30ml) Bibby Sterilin Ltd, UK 
Universal tubes, 25ml and 50ml Sterilin, UK 
24 well plates Nunclon, UK 
96 well plates Nunclon, UK 
2.1.1.4. Consumables 
Aero disc filter (0.2µM) Sartorius, Germany 
Autoclave bags NHS supplies 
Pipettes (0.5-1000Pl) SLS, UK 
Pipette tips (200µl and 1000µl) Starstedt, UK 
Reservoir liners (8 channel) Corning Incorpated, UK 
Scalpels SLS, UK 
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Universal graduated glass bottles SLS, UK 
Vinyl gloves Labsales Co.,UK 
Yellow biohazard bags NHS supplies 
2.1.1.5. Equipment used 
ASYS HITEC Expert 96 SLS, UK 
Assorted dissection instruments A. Durmount, Switzerland 
Autoclave Denley, UK 
Automatic egg turner MFG, USA 
Balance D 40T Stanton, UK 
Calibrated pipettes Gilson, France 
Centrifuge (centaur2) Fisons, UK 
Class 1 sterile laminar flow cabinet Glossop, UK 
Class 2 sterile laminar flow cabinet Rossandale, UK 
CO2 incubator Fisons, UK 
Cooled egg incubator Gallenkamp, UK 
FLUOROSTAR Galaxy BMJ Cambridge, UK 
Freezer New Brunswick, UK 
Grant Water bath Cambridge, UK 
Haemocytometer Hawksley, UK 
Ice machine Ziegra, UK 
Incubator LEEC, UK 
Laminar flow hood (Gelaire) ICN, UK 
Inverted Phase Microscope Nikon, Japan 
Light Microscope Vickers, UK 
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Plate shaker Luckham Ltd, UK 
Stirrer hot plate Gallenkamp, UK 
Warming block Camlab, UK 
Water purifier Egga, UK 
2.1.1.6. Software used 
Prism statistical software, version 5.0 Graph pad, USA 
2.1.1.7. Test Chemicals  
All-trans-Retinoic acid Sigma-Aldrich, UK 
Folic acid Sigma-Aldrich, UK 
Ethanol BDH, UK  
Vitamin C Sigma-Aldrich, UK  
Glucose Sigma-Aldrich, UK  
B hydroxybutyric acid Sigma-Aldrich, UK  
Nicotine Sigma-Aldrich, UK  
Sodium fluoride Sigma-Aldrich, UK  
Cadmium chloride Sigma-Aldrich, UK 
Superoxide dismutase Sigma-Aldrich, UK 
2.1.2. Preparation of culture Medium 
2.1.2.1. 'XOEHFR¶V0RGLILHG(DJOH¶V0HGLXP (DMEM) culture medium 
for chick heart cells 
'XOEHFR¶V 0RGLILHG (DJOH¶V 0HGLXP ZDV VXSSOHPHQWHG ZLWK  IHWDO
calf serum (heat inactivated), 2mM L-glutamine and 50U/ml penicillin 
with 50µgml-1 streptomycin.  Once prepared Medium was stored at 4oC 
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until use, and was warmed to 37oC prior to use.  The prepared medium was 
used within 2 weeks. 
2.1.2.2. Culture media quality control 
In bijoux bottles, 5 ml of prepared culture medium (section 2.1.2.1) was 
incubated in for 2-3 days at 37°c, 5% (v/v) CO2 in air and inspected 
microscopically for micro-organism contamination. If contamination was 
present, the medium was discarded. 
2.1.3. Preparation of stock solutions 
2.1.3.1. Resazurin solution 
 Resazurin 5mg 
 HBSS 50ml 
Resazurin stock (5ml, 1mg/ml in HBSS) was filter sterilized in to a 50ml 
universal container.  HBSS (45ml) with calcium and magnesium was added 
to create a working dilution of 100µg/ml.  This was subsequently diluted 
1:10 in HBSS and the tube wrapped in aluminium foil to avoid photo 
reduction.  Resazurin solution (10mg/ml) was stored at 4oC and used 
within 2 weeks.  Resazurin solution was warmed to 37oC prior to exposure 
to cells. 
2.1.3.2. Kenacid blue protein detection 
2.1.3.2.1. Kenacid blue fixative 
Fixative was prepared by adding 10ml glacial acetic acid to 500ml ethanol 
and 490ml distilled water.  It was stored at room temperature until 
required. 
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2.1.3.2.2. Kenacid blue stock solution 
Stock solution was prepared by dissolving 0.4g kenacid blue to 250ml 
ethanol and 630ml distilled water.  The solution was stored at room 
temperature. 
2.1.3.2.3. Kenacid blue working solution 
Working solution was formed by adding 6ml acetic acid to 44ml stock 
solution.  It was formed immediately prior to use. 
2.1.3.2.4. Kenacid blue washing solution 
Washing solution was formed by adding 50ml glacial acetic acid to 100ml 
ethanol and 850ml distilled water, and was stored at room temperature.  
2.1.3.2.5. Kenacid blue desorb solution 
Desorb solution was formed by dissolving 98.15g potassium acetate in 
700ml ethanol and 300ml distilled water.  The solution was stored at room 
temperature. 
2.1.4. Methods 
2.1.4.1 Sterilization  
2.1.4.1.1. Sterilization of solutions by Autoclaving 
Sterilization by autoclaving was carried out in an autoclave at 15lb/sq inch 
for 20 minutes at 120°C.   
All purchased media were supplied sterile.  The culture media were 
prepared using sterile stock solutions.  All non heat-labile stock solutions 
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were sterilised by autoclaving, while heat labile solutions were filter 
sterilized using irradiated cellulose acetate membrane filters. 
2.1.4.1.2. Sterilization of glassware by Autoclaving 
All glass bottles and beakers were first washed in ES®7X liquid detergent 
and then rinsed in distilled water to remove the detergent, air dried and 
sterilised by autoclaving. 
2.1.4.1.3. Sterilisation by Oven 
Oven sterilization was performed by placing all pasteur pipettes in a metal 
canister, which was then secured with autoclave tape and sterilised at 
180°C overnight. Alternatively disposable sterile plastic pipettes were 
employed.  
2.1.4.1.4. Sterilization of dissecting instruments 
Dissecting instruments were soaked overnight in trigene (2% v/v with 
water) after use. The instruments were then washed in tap water and with 
alcohol and dried before use. 
2.1.4.2. Microscopy 
2.1.4.2.1. Light Microscopy 
All microscopic observations were carried out using an inverted 
microscope using x 40, x10 and/or x4 objective lenses with x10 eye piece. 
2.1.4.2.2. Confocal Microscopy 
Fluorescein isothiocyanate (FITC), Tetramethylrhodamine isothiocyanate 
(TRITC), and Alexa 488 were detected using a Leica confocal microscope 
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with excitation filter of 485nm, and an emission of 530nm for FITC or 
545nm excitation filter and emission of 590nm for TRITC staining.   
 
2.1.4.3. Preparation of test chemicals 
All chemicals were made up at twice the concentration required as 500µl of 
test solution was added to the 500µl culture medium already present in the 
24 well plates, which gave the required concentration.  All the test 
chemicals were made up the day to be used and applied to the MM cultures 
24 hours after they were seeded from their stock solutions as shown in 
table 2.1.  
Table 2.1. Solvents and stock solutions of chemicals  
Chemicals Solvent Stock Concentrations 
All-trans retinoic acid Ethanol (100%) 50mM 
Ascorbic acid Medium 50mM 
ǺK\GUR[\EXW\ULFDFLG Medium 50mM 
Cadmium chloride Medium 50mM 
Folic acid Medium 50mM 
Ethanol Medium Immediately prepared 
before use 
Ginsenoside (Rb1) Medium 50mM 
Glucose Medium 50mM 
Nicotine DMSO 5mM 
Sodium fluoride Medium 50mM 
Trolox Medium 50mM 
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2.1.4.4. Calculation of cell number 
A haemocytometer was used to count cell number under light microscope.  
Cells that crossed or touched at the right side and bottom of the square 
were excluded from the count.  The volume of cell suspension needed to 
give the required seeding cell density was then calculated by following 
equation 
     V1=  (C2) (V2) 
        (C1) 
 V1 denotes total ml of cell stock required, C1 denotes total number of cells 
in stock, V2 denotes final volume of cell suspension needed and C2 is the 
final number of cells. 
2.1.4.5. Micromass cell culture 
2.1.4.5.1. Embryo culture 
Fertile White Leghorn chicken eggs were labelled with the date of delivery 
and stored in a cooled incubator at 12-14oC until required, and used within 
two weeks of being laid.  The eggs were placed onto the automated egg 
turner and incubated at 38oC with relative humidity of 100% for 5 days, 
day zero being defined as the day when the eggs were set in the incubator.  
A minimum of 24 eggs were incubated for each micromass system to 
ensure the availability of enough viable embryos.  All the embryos were 
killed by decapitation after being removed from incubator.   
2.1.4.5.2. Micromass culture  
On the day of dissection, the dissecting tissue culture laminar flow hood 
was swabbed down with 2% trigeneTM, followed by 70% alcohol 
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immediately prior to use.  All the dissection tools (curved and straight no 
toothed forceps) were cleaned with 70% ethanol before being placed in to 
the sterile culture hood in order to avoid contamination.  Sterile gloves 
were worn throughout the procedure.   
Eggs were removed from the incubator, six at a time and transferred to the 
culture hood.  Using the blunt end of the curved forceps the broader end of 
the eggs (near air sac region) was struck until the broken shell could be 
gently removed and discarded.  The shell and all the membranes including 
vitelline membranes were removed with the help of sterile forceps to 
expose the embryo.  The embryo was lifted from the egg with curved 
forceps and placed into a petri dish containing Hank¶s balanced salt 
solution (HBSS).  After removing the allantois and remaining amnion, 
under the dissecting microscope, the heart was taken out from the embryo 
and transferred using sterile forceps to a sterile universal tube containing 
horse serum (50% v/v in HBSS) and stored on ice.  Once all the hearts had 
been collected, the solution of horse serum (50% v/v in HBSS) was 
removed and tissues were washed twice with HBSS.  Heart tissue was 
incubated in 4ml of trypsin/EDTA (for 24 eggs) at 37oC in 5 % (v/v) CO2 
in air for 20 minutes, agitating every 5 minutes for further disassociation of 
tissue.  The solution was triturated numerous times in order to break the 
tissues as much as possible.  To inhibit further actions of trypsin 6ml of 
DMEM culture medium was added.  Samples were centrifuged at 1500rpm 
for 5 minutes, the supernatant was removed and the pellet resuspended in 
1ml of pre warmed DMEM culture medium.  Cell density was established 
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using a haemocytometer and the cell suspension diluted to 3x106 cells ml-1.  
A 20µl aliquot of the cell suspension was pipetted on to the centre of the 
well within a 24 well plate for about two and half hours, to allow them to 
attach, before being flooded with 500µl of prewarmed culture medium 
(DMEM), and returned to the incubator for 24 hours to recover. 
 
 
 
 
 
 
          
Figure 2.1. Light microscopy of micromass. Original magnification x200 
2.1.4.5.3. Scoring method for cardiomyocyte activity 
A numerical morphological scoring system was constructed to determine 
the amount of contractile activity observed for heart micromass (MM).  
Cardiac foci that were observed to be contracting throughout entire plate 
were scored a total of 3, whereas no contractile activity was scored as zero.  
Table 2.2 illustrates the scoring criteria for determination of contractile 
activity of cardiomyocytes. 
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Table 2.2. Morphological scoring system to determine contractile 
activity of cardiomyocytes 
              
2.1.4.5.4. Chemical dose testing 
The micromass cells were prepared as in section (2.1.4.5.2) and cultured 
for 24 hours. The media were aspirated before performing a resazurin 
assay.  The cells were cultured within a 24 well plate in media containing 
the varying concentrations of different chemicals.  MM cultures were 
observed at 24 hours intervals up to 144 hours post exposure.  The 
arrangement of a typical 24 well plate in respect to the chemical 
concentrations can be seen in fig 2.2.  
 
 
 
 
Numerical morphological score Contractile activity 
0 No contractile activity 
1 Few contracting foci 
2 Numerous contracting foci 
3 Entire plate contracting 
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Figure 2.2. The arrangement of a 24 well plate for micromass culture. B 
indicates for blank, C for control and other wells for chemicals used, 
with increasing concentrations from left to right.  
2.1.5. Cell viability and cytotoxicity assays 
2.1.5.1. Resazurin conversion assay 
The resazurin assay was performed on day 6 following explantation.  The 
resazurin stock (100µg/ml) solution was diluted 1:10 in sterile HBSS and 
warmed to 37oC in a water bath prior to use.  The medium was removed 
from the 24 well plates and replaced with 500µl resazurin solution.  The 
plates were then incubated for one hour at 37oC and 5% (v/v) CO2 in air.  
The optical density was read using a FLUOR star plate reader, excitation 
wavelength of -530±12.5nm, with a gain of 10. The data was expressed as 
the increase in optical density above the non-cell blank as a percentage of 
the untreated cultures.  Analyses of data, for statistically significant 
differences, were performed on the raw data.  If repeat assays were 
performed, once the plate had been read in the spectrofluorimeter, the 
B 
B 
B 
B 
C 
C 
C 
C 
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resazurin solution was removed and the cells were fixed with 300µl of 
kenacid blue fixative.  The plates were then kept in refrigerator until the 
kenacid blue assay was performed.   
2.1.5.1.1. Resazurin standard curve 
Interpretation of resazurin results was made possible by the creation of a 
standard curve.  The optical density could be converted into resorufin 
production by plotting the resorufin standard curve.  Resorufin solutions of 
different concentrations 4000ng/ml, 2000ng/ml, 1000ng/ml, 500ng/ml, 
250ng/ml and blank consisting of just HBSS solution were prepared.  
Aliquots of 500µl of each concentration were transferred in to a 24 well 
plate.  The plate was then read in the cytofluorimeter with excitation 
wavelength of -530±10nm, and emission of 590±12.5nm, with a gain of 10.  
Results were plotted on a scatter graph and a line of best fit added in order 
to form an equation to allow interpretation of raw data of the assay from 
plate reader (Fig. 2.3).   
 
  
 
 
 
            Fig. 2.3. Resazurin reduction assay standard curves (±S.D. n=3). 
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2.1.5.2. Kenacid blue total protein assay 
Wells were aspirated and 300µl kenacid blue fixative was added and 
allowed to evaporate overnight at 4oC.  Kenacid blue working solution 
(400µl) (Knox et al, 1986) was added to each well and the plate placed on a 
plate shaker for at least 2 hours.  Excess stain was removed and cells were 
quickly rinsed in 400µl of washing solution before being washed for 20 
minutes with agitation.  The washing solution was replaced with 400µl of 
desorb and gently agitated on the plate shaker for one hour.  The optical 
density was read on an ASYS HITEC Expert 96 plate reader with a 
reference filter of 405nm, and a reading filter of 570nm.  The amount of 
protein per well was calculated from standard curves.   
2.1.5.2.1. Protein standard curve 
For plotting a standard curve bovine serum albumin was used.  2.4 mg 
BSA was dissolved in 3 ml of distilled water.  7 ml of 100% ethanol was 
added to produce a concentration of 2.4mg/10ml 70% ethanol or 0.24 mg 
BSA/ml 70% ethanol.  3 ml was added to 6 ml of 70% ethanol, to give a 
concentration of 80µg/ml BSA, the highest concentration.  From this 
maximum concentration (80µg), all other concentrations (40µg/ml, 
20µg/ml, and 10µg/ml) were serially diluted and prepared. The 70% 
ethanol was allowed to evaporate overnight enabling the BSA to adhere to 
the bottom of each well.  Plates were then fixed with kenacid blue fixative 
and left overnight at 4oC.  The Kenacid blue assay was performed as 
described above.  Results were plotted on a scatter graph with the equation 
of the best fit line used (Fig. 2.4).  The optical density could then be 
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converted in to the amount of protein present in each test well using the 
protein standard curves and following formula 
 
Protein content (µg)=Optical density(OD)/0.016 
Figure. 2.4. Standard curve for kenacid blue assay. 
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2.2. Materials and Methods for in ovo chick  
2.2.1 Materials 
2.2.1.1. Eggs 
White Leghorn chicken Eggs Henry Stewart & Co. UK.  
2.2.1.2. Tissues and cell culture reagents 
Ethanol BDH, UK 
Formaldehyde Sigma-Aldrich, UK 
HBSS Sigma-Aldrich, UK 
Neutral red dye Sigma-Aldrich, UK 
Phosphate buffered saline tablets Oxoid, UK 
2.2.1.3. Plastic and Glass ware 
Adhesive tap ComplyTM , UK  
Disposable syringe B.D. Republic of Ireland  
Disposable needles (25guage) B.D. Republic of Ireland 
Para film Pechiney plastic, UK  100mm 
rounded petri dish Sterilin, UK    
Universal containers (50ml)  Sterilin, UK 
2.2.1.4. Sectioning and H&E staining 
Eosin 1% aqueous Raymond A lamb limited, UK 
Haemotoxylin Raymond A lamb limited, UK 
Histology moulds Fisher scientific, UK 
/DPE¶s cassettes (Blue) Raymond A Lamb-limited UK 
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Lambs cassette lids Raymond A Lamb-limited UK 
Leica automatic tissue processor (TP1020) Leica, Germany 
Microtome Sleemainz, UK 
Paraffin section mounting bath Electrothermal,UK 
Wax dispensor Leica, Germany 
Whatman filter paper Whatman international , UK 
0DVVRQ¶VWULFKURPHVWDLQLQJ 
Ethanol BDH, UK 
0.2% light green in 0.2% acetic acid Raymond A lamb limited, UK 
Mayers Haematoxylin Raymond A lamb limited, UK 
Ponceau Acid Fuschin Raymond A lamb limited, UK 
1% Phosphomolybdic acid Raymond A lamb limited, UK 
2.2.2. Preparation of solutions 
2.2.2.1. Preparation of 10% formalin solution 
10% formalin solution was made by adding 10 ml of formalin to 90ml 
distilled water.  This solution was prepared inside the fume cupboard as 
formaldehyde is highly toxic and carcinogenic.   
2.2.2.2. Preparation of PBS 
PBS was prepared by adding 5 tablets PBS to 500ml distilled water . 
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2.2.3. Methods 
2.2.3.1. Chick embryos and treatment groups 
White leghorn fertilized chicken eggs were obtained from Henry Stewart 
and Co. Ltd. Eggs were labelled with the date, received and kept in a 
cooled incubator until use. Ideally eggs should be used within 15 days of 
being laid.  Eggs were randomly selected and divided in to 4 groups 
immediately before incubation. The first group was incubated as the non-
treated group (n = 12). The rest were labelled according to different 
treatment modes. The day on which the eggs were incubated was counted 
as day zero. On day 3 of incubation the eggs were taken out of the 
incubator 3 at a time, after being swabbed down with 70% ethanol and 
under sterile conditions the blunt ends of eggs was struck with forceps to 
make a small hole. Eggs were injected with either test chemical or PBS 
alone, using a 25- gauge needle attached to a 1 ml disposable syringe.  All 
the injections were under the vitelline membrane through air sac region. 
After being injected the holes were sealed with parafilm and taped with 
insulating tape in order to avoid drying out of the embryos. Only viable 
embryos were injected in each group. All the eggs were placed blunt end 
up into the automated egg turner and incubated at 37.5 °C and relative 
humidity of 55% with 5% CO2 in air till day 9 of incubation. 
2.2.3.2. Sample collection and measurements 
On day 9 eggs were cracked under sterile hoods and embryos were 
examined in terms of their viability. After removing all the membranes 
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viable embryos were examined for any growth retardation by measuring 
crown rump length, and any malformations or gross abnormalities 
observed including limb deformities, facial defects, and brain vesicle 
development.  Hearts were taken out and fixed in 10% formaldehyde.  All 
the hearts were kept at 4oC, until used for sectioning. 
2.2.3.3. Paraffin tissue processing for sectioning 
Fixed hearts went through a series of processes starting from dehydration 
and clearing to wax impregnation before being sectioned. 
2.2.3.3.1. Dehydration 
Dehydration was carried out by placing the tissues in increasing 
concentrations of alcohol ranging from 70% to 100%. 
2.2.3.3.2. Clearing 
After removing all the water from tissue samples, they were cleared of 
alcohol by means of xylene in order to mix wax into them. 
2.2.3.3.3. Wax impregnation 
Following all the clearing the samples were transferred to two changes of 
molten wax till thoroughly impregnated.  At this point temperature was 
strictly controlled. 
2.2.3.3.4. Automatic tissue processing 
An automatic tissue processor, (Leica TP1020) was used to perform all the 
above mentioned processes. 
The tissues were sectioned at 25µm by microtome and slides were prepared 
using APES coated glass slides. 
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2.2.3.4. Haematoxylin and Eosin staining of tissue slides 
Once all the slides were prepared, they were hydrated with water and then 
placed into the Haematoxylin solution for 5 minutes.  The haematoxylin 
was removed and tissues were washed with tap water.  Tissues were 
differentiated in acid alcohol to remove excess stain before bluing the 
nuclei in a saturated solution of lithium carbonate.  The tissues were again 
washed in tap water then placed in to 1% eosin for approximately 1-2 
minutes.  Excess stain was removed and slides were washed in tap water.  
Finally the tissues were dehydrated by passing through increasing 
concentrations of alcohol and allowed to dry before being covered with 
cover slips. 
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2.3. Materials and Methods for 
immunohistochemistry 
2.3.1. Immunostaining reagents 
Bovine serum albumin (BSA) Sigma-Aldrich, UK 
Frozen tissue matrix (OCT) Lamb, UK 
2-methylebutane (isopentane) Fisher Scientific, UK 
Normal goat serum (NGS) Sigma-Aldrich, UK 
Paraformaldehyde Phosphate Buffered Saline Sigma-Aldrich, UK 
Triton X100 Sigma-Aldrich, UK 
VectashieldTM (containing DAPI) Vector Laboratories, UK 
2.3.2. Plastic and glass ware 
APES coated slides Menzel Glaser, UK 
Chamber slides Nunc, UK 
Glass containers Storopack, Germany 
Glass coverslips VWR international, UK 
Plastic moulds VWR international, UK 
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2.3.3. Antibodies  
2.3.3.1. Primary antibodies 
Table  2.3. Primary antibodies used  
Antigen 
Specificity 
Host Form Reactivity Dilution Source 
Skeletal 
muscle 
Mouse Monoclonal Rabbit, Rat, 
Chicken, 
Mouse, 
Xenopus 
25µg/ml DSHB, 
lowa, 
USA 
Cardiac 
troponin T 
Mouse Monoclonal Broad species 
specificity 
25µg/ml DSHB, 
lowa, 
USA 
Striated 
muscle 
(Sarcomere 
myosin) 
Mouse Monoclonal Mammalian, 
Avian, 
Amphibian 
25µg/ml DSHB, 
lowa, 
USA 
Connexin 43 Rabbit Polyclonal Hu, Ms, Rat, 
Chk, Cow, Hm, 
Mk 
1:500 Abcam, 
UK 
Endothelin 1 Rabbit Polyclonal Hu, Ms, Por, 
canine, Rat,  
Bovine 
1:500 Phoenix 
pharmace
u-ticals, 
UK 
 
2.3.3.2. Secondary antibodies 
Table  2.4.  Secondary antibodies used 
Antigen 
Specificit
y 
Host Form Reactivity Label Dilutio
n 
Source 
Rabbit 
IgG 
Goat Polyclonal Rabbit Alexa 
488 
25µg/ml Sigma-
Aldrich, 
UK 
Rabbit 
IgG 
Goat Monoclonal Rabbit Fc FITC 25µg/ml Sigma-
Aldrich, 
UK 
Mouse 
IgG 
Goat Monoclonal Mouse Fc FITC 25µg/ml Sigma-
Aldrich, 
UK 
Hu (Human); Ms (Mouse); Por (Porcine) 
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Mouse 
IgG 
Goat Monoclonal Mouse Fc TRITC 25µg/ml Sigma-
Aldrich, 
UK 
2.3.4. Stock solutions 
2.3.4.1. Normal goat serum (NGS) (0.5% v/v) 
5% NGS was prepared by adding 500µl NGS to 9.5ml PBS immediately 
before use. 
2.3.4.2. Paraformaldehyde solution (4% w/v) 
4% paraformaldehyde solution was made by adding 4g of it to 100ml PBS, 
solution was then heated to 60oC with continuous agitation until 
completely dissolved.  All this procedure was done in a fume cupboard 
(paraformaldehyde is a carcinogen). The solution was further diluted to 2% 
by adding to PBS and stored at -20oC until required. 
2.3.4.3. Triton X 100 (0.2% v/v) 
Triton X 100 (20µl) was mixed with 9.98ml PBS just prior to use. 
2.3.5. Methods 
2.3.5.1. Indirect immunohistochemistry 
The cultures were fixed in paraformaldehyde solution (2% w/v in PBS) for 
1 hour at room temperature. This was aspirated and the cells were washed 
thrice with PBS each for 5 minutes, before being permeabilised with 0.2% 
Triton X-100 in PBS (v/v) for 10 minutes.  Once permeabilised, the cells 
were incubated in 5% goat serum in PBS for 1 hour to block nonspecific 
binding of secondary antibody.  The goat serum was removed and the cells 
were incubated with the primary antibody (200µl) (Table2.3) overnight at 
4oC. The primary antibody was removed and the cells were washed 3 times 
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in 0.1% BSA in PBS (w/v).  The secondary antibody (Table 2.4) diluted in 
0.1% BSA in PBS and incubated for 1 hour in the dark.  Cells were washed 
in PBS (3 x 5 minutes) to remove excess unbound secondary antibody 
EHIRUH PRXQWLQJ ZLWK 9HFWRUVKLHOG FRQWDLQLQJ '$3,  6HFWLRQV ZHUH
viewed under a confocal microscope. 
2.3.5.2. Double immunofluorescence 
For double immunostaining micromass cultures were treated in a similar 
way as described in previous section.  Here two monoclonal antibodies 
were used to assess the composition of the cardiomyocyte MM cultures.  
The first primary (table 2.3) antibody was applied and incubated overnight 
at 4°C.  The MM cultures were rinsed with 0.1% BSA in PBS (w/v). The 
secondary antibody FITC (table 2.4) was applied and incubated at room 
temperature for 1 hour in the dark.  Slides were rinsed and then washed in 
fresh BSA solution (0.1% w/v in PBS).  The process was repeated for the 
second primary antibody (table 2.3) using the secondary antibody TRITC 
(table2.4). Slides were washed in distilled water and mounted using 
9HFWDVKLHOGFRQWDLQLQJ'$3,JPO-1). The slides were viewed under 
a confocal Microscope.  
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2.4. Materials and methods for Western blotting 
2.4.1. Plastic and glass ware 
Cassettes Millipore, UK 
Centrifuge (cold) Sigma, UK 
Centrifuge (room temperature) Sanyo, UK 
Electrophoresis module Bio-Rad laboratories, UK 
Filter paper :KDWPDQ¶V/WG8. 
Fish skin gelatine Sigma-Aldrich, UK 
Loading marker Lonza, UK 
Nitorcellulose membrane Shleicher & Schuell, 
Germany 
Oddyssey scanner Licor, UK   
Plate reader Dynax, UK 
Polytron homogenizer Heildolph, UK 
Precast gels (10% 1mm) Lonza, UK 
Snap i.d. Millipore, UK 
Transfer module Bio-Rad laboratories, UK  
Tanks Bio-Rad laboratories, UK 
Transfer cassettes Bio-Rad laboratories, UK 
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2.4.2. Antibodies  
2.4.2.1. Primary antibodies  
Table 2.5. Primary antibodies used in western blotting 
Antigen 
specificity 
Host Form Source Working 
dilution 
Cx 43 Rabbit Polyclonal Abcam 
(UK) 
1:500 
GAPDH Mouse Monoclonal Sigma-
Aldrich, 
UK 
1:3000 
 
2.4.2.2. Secondary antibodies  
Table 2.6. Secondary antibodies used in western blotting 
Secondary 
antibodies 
Host Form Source Working 
dilution 
Green Rabbit Polyclonal Licor, UK 1:9000 
Green Mouse Monoclonal Licor, UK 1:9000 
Red Rabbit Polyclonal Licor, UK 1:9000 
Red Rabbit Monoclonal Licor, UK 1:9000 
 
2.4.3. Solutions and Reagents 
Lysis Buffer pH 7.6 
20mM Tris Invitrogen, UK  
1mM EGTA  Sigma-Aldrich, UK 
320mM Sucrose  BDH, UK 
0.1% Triton X100  Sigma-Aldrich, UK 
1mM NaF Sigma-Aldrich, UK 
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10mM Beta glycerophosphate  Sigma-Aldrich, UK  
2X solubilisation Buffer 
0.5M Tris Invitrogen, UK   
Glycerol Sigma-Aldrich, UK   
10% SDS Fisher Scientific, UK  
ȕ- mercaptoethanol Fisher Scientific, UK 
2.5% Bromophenol Blue Fisher Scientific, UK 
TBST 0.1% tween 
25mM tris Invitrogen, UK   
125 mM NaCL Sigma-Aldrich, UK   
Lowry A 
NaOH Fisher Scientific, UK 
SDS Sigma-Aldrich, UK 
Na2Co3 Fisher Scientific, UK  
Lowry B 
CuSo4 Sigma-Aldrich, UK 
Na K tartarate Fisher Scientific, UK 
)ROLQ¶V5HDJHQW Sigma-Aldrich, UK  
2.4.4. Sample preparation 
2.4.3.1. Preparing cell lysates 
Chick micromass cardiomyocyte cultures were prepared, grown and treated 
with teratogens in 24 well plates as described in section 2.1.4.5.2.  Cell 
lysates for western blotting were prepared by following method.   
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Cells in each well of 24 well plates were washed with ice cold PBS on ice 
and then cells were scraped off from the bottom of the well. 100µl of 
freshly prepared lysis buffer with protease inhibitor was added to each 
well.  Plates were then kept on a plate shaker for 1 hour at 4oC.  Then 
100µl of 2X solubilisation buffer was added to the wells. 
2.4.3.2. Preparing tissue lysates 
Chick hearts were collected in 1.5 ml Eppendorfs on ice.  1ml of lysis 
buffer with protease inhibitor was added to each 100mg of tissue, such that 
the final concentration of tissue solution would be 100mg/ml.  Tissues 
were then homogenized with polytron homogenizer until all tissues were 
homogenized properly.  During homogenization, tissues were placed on ice 
at all times.  Once homogenized, Eppendorf tubes were kept on the wheel 
in the cold room for 1 hour followed by centrifugation for 5 minutes at 
13000rmp at 4oC.  After centrifugation, supernatant was removed and 
collected in a separate Eppendorf tube.  10µl of supernatant was taken for 
the Lowry test.  To the remainder of supernatant 2X solubilisation buffer 
was added in 1:1 ratio.  After the protein concentration had been 
determined by the Lowry assay, 1:1 solution of lysis buffer and 2X 
solubilisation buffer was added to the samples to normalize them. 
2.4.3.2.1. Lowry test 
For the Lowry test, prepared tissue samples were diluted in 1:20 dilutions 
in distilled water.  BSA standards were prepared in 1mg/ml concentrations.  
Then 1 ml of Lowry AB solution (Lowry A+ B; 1:1) was added to all 
samples and standards.  Samples were incubated for 10 minutes.  100µl of 
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1:1 the Folin reagent to water was added to all samples and standards.   
After leaving the samples and standards for more than 45 minutes at room 
temperature, 200µl of each sample and standard were pipetted in to a clear 
96 well plate in triplicate as shown in figure 2.5.  The plate was read at 750 
nm.  A standard curve was plotted and proteins were normalized to 
1mg/ml.  
 B1   S8   T8     
 S1   T1        
 S2   T2        
 S3   T3        
 S4   T4        
 S5   T5        
 S6   T6        
 S7   T7        
 Figure 2.5. Arrangement of standards and samples in 96 well plate 
2.4.5. Western blotting 
The proteins were denatured by heating the samples to 95oC for 5 minutes 
in a heating block.  The samples were then vortexed and centrifuged at 
13000rmp for 1 minute.  Then 20µl of each sample was loaded on to the 
precast gels, along with 1µl of marker.  The gel was run in 1X electrode 
buffer for approximately 45 minutes at 200V.  When the gel had finished 
running, it was removed from the electrophoresis unit.  The gel was then 
transferred to nitrocellulose membrane.  The transfer was performed in 
cold transfer buffer for 60 minutes at 100V.  The transfer was checked by 
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adding few drops of Ponceaus solution on the blot.  Once good transfer of 
protein was confirmed, the blot was cut into appropriate sections.   
The rest of the procedures including blocking and adding primary and 
secondary antibodies were carried out in Snap i.d, using Snap i.d cassettes. 
2.4.5.1. Blocking 
The nitrocellulose blot was placed in a pre-soaked Snap i.d cassette.  The 
cassette was then put in to Snap i.d and blot was blocked by 1.5% fish skin 
gelatine (FSG) in TBST (v/v) by turning on the Snap i.d.   
2.4.5.2. Adding Primary antibody 
Primary antibody (Cx 43+ GAPDH) was made in 1.5% FSG.  It was added 
to the blot by turning off the Snap i.d.  The blot was covered in primary 
antibody for at least 10 minutes.  The blot was then washed three times 
with TBST by turning on the Snap i.d.  
2.4.5.3. Adding Secondary antibody 
Secondary antibody was made at a dilution of 1:9000 in 1.5% FSG.  It was 
added to the blot by turning off the Snap i.d.  Blot was covered in 
secondary antibody for at least 10 minutes in dark as secondary antibody is 
light sensitive.  The blot was then washed three times with TBST by 
turning on the Snap id. 
The blot was scanned by the Odyssey scanner at resolution of 84µm and 
was statistically analysed using Prism 5. 
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2.5. Statistical analyses  
The raw data was calculated using Microsoft Excel and analysed by one 
way ANOVA with the post hoc DunnetW¶s test for parametric data.  For 
nonparametric data (scoring of cells), a Kruskal-Wallis test was performed 
DQGD'XQQ¶VSRVWKRFWHVWZDVXVHGWRWHVWWKHVLJQLILFDQFH,QDOOFDVHVS
value < 0.05 was considered significant.  For all statistical analysis Prism 5 
software was used. 
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Chapter 3 
Evaluation of chick cardiomyocyte micromass 
culture 
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3.1. Introduction 
In order to obtain reproducible results with chick cardiomyocyte cultures, it 
was necessary to establish a protocol.  This required determining the 
optimum day of explantation and cell density which were necessary to 
form cultures with identifiable contractile foci.  Once a standardised 
protocol had been established, teratogenicity of different chemicals was 
measured by observation of contractile activity.   The cytotoxic effects 
were measured by the use of the resazurin reduction and kenacid blue 
assays (Knox et al., 1986; Clothier, 1992).  
3.1.1. Chick embryonic development 
Some embryonic development has already occurred before the egg is laid, 
and usually stops until proper cell environmental conditions are established 
by incubation under appropriate conditions for development to restart.  At 
first, all the cells are alike, but as the embryo develops, cell differences are 
observed. Some cells may become vital organs; others become a wing or 
leg.  Soon after incubation begins, the primitive streak appears as a pointed 
thickened layer of cells in caudal or tail end of the embryo.  The formation 
of the primitive streak starts the process of gastrulation.  Gastrulation is the 
process of development of three germ cell layers by mass migration of 
cells, so that they come to lie in appropriate areas and are ready to begin 
differentiation.   The development of gut and neural tube follows 
gastrulation and starts from the first day of development.  On day 2 of 
incubation, small blood islands form and begin linking and form a vascular 
system (vitelline circulation), at the same time the heart is being joined by 
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these blood islands and beginning to beat.  The neural groove starts to close 
and forms three distinct brain regions (forebrain, mid brain and hind brain).  
By the end of the third day of incubation, the beak begins to develop and 
limb buds for future wings and legs become visible.  The mouth, tongue, 
and nasal pits develop as parts of the digestive and respiratory systems.  At 
this time the head and tail regions come close together so the embryo forms 
a "C" shape.  The heart continues to enlarge even though it has not been 
enclosed within the body.  At the end of the fourth day, the embryo 
develops all organs needed to sustain life after hatching, and most of the 
embryo's parts can be identified as shown in figure 3.1.   However the 
chick embryo can hardly, be distinguished from mammalian embryos at 
this time point.  The growth and development of the embryo becomes more 
rapid beyond this time up until 21 days of incubation when the chick 
finally begins its escape from the shell (Bellairs & Osmond, 2005). 
95 
 
Fig 3.1 Developmental stages of chick embryo from day 4 to day 6 
Days of 
incubation 
Photographs of chicks HH 
stage 
HH stage description 
(Hamburger & Hamilton, 1951) 
 
 
 
 
Day 4 
(A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
HH 24 
 
 
Limb buds and wings are much 
longer then are wide.  The toe 
plate in leg bud is distinct but 
toes are not demarcated. 
 
 
 
 
 
Day 5 
(B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
HH 26 
 
 
Limb buds are considerably 
longer and contour of digital 
plate is round.  Demarcation of 
first three toes is distinct.  Beak 
is barely prominent. 
 
 
 
 
 
Day 6 
(C) 
 
 
 
 
 
 
 
 
 
 
 
 
HH 29 
 
 
 
Wings are bent at elbow and 
second digit is larger than 
others.  Grooves between the 
digits are prominent.  Beak is 
more prominent but no egg 
tooth is visible. 
 
Fig.3.1: Shows external features of day 4 (A), day 5 (B), and day 6 (C) chick 
embryos. Original magnification 200x.  MB midbrain; FB forebrain; HB hind 
brain; E eye; H heart; LB limb bud. 
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3.1.2. Development of chick heart 
The heart is one of the earliest organs to develop during embryonic life.  
The chick heart primordial cells develop few hours after incubation in the 
epiblast layer at the time of its separation from the hypoblast.  These 
cardiac progenitor cells moved towards the rostral end of the primitive 
streak at around 12-13 hours of incubation.  These then begin to extend 
caudally in the primitive streak.   These cardiac progenitor cells give rise to 
endocardium, myocardium, and parietal pericardium.  By 18-22 hours 
these cardiac progenitor cells move toward the lateral plate mesoderm and 
align themselves in to the splanchnic layer on both sides of the primitive 
streak and form the crescent shaped primary heart field.  These heart 
forming cells ultimately differentiate to form different segments of the 
KHDUW XSRQ LQGXFLQJ VLJQDOV IURP WKH KHDG RUJDQL]HU +HQVRQ¶V QRGH LQ
chick), whereas the definitive endoderm provides some signals later that 
reinforce the initial induction of the precardiac mesoderm (Martinsen, 
2005).  Once differentiated, these presumptive endocardial cells begin to 
separate from the splanchnic mesoderm by the process of epithelial to 
mesenchymal transformation and migrate to start the formation of the 
bilateral heart tubes at around 23 hours.  The two heart tubes begin to fuse 
and form a straight heart at 26-29 hours at HH stage 8+ or 9 (Manner, 
2000).  The newly formed heart begins to beat and starts its function even 
before the process of looping at nearly around 42 hours of gestation.  The 
initial contractions by myocytes are peristaltic, but with maturation of the 
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heart, and once the conduction system is fully functional, the contractions 
become more synchronous.  Although beating and contractile activity is an 
intrinsic property of cardiomyocytes, yet there must be some signals to 
initiate and propagate these contractions within different chambers of the 
heart.  Cardiomyocytes contain some contractile proteins such as actin and 
myosin, which are assembled at the sarcomere of cardiac muscles and help 
in the generation and propagation of contractions and beating.  
Cardiomyocytes also have some specialized communications at cellular 
junctions known as gap junctions which allow them to contract 
synchronously (Bellairs and Osmond, 2005; Fishman et al., 1997).  
3.2. Effects of days of development on explantation of 
chick heart micromass culture systems 
3.2.1. Introduction 
Micromass culture systems have been used to study development and to 
evaluate the potential teratogenicity of chemicals (Flint, 1980).  This 
chapter will focus on the heart micromass culture technique as an 
embryotoxicity testing system. The methods for cardiomyocyte micromass 
culture were evaluated to be used for all micromass experimentations 
carried out in this project.  The chick was chosen because of the ease of 
storage and handling of the eggs.  
3.2.2. Materials and Methods 
Chick cardiomyocytes were seeded into 24 well plates at a cell density of 
3.0 x 106 cell ml-1 and cultured in DMEM supplemented growth media 
98 
 
(chapter 2, section 2.1.4.5.2).  For each time point triplicate plates were 
established.  All micromass cultures were maintained at 37ºC, 5% CO2 
(v/v) in air.  To determine the optimal day of explantation, isolations were 
taken from day 4, 5 and 6.  The resazurin reduction, the kenacid blue 
(chapter 2, section2.1.5.2) assays and microscopic observations were 
employed to detect the optimal day, suitable for chick micromass cultures 
used in this project.   
3.2.3. Results 
The microscopic observations revealed that micromass cultures of 
cardiomyocytes from days 4, 5 and 6 appeared to attach successfully to the 
bottom of tissue culture treated plastic plates with majority of foci having 
good contractile activity (Figure 3.4).  However, it has been observed that 
those micromass cultures taken from day 4 have a tendency to detach 
during the total protein (kenacid blue) assay, resulting in a lower 
absorption reading than would be otherwise expected as shown in figure 
3.2.  The reason for this detachment has yet to be investigated, but it may 
well be related to the development of the capacity of the cells to adhere to 
other cells and the tissue culture plate. The cells in the early stages of 
development are likely to be more mobile within the embryo until the 
tissues are developed.  Resorufin production by cells was consistent 
throughout all explantation days (figure 3.3). 
3.2.4. Conclusions 
Heart micromass cultures generated from days 4, 5 and 6 showed a good 
tendency to differentiate in to contractile foci with beating.  However 
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cultures from day 4 had poorer attachment capacity than embryos from 
other days.   Day 5 embryos were also chosen in this study due to the fact 
that they still have differentiating cells within developing organs, 
particularly the heart, brain and limb buds.  The time of embryonic organ 
development is an important factor, due to the fact that differentiating cells 
have the maximum potential to be affected by teratogens (Moore & 
Persaud, 1988).  
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Figure 3.2  
Effects of explantation day on protein 
content (µgml-1) of heart micromass 
cultures 144 hours post seeding 
grown in DMEM. The protein 
content was significantly lower at 
day 4 compared to cultures explanted 
at day 5 and day 6 (mean±S.D, n=3).  
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Figure 3.3  
Effect of explantation day on 
resorufin production of heart 
micromass cultures 144 hours post 
seeding grown in DMEM.  The 
resorufin production was consistent 
throughout all explantation days.  
(mean± S.D, n=3). 
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Figure 3.4  
Effects of days of explantation on 
contractile activity of chick 
cardiomyocytes cultured in DMEM 
supplemented medium.  The 
contractile activity was consistent for 
all 3 days.  
(mean± S.D, n=3). 
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3.3.  Effects of seeding density on optimal chick heart 
micromass culture systems 
3.3.1. Introduction 
Preliminary studies were carried out to determine a suitable seeding density 
whereby the heart micromass would have optimal culture conditions.  In 
addition, the resazurin reduction, and kenacid blue assays for cell activity 
and total protein respectively, were optimized for use with the micromass 
culture when utilizing 24 well plates. 
3.3.2. Material and Methods 
The 24 embryonic hearts from day 5 embryos generate approximately 5 x 
106 cells sufficient for 8 replicates of micromass cultures.  A larger number 
of embryos could be dissected but the tissue extraction step can become too 
long with the resultant risk of lower overall viability. Micromass cultures 
were seeded at 1 x 106cells ml-1, 2 x 106cells ml-1, 3 x 106cells ml-1, 4 x 
106cells ml-1, 5 x 106cells ml-1and 6 x 106cells ml-1.  Twenty microlitre 
droplets of cell suspension were seeded per well into 24 well plates and 
incubated at 37oC, 5% CO2 in air with a relative humidity of 100% for 2 
hours, after which DMEM medium was added as described in (chapter2, 
section 2.1.4.5.2).  The resazurin reduction and kenacid blue assays 
(chapter2, section 2.1.5.1 and 2.1.5.2 respectively) were performed 
sequentially the on the same cultures.  The cells were also morphologically 
inspected under a light microscope for intrinsic beating and contractile 
activity of cardiomyocytes. 
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3.3.3. Results 
In addition to protein measurements, microscopic observations revealed 
that a seeding density of 3.0x106 cells ml-1 resulted in optimal culture.  At 
densities 1.0 x 106 cells ml-1 to 4.0 x 106 cells ml-1, cellular protein 
measurement increased in direct proportion to cell densities which reached 
to a plateau at 5.0 x 106 cells ml-1 and 6.0 x 106 cells ml-1 (figure 3.5). This 
apparent inconsistency is associated with the increased cellular packing, 
within the micromass that occurs at higher seeding densities.  
At seeding densities ranging from 1.0 x 106 cells ml-1 to 4.0 x 106 cells ml-1 
resorufin production also increased proportionally with increasing density.  
A plateau of resorufin production was achieved at seeding densities 
between 5.0 x 106 cells ml-1 and 6.0 x 106 cells ml-1 which was consistent 
with the total well protein content reaching a maximum at these higher 
seeding densities (figure 3.6). 
When the cells were plated at 1.0 x 106cells ml-1, the micromass cultures 
generated were very small. At 2.0 x 106 cells ml-1 cultures were satisfactory 
in terms of attachment and cardiomyocyte beating could be observed, as 
found for the 3.0 x 106 cells ml-1 recommended cell density, but at 2.0 x 
106 cells ml-1 cells did not show any joining with one another and intrinsic 
synchronous beating was not observed in all areas of the micromass 
cultures at this seeding density. At 5.0 x 106 cells ml-1 and above cultures 
attached sufficiently but were too densely packed and it was very difficult 
to observe individual beating of the cardiomyocytes. 
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Figure 3.5   
Effect of seeding density protein content 
of heart micromass cultures 144 hours 
post seeding grown in DMEM 
supplemented media. The protein 
content increased significantly with 
respect to previous seeding densities 
when cultured up to and including 
5.0x106 cells ml-1.(mean± S.D, n=3).   
{* (p<0.05) for 'XQQHWW¶VSRVWKRFWHVW` 
 
Figure 3.6  
Effect of seeding density on resorufin 
production of cultures 144 hours post 
seeding grown in DMEM media. The 
resorufin production increased 
significantly with respect to previous 
seeding densities when cultured up to 
and including 5.0x106 cells ml-1.(mean± 
6' Q   ^ S IRU 'XQQHWW¶V
post hoc test}. 
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3.3.4. Conclusions 
The results show that 3x106 cells ml-1 was the optimal cell density to be 
used in further experiments.  Concentrations below this level were shown 
to have no synchronous beating, while concentrations above 3x106 cells ml-
1 were too densely packed and were difficult to observe. 
3.4.  Identification of cell types present  in chick 
heart micromass cultures 
Micromass (MM) cell cultures are derived from primary cells, and involve 
the dissection of relevant organ or tissue to be used, with subsequent 
enzymatic dissociation of tissues in to cells, before plating the cell cultures 
into a suitable growth medium. Although the tissues can be accurately 
dissected under the microscope, it is questionable whether there are any 
other cell types present within the MM cultures apart from the cells which 
are required i.e. cardiomyocytes.  The purpose of this investigation was to 
observe whether the heart MM cells differentiated into cardiomyocytes or 
other cell types were also present. To determine the cell types present 
within the cardiomyocyte cultures, cells were stained with either 
histological or immunohistochemical staining.  
3.4.1. Histological staining 
In order to detect particular cell types within MM cultures, traditional 
histological staining techniques can be used.  For example, the MM 
cultures derived from embryonic hearts can be stained to detect 
cardiomyocytes by using stains that are specific to muscle these include 
105 
 
9DQ *LHVRQ¶V DQG 0DVVRQ¶V 7ULFKURPH (Carleton, 1967).  The heart is 
composed of myocytes that are joined together in fibres by intercalated 
discs (Kerr, 1999).  7KH KLVWRORJ\ VWDLQ IRU PXVFOH FHOOV LV WKH 0DVVRQ¶V
trichrome stain. The rationale for using this technique is that the 
components of trichrome stains select specific tissue due to the dye 
molecule size and tissue permeability (Bradbury et al., 1977).  When 
VWDLQLQJ ZLWK 0DVVRQ¶V 7ULFKURPH UHG EORRG FHOOV WDNH XS WKH Gye 
consisting of the smallest molecular size; muscle is stained by an 
intermediate molecular size and collagen by the largest molecular size 
(Bradbury et al., 1977). 
3.4.2.  Heart/cardiomyocyte immunohistochemistry 
The MM cultures were stained with an antibody specific to muscle cells, to 
make sure that most of the cells present in the culture are cardiomyocytes.  
Kolker and his colleagues used an anti-tropomyosin antibody to detect 
cardiac cells in cultures (Kolker et al., 2000).  Here in this study an anti 
tropomyosin antibody (CH1) was used to detect muscle cells in culture.  As 
tropomyosin is a protein which is found in the contractile apparatus of all 
muscle cells (Gartner et al., 1994), it was necessary to double stain the 
micromass cultures with other antibodies specific to cardiac muscles.  For 
these reasons an antibody specific to the myosin (sarcomere) (MF20) was 
double stained with an antibody marker for skeletal muscle only (12/101). 
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3.4.3. Materials and Methods 
3.4.3.1. Histochemical staining 
The following histology staining methods were performed on micromass 
cultures, cultured in chambers slides. 
3.4.3.1.1 Haematoxylin and Eosin staining (H & E) 
The following staining technique is an adapted method from Stevens, 1977.  
The cells were hydrated with tap water and then placed into the 
haematoxylin solution for 5 minutes.  The haematoxylin was removed and 
the cells were washed several times in tap water.  Then they were 
differentiated in acid alcohol to remove excess stain before blueing the 
nuclei in a saturated solution of lithium carbonate.  Once stained in lithium 
carbonate the cells were washed in tap water and then placed into the 1% 
eosin for approximately 1 minute.  Excess eosin stain was removed and the 
cells were again washed in tap water.  All slides containing cells were then 
dehydrated through graded alcohol and then placed into xylene before 
mounting with DPX. 
 3.4.3.1.2. 0DVVRQ¶V7ULFKURPH 
This technique is adapted from the methods described by Carleton, 1967.  
Cells were incubated in WeigeUW¶V KDHPDWR[\OLQ IRU  PLQXWHV DW URRP
temperature (RT).  Excess stain was removed with several washes in tap 
water and the nucleL µEOXHG¶ LQ OLWKLXP FDUERQDWH  Cells were then 
incubated in Ponceau-acid fuchsin solution for 5 minutes, rinsed in tap 
water to remove excess stain and incubated for 5 minutes in 1% 
phosphomolybdic acid.  The cells were quickly washed before incubation 
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for 5 minutes in the light green solution, followed by a rinse in tap water.  
All slides were then dehydrated through graded alcohol and then placed 
into xylene before mounting with DPX. 
3.4.3.1.3. Immunohistochemistry 
The cardiomyocytes were seeded in 20µl droplets at 3x106cells ml-1 in the 
DMEM culture medium as described in chapter 2 (section 2.3.5.1), but 
instead of using 24 well plates they were cultured in 8 well chamber slides. 
The cultures were fixed in paraformaldehyde solution (2% w/v in PBS) for 
1 hour. This was aspirated and the cells were washed thrice with PBS each 
for 5 minutes, before being permeabilised with 0.2% Triton X-100 in PBS 
(v/v) for 10 minutes.  Once permeabilised, the cells were incubated in 5% 
goat serum in PBS for 1 hour to block nonspecific bindings of secondary 
antibody.  The GS was removed and the cells were incubated with the 
undiluted primary antibody (CH1) overnight at 4oC. The primary antibody 
was removed and the cells were washed 3 times in 0.1% BSA in PBS 
(w/v).  The secondary antibody, FITC goat anti-mouse, was diluted 1:300 
in 0.1% BSA in PBS and incubated for 1 hour in the dark.  Cells were 
washed in PBS (3 x 5 minutes) to remove excess unbound secondary 
DQWLERG\EHIRUHPRXQWLQJZLWK9HFWRUVKLHOGFRQWDLQLQJ'$3,6HFWLRQV
were viewed under a confocal microscope. 
3.4.3.1.4. Double immunofluorescence 
For double immunostaining micromass cultures were treated in a similar 
way as described in previous section.  Here two monoclonal antibodies 
were used to assess the composition of the cardiomyocyte MM cultures.  
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The primary antibody 12/101 identified specifically skeletal muscle and 
MF20 identified striated muscle, but also reacts with all sarcomere myosin 
both present in skeletal and cardiac muscle.  These antibodies cross react 
with chick skeletal only or skeletal and cardiomyocytes respectively.  The 
primary antibody was applied and incubated overnight, at 4°C.  The MM 
cultures were rinsed with 0.1% BSA in PBS (w/v). The secondary 
antibody, fluorescein isothiocyanate (FITC) labeled goat anti-mouse was 
applied at a concentration of 0.1µgml-1 in (0.1% BSA w/v in PBS) and 
incubated at room temperature for 1 hour in the dark.  Slides were rinsed 
and then washed in fresh BSA solution (0.1% w/v in PBS).  The process 
was repeated for the second primary antibody MF20 using the secondary 
antibody tetramethylrhodamine isothiocyanate (TRITC) label. Slides were 
washed in distilled water and mounted using VectaVKLHOG FRQWDLQLQJ
DAPI (50µgml-1). The slides were viewed under a confocal Microscope.  
3.4.4. Results 
3.4.4.1. H & E and 0DVVRQ¶VWULFKURPHVWDLQLQJ 
H & E staining of chick cardiomyocytes shows that cardiomyocytes have 
an irregular shape and many other cells apart from cardiomyocytes are 
visible as well.  Also cells in the culture form connections with each other 
DQG LW¶V YHU\ KDUG WR GLVWLQJXLVK LQGLYLGXDO FHOOV LQ FRQWUDFWLOH XQLWV (fig 
  0DVVRQ¶V WULFKURPH FOHDUO\ UHYHDOV WKH SUHVHQFH RI RWKHU FHOls 
(fibroblasts and epithelial cells) surrounding cardiomyocytes (fig 3.8). 
109 
 
Fig. 3.7. H & E staining of cardiomyocytes 
Original magnification 200x. 
)LJ0DVVRQ¶VWULFKURPHVWDLQLQJRI
cardiomyocytes staining of cardiomyocytes.  
Original magnification 200x. 
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3.4.4.2. Immunohistochemistry 
The chick heart micromass cultures were stained with antitropomyosin 
(CH1) as shown in figure 3.9 (A).  Positive stain (green) can be clearly 
seen in culture, indicating that there were predominately muscle cells in 
culture.  The staining with DAPI indicates the presence of active viable 
cells prior to fixation in micromass culture fig 3.9 (B & C). 
To identify the presence of cardiac muscle cells in the cultures double 
immunostaining was done.  The positive labeling with MF20 (reacts with 
sarcomere myosin of all muscles) for striated muscle indicates that most of 
the muscle cells present in the culture were striated fig 3.10 (A).  While 
labeling with skeletal muscle specific antibody (12/101) shows negative 
staining fig 3.10 (B), indicating that there were no skeletal muscle cells 
present.  The nuclear labelling with DAPI show that nuclei were all bound 
to MF20, while 12/101 shows negative stain fig 3.10 (C & D).  These 
results confirm the presence of cardiomyocytes in micromass cultures. 
3.4.5. Conclusions 
The histological staining results show some epithelial cells as well apart 
from cardiomyocytes.  The antibodies used to identify the cardiomyocytes 
in chicks were all anti mammalian antibodies, but these antibodies reacted 
with chick cardiomyocytes confirmed that most of the cells present in the 
micromass cultures were cardiomyocytes.  No skeletal muscle or epithelial 
tissue had overgrown the cardiomyocytes. 
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Figure 3.9.{A}Immunofluoresence staining of tropomyosin (CH1) in chick 
heart micromass cultured in DMEM supplemented media. {B} the same 
cultures with DAPI staining, {C} both staining for tropomyosin and nuclei. 
Original magnification 200x. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Shows Double immunofluorescence for {A} myosin (MF20 
stained with TRITC) and staining for {B} skeletal muscle (12/101 with 
FITC) in chick cardiomyocyte micromass cultures.  {C and D} shows 
DAPI nuclear staining.  Original magnification 200x. 
 
A B C 
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C D 
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3.5. Conclusions 
The results in this chapter demonstrate that, from all the days examined it 
was clear that for both day 5 and day 6 cells, the cellular differentiation, 
protein level and cell viability were similar while day 4 cells showed less 
protein content.  The day 5 embryos still have the ability to differentiate, 
and for teratogenicity testing it is necessary to test the chemicals during the 
embryogenesis period.  As far as cell density is concerned 3 × 106 cells/ml 
were chosen due to the fact that cell densities below this showed no 
intrinsic synchronous beating while at higher densities cells were highly 
packed and it was very difficult to analyze them individually. 
The histological staining showed apart from cardiac cells some epithelial 
cells were present as well.  However double immunofluoresence revealed 
that the majority of cells in micromass cultures were cardiomyocytes and 
not endothelial cells or skeletal muscle cells. 
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Chapter 4 
Evaluation of chick embryos in ovo culture 
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4.1. Introduction 
For in ovo culture, preliminary experiments were conducted to ensure that 
the injection volume, PBS (vehicle control), neutral red dye (used as a 
guide for injections) and Para film (to seal the eggs) had no teratogenic or 
toxic effects on chick embryos.  Also ethanol a known teratogen was used 
in two different concentrations to check the effectiveness of the technique.  
Furthermore a scoring system was also developed with reference to 
Hamburger and Hamilton (Hamburger & Hamilton, 1951) developmental 
series to compare the results of different treatments. 
4.2. Materials and methods 
White leghorn fertilized chicken eggs were obtained from Henry Stewart 
and Co.Ltd as described in chapter 2 section 2.1.1.1.  Eggs were randomly 
selected and divided in to 5 groups immediately before incubation. The 
first group was incubated as the non-treated group (n = 12). The rest were 
labelled according to different treatment modes, either PBS (vehicle 
control, n = 12), Neutral red dye, or EtOH solutions at different doses 
(10%, n = 12, and 20%, n = 12 v/v in PBS) (chapter 2, section 2.2.3.1). 
The day on which the eggs were incubated was counted as day zero. On 
day 4 of incubation the eggs were taken out of the incubator 3 at a time, 
after being swabbed down with 70% ethanol and under sterile conditions 
the blunt end of eggs was struck with forceps to make a small hole.  Eggs 
were microinjected with 100µl of either neutral red dye dissolved in PBS, 
10% or 20% ethanol in PBS, or PBS alone, some eggs were also injected 
with 50 µl of PBS using a 25- gauge needle attached to a 1 ml disposable 
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syringe.  All injections were under the vitelline membrane through the air 
sac region.  After being injected the holes were sealed with parafilm and 
taped with insulating tape in order to avoid drying out of the embryos. 
Only viable embryos were injected in each group.  All the eggs were 
placed blunt end up into the automated egg turner and incubated at 37.5 °C 
and relative humidity of 60% with 5% CO2 in air until day 9 of incubation.  
Non treated embryos were just struck and sealed with parafilm and 
adhesive tape without any injection (chapter 2, section 2.2.3.1). 
4.2.1.  Sample collection and measurements 
On day 9 eggs were cracked under the sterile hood and embryos were 
examined in terms of their viability. After removing all the membranes 
viable embryos were examined for any growth retardation by measuring 
crown rump length, and any malformations or gross abnormalities 
observed including limb deformities, facial defects, and brain vesicle 
development according to the criteria shown in table 4.1 (chapter 2, section 
2.2.3.2). 
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Table 4.1. Morphological scoring system based on Hamburger and 
Hamilton staging of chick development (Hamburger & Hamilton, 1951). 
  
 
Hearts were then taken out and fixed in 10% formaldehyde.  All the hearts 
were kept at 4oC, until used for sectioning. 
4.2.2.  Paraffin tissue processing for sectioning 
Fixed hearts were taken through a series of processes starting from 
dehydration and clearing to wax impregnation before being sectioned as 
shown in chapter 2, section 2.2.3.3). 
EMBRYONIC 
FEATURE 
 
0 1 2 3 4 
VITELLINE 
CIRCULATION 
  5-6 large 
vitelline 
vessels 
Extensive 
network of 
vessels 
Entire 
vitelline 
membrane 
well 
supplied 
FLEXION None Cranial 
flexure 
visible 
Trunk 
rotation in 
addition to 
cranial 
flexion 
visible 
Trunk rotation 
and tail bud 
rotation visible 
Cranial 
flexure, 
trunk 
rotation and  
tail bud 
bending 
visible 
HEART No 
beating 
Paired heart 
primordia 
Beating heart 
bent to right 
Atrioventricular 
canal and 
ventricular loop 
Four-
chambered 
appearance 
BRAIN 
 
Primitive 
streak 
Neural 
folds 
visible 
Brain vesicle, 
Anterior 
neuropore 
closed 
Telencephalon 
enlarged, 
Forebrain forms 
right angle with  
hindbrain 
Enlarged 
and 
transparent, 
Forebrain 
parallel to 
hindbrain 
GROSS 
FACIAL 
DEFORMITIES 
None Primary 
optic 
vesicles 
Optic vesicles  
constricted at 
base 
Optic cup 
completely 
formed on one 
side 
Optic cup 
completely 
formed on 
both sides + 
beak is 
fully 
formed 
LIMBS None None None Digits and toes 
visible  
Digits and 
toes visible 
on both 
sides 
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4.2.3.  Automatic tissue processing 
An automatic tissue processor, (Leica TP1020) was used to perform all the 
above mentioned processes.  The tissues were sectioned at 25µm by 
microtome and slides were prepared using glass slides. 
4.2.4. Haematoxylin and Eosin staining 
Once all the slides were prepared, they were hydrated with water and then 
placed into the Haematoxylin solution for 5 minutes.  The haematoxylin 
was removed and tissues were washed with tap water.  Tissues were 
differentiated in acid alcohol to remove excess stain before bluing the 
nuclei in a saturated solution of lithium carbonate.  The tissues were again 
washed in tap water then placed in to 1% eosin for approximately 1-2 
minutes.  Excess stain was removed and slides were washed in tap water.  
Finally the tissues were dehydrated by passing through increasing 
concentrations of alcohol and allowed to dry before being covered with 
cover slips. 
4.3. Results 
This investigation was done as a pilot study to check the reliability of in 
ovo culture, which would be used in our future studies. Ethanol was used 
as a test chemical, with 2 different concentrations (10% and 20%).  
Embryos were scored according to the criteria shown in table 4.1.  
Embryos which were either kept untouched or only treated with PBS and 
neutral red dye showed no gross abnormalities.  Statistical analysis showed 
that the embryos treated with 10 and 20% ethanol were significantly 
different to other all groups in terms of forelimb developmental 
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abnormalities Fig 4.3 (E), brain vesicle defects figure 4.3 (D).  Also 
ethanol treated embryos had heart defects figure 4.3 (C) and gross facial 
malformations figure 4.3 (F) as compared to controls.  Moreover it was 
also observed that the embryos with ethanol treatment were smaller in 
length figure 4.2 (B) with less flexion, and also had a less vitelline 
circulation fig 4.3 (A).   
Histological examination of hearts showed dilated ventricles and few 
papillary muscles in both groups of ethanol treated embryos (fig4.1 C, D), 
while all other groups in this study showed no histological abnormalities of 
the hearts (figure 4.1 A, B, E).  
4.4. Conclusions 
The results of this chapter show that in ovo culture is a good model to 
detect developmental defects caused by teratogens.  In preliminary studies 
ethanol was used to check the reliability of this system, as ethanol is a 
known teratogen and proved to have toxic effects in many animal models.  
The chick embryos also show spectrum of malformations when treated 
with ethanol.  Also effects of vehicle control, dye and adhesive tapes were 
examined and none of them showed any defects in developing embryos.  
On the basis of these preliminary experiments, this system was chosen for 
further experiments with different teratogens. 
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Fig. 4.1 Showing 5 days old Chick Hearts without any treatment A, treated 
with PBS B, 10% Ethanol C, 20% ethanol D and Neutral red dye E.  
Fig E: Hearts treated with Neutral red  
Fig A: Heart without any treatment Fig B: Hearts treated with PBS 
only 
Fig C: Hearts treated with 10% Ethanol Fig D: Hearts treated with 20% Ethanol 
121 
 
Original magnification x200).  Black arrows indicate interventricular 
septum and white arrow indicates ventricular muscular wall. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Shows crown rump length of different groups of day 9 old chick 
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Chapter 5 
Evaluation of known teratogens on cardiomyocyte 
micromass culture and potential protective effects of 
vitamin supplementation 
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5.1. Introduction 
Proper nutrition during pregnancy plays an important role for normal 
growth and development of the fetus.  A healthy diet with both macro- and 
micronutrients is essential for a woman to sustain pregnancy, and also for 
appropriate growth of the fetus (Shah & Ohlsson, 2009).  This chapter aims 
to evaluate the effects of certain nutritional elements particularly vitamins 
and other drugs which might have some impacts on pregnancy and 
embryonic heart development.   
In order to investigate the effects, chick heart cells were cultured by 
micromass culture technique (chapter 2 section 2.1.4.5.2), a useful 
techniques for developmental toxicity studies.   Micromass is a culture of 
primary cells (heart or the brain and limb buds) at high density, obtained 
from chick, mouse or rat embryos (Flint & Orton, 1984; Wiger et al., 1988; 
Atterwill et al., 1992). 
5.1.1. Folate 
The term folate represents all forms of the B vitamin series with same 
structure and function, including many derivatives found in biological 
systems (Tamura & Picciano, 2006).  The primary ingested forms of folate 
include folic acid consumed in supplements and added to foods as the 
mono glutamyl form and the main naturally occurring folates that exist in 
various vegetables and fruits, such as tetra hydro folate species, are often in 
the poly glutamyl form (Gregory, 2001). 
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5.1.1.1. Structure of Folate 
Folic acid is composed of a pterin core ring, which is conjugated to para-
aminobenzoic acid by a methylene bridge to form pteroic acid as shown in 
fig 5.1. The carboxyl group of the para-amino benzoic acid is bound via a 
peptide to the alpha amino groups of glutamate to form folic acid. All three 
components must be present for biological activity (Moat et al., 2004). 
Fig.5.1. Structure of folic acid 
5.1.1.2. Sources of Folate 
All mammals lack the ability to synthesise folate de novo, as there are no 
folate forming enzymes present in them and therefore they depend entirely 
on preformed folates in the diet (Moat et al., 2004).  Folates which are 
consumed in the diet are either present in their natural form, found in green 
leafy vegetables e.g. broccoli, cauliflower, parsnips, fruits like oranges and 
pulses etc.  In addition liver and yeast extracts are also good sources of 
natural folates.  In the synthetic form (folic acid), they are found in many 
breakfast cereals, flour and some bread as a fortificant.  There are also 
several multivitamin supplements available in the market which contain 
folic acids (Hughes & Buttris, 2000; Williumson, 2006).  Food folates 
(natural) exist primarily as polyglutamate forms with bioavailability of 
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50% compared to that of folic acid (synthetic form) which is present as 
monoglutamate (Moat et al., 2004).       
5.1.1.3. Dietary recommendations 
It is advised by the expert advisory group on folic acid (1992) in UK that 
all women of child bearing age, who may become pregnant, should take a 
supplement of 400µg of folic acid/day until the 12th week of pregnancy and 
also try to consume foods which are rich sources of naturally occurring 
folates to prevent the occurrence of NTDs for the first time, while they 
should take 5mg/day to prevent recurrence of NTD (Williumson, 2006).  
5.1.1.4. Uses/Biochemical functions 
Folates play a role in the biosynthesis of pyrimidines and purines and thus 
in the synthesis of DNA and cell division.  High intake of folates reduces 
the risk of certain cancers, such as colorectal cancers and breast cancers, as 
well as cardiovascular diseases (Hughes & Buttris, 2000).  Folate has 
several important functions as a co enzyme including redox processing, 
DNA synthesis, protein metabolism and serving as a methyl donor (Dyke 
et al., 2002).  All these processes are essential for normal metabolism and 
homeostasis of the body; therefore any deficiency of folates leads to 
defective methylation and accumulation of cell metabolites and eventually 
disturbs normal homeostasis (Power et al., 2000).   
5.1.1.5. Absorption 
Absorption of dietary folate is a two step process which starts in the 
proximal small intestine. Enzymatic deconjugation in the intestine is 
catalysed by a pteroyl polyglutamate hydrolase associated with the jejunal 
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brush border membrane, with possibly some contribution by hydrolase 
activity from pancreatic secretions, whereas pure folic acid is absorbed 
unmodified or in the reduced or methylated form. The optimum pH for 
folate transport is ~5 while enzymatic deconjugation is ~6-7.  Physiological 
conditions or medications that alter the pH of small intestine could impair 
folate absorption.  The liver is the main storage organ of folates (Gregory, 
2001; Dyke et al., 2002).  
5.1.1.6. Role in embryogenesis 
An adequate supply of dietary folate in pregnancy is essential for normal 
embryonic development, including that of cardiovascular development, and 
its supplementation lowers the incidence of congenital defects (Tang et al., 
2004; Torrens et al., 2006).  Much of the birth defect data focus on the well 
substantiated relationship between folic acid and prevention of neural tube 
defects (Green, 2002).  It has been shown in several studies that 
supplemental folic acid can prevent >70% NTDs and spina bifida.  
Multivitamins that contain folic acid, have also been shown to prevent 
cardiovascular abnormalities, while a higher risk of abruptio placenta has 
been found in those mothers that are folate deficient (Burgoon et al., 2002). 
Several epidemiological studies showed an association between folic acid 
deficiency and the occurrence of congenital heart disease and a significant 
reduction of conotruncal heart defects with the daily intake of folic acid 
fortified cereals (Rosenquist et al., 1996; Hagroot et al., 2006). 
Moreover, it is also proved by experimental studies that additional 
supplementation with folic acid could prevent neural tube, orofacial and 
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conotruncal defects (Boot et al., 2003). However the mechanisms 
underlying this effect remain unidentified (Brauer & Rosenquist, 2002; 
Hobbs et al., 2005), but it is also thought that folate is intimately involved 
in the metabolism of homocystine and hyperhomocystinuria in maternal 
urine and a raised homocystine level in amniotic fluids is observed in the 
fetuses born with NTDs and cardiac defects (Brauer & Rosenquist, 2002). 
5.1.2. Vitamin C 
Vitamin C (ascorbic acid) is a water soluble micronutrient which is 
required for normal metabolic functioning of the body (Jaffe, 1984).  
Vitamin C acts as an antioxidant by removing oxygen derived free radicals, 
and thus protects the cells and tissues from damage by oxidation (Ames et 
al., 1993). Ascorbic acid acts an electron donor for different enzymes, and 
it also participates in the biosynthesis of nor-epinephrine from dopamine.  
In addition, L-ascorbic acid helps in the maintenance of integrity of 
connective tissue, and plays a preventive and therapeutic role in many 
diseases including cancer and atherosclerosis (Chen et al., 2005; Das et al., 
2006 ).                    
5.1.2.1. Sources of vitamin C 
Humans and other primates have lost the ability to synthesise vitamin C.  
Vitamin C or ascorbic acid is synthesised by liver cells in many animals 
(Nishikimi & Yagi, 1991) but not in humans due to a mutation in the gene 
coding for L-gulonolactone oxidase, an enzyme required for the 
biosynthesis of vitamin C via the glucoronic acid pathway.  So humans rely 
totally on their diet to get enough vitamin C.  Many citrus fruits and 
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vegetables e.g. broccoli, brussel sprouts, cauliflower, cabbage,  green leafy 
vegetables, red peppers, chillies, watercress, parsley, blackcurrants, 
strawberries, kiwi fruit, guavas, citrus fruits are a rich source of vitamin C 
and it is also commercially available in tablet forms (Asard et al., 2004). 
5.1.2.2. Recommended dose 
The current recommended dose during pregnancy in the western world is 
60-80 mg/day. The Tolerable Upper Level (UL) for adults is 2 g/day; the 
adverse effects upon which the UL is based are osmotic diarrhea and 
gastrointestinal disturbances (Rumbold & Crowther, 2005). 
5.1.2.3. Absorbtion, metabolism and excretion 
Once ingested, it is absorbed in the intestine through a sodium-dependent 
active transport process (Tsao, 1997; Rumsey & Levine, 1998).  Nearly 70 
to 90 percent of ingested dietary ascorbic acid (30 to 180 mg/day) is 
usually absorbed; however, absorption falls to about 50 percent or less with 
increasing doses at or above 1 g/day (Kallner et al., 1979). With large 
intakes of the vitamin, unabsorbed ascorbate is degraded in the intestine, 
which causes diarrhea and intestinal discomfort.  Cellular transport of 
ascorbic acid is mediated by transporters that vary by cell type (Jacob et 
al., 1992; Tsao, 1997).  Once taken up by the cells, it is localized mostly in 
the cytoplasm and exists predominately in the free reduced form as the 
ascorbate mono anion.  Apart from its dose dependant absorption, its levels 
are maintained in the body by renal excretion as well.  These two 
regulatory mechanisms allow conservation of ascorbic acid by the body 
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during low intakes and limitation of plasma levels at higher concentrations 
(Tsao, 1997).  
5.1.3. Vitamin E 
Vitamin E is a lipid soluble vitamin and includes a group of compounds 
with similar antioxidant activity.  It was in 1922 when Bishop and Evon 
discovered the indispensible role of vitamin E in reproduction of rats 
(Evans & Bishop, 1922).  Vitamin E was subsequently placed in the 
context of cellular antioxidant system and proved to be effective in 
preventing peroxidation of lipids and other free radical derived events in 
the body.  Epidemiological studies have reported a direct relation of 
vitamin E intake and reduced risks of cardiovascular diseases in dose 
dependent manner.  In 1966 the Cambridge Heart Antioxidant Study 
(CHAOS) reported that daily intake of vitamin E in patients with 
angiographically proved coronary atherosclerosis significantly reduced the 
incidence of myocardial infarction and death (Losonczy et al., 1996).  This 
could be due to decrease lipid peroxidation of low density lipoproteins 
(Wolf, 2005).  Apart from its antioxidant functions, vitamin E, in particular 
Į-tocopherol, also plays a significant role in cell signalling, it inhibits 
smooth muscle cell proliferation, increases phosphoprotein phosphatase 2A 
activity, and decreases protein kinase C activity.  Its effects on protein 
kinase C inhibition have been reported in human platelets and monocytes.  
Vitamin E also plays a critical role in the male reproductive system (Traber 
& Atkinson, 2007).  It prevents loss of spermatogenesis and thus helps in 
prevention of male infertility.  The deficiency of vitamin E in humans 
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causes abnormalities in neuromuscular systems and is characterized by 
ataxia, peripheral neuropathies and myopathies (Bieri et al., 1983).  These 
are likely to occur due to free radical damage to these tissues.  Patients with 
familial vitamin E deficiency present with many neurological symptoms 
such as cerebellar ataxia, absence of deep tendon reflexes, vibratory and 
proprioceptive sensory loss, dysarthria, and +ve BabinVNL¶V sign.  These 
symptoms can be ameliorated with up to 2000 mg of vitamin E per day 
(Ouahchi et al., 1995). 
5.1.3.1. Sources of Vitamin E 
9HJHWDEOHRLOVDUHWKHULFKHVWVRXUFHRIYLWDPLQ(7KHĮ-tocopherol is also 
found in nuts like almonds and walnuts and its synthetic analogues are 
present in tablet form as well.   
5.1.3.2. Structure of vitamin E 
Vitamin E family comprises of eight different forms of molecules of 
related structure, each consists of a chromanol ring and an aliphatic side 
FKDLQ7KHVHPROHFXOHVDUHV\QWKHVL]HGE\SODQWVDQGDUHFRQVLVWLQJRIĮ-, 
ȕ-Ȗ-DQGį-tocopherols and the corresponding four tocotrienols depending 
on the saturation or unsaturation of their side chain respectively (Mustacich 
et al., 2007) as shown in figure 5.2.  All these molecules possess vitamin E 
activity and act as antioxidants.  Apart from their antioxidant function they 
might have some other properties independent of their antioxidant activity 
(Schneider, 2005).  Out of all nDWXUDOO\RFFXUULQJYLWDPLQ(DQDORJXHVĮ-, 
DQGȖ- tocopherols are the most abundant in the human diet (Roy, 1999).  
Į- tocopherol is the only one which is maintained in human plasma and 
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WLVVXHV GXH WR WKH IXQFWLRQ RI KHSDWLF WUDQVIHU SURWHLQ  7KHUHIRUH Į-
tocopherol is the most biologically active form of vitamin E and is present 
in the membranes of cells and organelles, where it plays an important role 
in the suppression of lipid peroxidation (Traber et al., 2005).   
       
Fig.5.2. Structure of different forms of vitamin E  
www.vita-dose.com/structure-of-vitamin-e.html 
5.1.3.3. Metabolism of vitamin E 
Once ingested all forms of vitamin E (natural and synthetic) are absorbed 
in the intestine together with lipids.  They are then packed in to 
chylomicrons and transported to the liver via chylomicron remnants 
(Traber & Sies, 1996).  There is no discrimination between all forms of 
vitamin E until they are taken up by the liver. Once taken up by the liver, 
regulation of the forms and concentrations appear to take place.  The liver 
VHOHFWLYHO\ VRUWV RXW Į-tocopherol from all incoming forms for 
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incorporation in to VLDL.  This is probably due to the presence of a 
specLILF SURWHLQ FDOOHG Į WRFRSKHURO WUDQVIHU SURWHLQ Į-TTP).  All other 
forms are excreted via bile or urine (Traber, 2007).     
5.1.4. Retinoic acid 
Vitamin A (retinoic acid), a fat soluble vitamin, and its active metabolites 
play an essential role in various life processes including cell proliferation, 
differentiation, vision, reproduction and immune functions (Vliet et al., 
2001). These compounds are also used in chemoprevention of some 
cancers e.g. acute promyelocytic leukemia.  Isotretinoin, a vitamin A 
analogue, is effective in a wide variety of dermatologic disorders, including 
the treatment of severe, reluctant nodular acne refractory to conventional 
therapy (Robertson et al., 2005).   
Apart from its many effects on adults, Vitamin A also plays an important 
role during development, where it influences pattern formation of several 
organs including hind brain, heart, spinal cord, kidneys, and limb buds 
(Mic et al., 2003).   
Although these compounds are essential for normal development, both 
excess and deficiency results in developmental defects.  A constellation of 
birth defects called retinoic acid embryopathy which includes craniofacial, 
cardiac and thymic abnormalities result from excessive intake of retinoids 
(Mulder et al., 2000), while its deficiency or absence causes embryonic 
segmentation, growth failure and eventual resorption.  These 
considerations make it necessary to maintain retinoid homeostasis during 
developmental processes (Ross et al., 2000). 
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5.1.4.1. Sources of Retinoids 
No animal has the capability for de novo synthesises of Vitamin A and 
therefore it must be consumed in the diet (Tzimas & Nau, 2001).  The main 
sources of the preformed vitamin include animal foods (dairy products, 
liver, eggs etc.), fortified foods and pharmaceutical supplements, while 
several fruits and green leafy vegetables constitute rich sources for the 
provitamin form or carotenoids (Debier & Larondelle, 2005; Penniston & 
Tanumihardjo, 2006).   
In Western countries, 25-75% of the total dietary intake of vitamin A 
includes the preformed form while the rest is being taken as carotenoids 
(Blomhoff & Blomhoff, 2006).  
5.1.4.2. Structure of Retinoids 
The retinoids are composed of three distinct structural domains, a B ionone 
ring, an isoprenoid tail, and a polar end group with an oxidation state (Ross 
et al., 2000) as shown in fig 5.3. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5.3:http://www.vivo.colostate.edu/hbooks/pathphys/misc_topics/vitamina.ht
ml 
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5.1.4.3. Metabolism of Retinoids 
As mentioned previously, vitamin A is either ingested in the form of retinyl 
HVWHUVRUȕFDURWHQHV7KHVHUHWLQ\OHVWHUVDQGȕFDURWHQHVDUHK\GURO\VHG
to retinol and retinaldehyde in the intestine.  Both of them bind to CRBP 11 
protein.  The CRBP 11-retinol complex serves as a substrate for retinol 
acyltransferase enzymes which reconvert the retinol to retinyl esters 
(Collins & Mao, 1999; Petkovich, 2001).   
Once absorbed in enterocytes, these retinyl esters are packed in to 
chylomicrons, which are then taken up by hepatocytes.  In the liver these 
esters are again hydrolysed into retinol.  In satisfactory conditions, the 
newly formed retinol is transferred in the form of retinyl esters to hepatic 
stellate or Ito cells, where they can be stored in large quantities in the form 
of lipid droplets.  If the vitamin A status in the body is insufficient, the 
retinol is bound to retinoid binding protein (RBP), and secreted in the 
blood, and taken up by the cells either by specific receptors or by the 
particular lipid composition of the cell membrane.  Once inside the cell, the 
retinol is bound to cytoplasmic retinoid binding protein (CRBP) and 
oxidized to retinal and then retinoic acid.  Vitamin A can be metabolized in 
4 different ways, esterification, conjugation, isomerisation and oxidation.  
Each route will give rise to different metabolites.  Retinyl esters are formed 
from esterification, while conjugation produces retinyl ±ȕ-glucoronide.  
During isomerisation there is interconversion between all-trans-retinal and 
11-cis-retinal.  Retinol can be reversibly oxidized to retinal, while retinal 
once formed is oxidized to retinoic acid in an irreversible manner.   
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Excess vitamin A is either excreted in urine or by the faecal route (Clagett-
Dame & Deluca, 2002). 
5.1.4.4. Role of retinoids in embryogenesis 
Retinoic acid is an important signalling molecule during development, 
when administered in excess, RA produces striking teratogenic effects on 
early heart development.  Adverse effects include either lack or fusion of 
the paired cardiac primordia, impaired or reversed heart looping and 
truncation of the posterior portion of the heart tube with abnormal 
expansion of anterior structures.  All undesired effects depend on species, 
mode of administration and stage of development (Niederreither et al., 
2001).  However maternal insufficiency of vitamin A also results in 
abnormal heart development and leads to abnormalities in the ventricular 
chambers, sometimes causing premature differentiation of ventricular 
cardiomyocytes and defects in the outflow tract (Zile, 2001; Niederreither 
et al., 2003).   
5.1.5. Cadmium chloride 
Cadmium chloride is a non essential heavy metal with no known biological 
role in humans.  Environmental sources of cadmium include combustion of 
fossil fuel, certain agriculture fertilizers, mining residues etc (Vahter et al., 
1992).  It is also found in tobacco which is a significant source.  One 
cigarette contains about 1-2µg of cadmium (Lewis  et al., 1972 ).  
Cadmium has been implicated in various deleterious effects on different 
species due to its very long half life.  Cadmium is a well known 
developmental toxin.  Its teratogenicity in many vertebrates is well 
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documented, depending on the species and the stage of treatment.  
Cadmium exposure gives rise to many developmental defects in chick 
including limb and anterior body wall defects (Gilani & Alibhai, 1990; 
Thompson et al., 2005).  Environmental exposure to cadmium also 
produces developmental defects in other species including rats (Chen & 
Hales, 1994), mouse (Jeong et al., 2000), frog (Sunderman et al., 1992) and 
zebra fish (Chan & Cheng, 2003b; Hen Chow & Cheng, 2003).  
5.1.6. Sodium fluoride  
 Different forms of fluoride, including sodium fluoride have been added to 
drinking water by many countries to protect against dental caries.  Other 
sources of exposure are through toothpastes, mouth washes, dietary 
supplements and food (Mullenix et al., 1995).  Although it is an essential 
component for humans at low concentrations but if consumed more than 
1ppm, it causes fluorosis (Verma & Guna Sherlin, 2002), even if it is taken 
in lower concentrations but for prolonged duration it accumulates in 
different body tissues particularly bones and muscles and produce skeletal 
complications and locomotor impairment (Guna Sherlin & Verma, 2001; 
Verma & Sherlin, 2001; Verma & Guna Sherlin, 2002).  Studies also reveal 
an association of fluorosis and increased birth defects and low birth rate in 
humans. Epidemiological data suggest that occupational exposure to 
fluorine causes abnormalities in menstrual cycles, and increases the 
frequency of miscarriages and abortions in female workers (Al-Hiyasat et 
al., 2000).  Animal studies also show an association between excess 
fluoride consumption in water and diet by the mother and abnormal 
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embryonic development, particularly skeletal and brain abnormalities (Goh 
& Neff, 2003).  Furthermore excess fluoride has a toxic effect on the male 
reproductive system, resulting in abnormal spermatogenesis and infertility 
(Heindel et al., 1996; Pushpalatha et al., 2005; Izquierdo-Vega et al., 
2008). 
5.1.7. Ginseng 
Ginseng, a herbal medicine, has long been used as a tonic for prolonging 
life span, and is available without prescription (Poindexter et al., 2006).  It 
is employed by different people, including pregnant women (Gibson et al., 
2001).  In a recent survey, 9.1% of pregnant women reported use of herbal 
supplements (Gibson et al., 2001), including ginseng.  In Asian countries, 
up to 10% of women had taken ginseng during their pregnancy (Chin, 
1991).  Although it is a general belief that herbal medicines are much better 
and safer than conventional medicines, in fact many herbal medicines are 
actually associated with serious developmental toxic effects (DeSmet, 
1995).  Ginseng is a common term used for Asian ginseng (Panax ginseng), 
prepared from a different plant and Siberian ginseng.  Asian ginseng is 
commonly used as an antioxidant, anti-inflammatory agent, and an 
anticancer remedy (Kiefer & Pantuso, 2003).  It also believed to have 
cardioprotective effects.  Panax ginseng was reported to be effective in 
treating angina pectoris (Yuan et al., 1997).  It has also been used for its 
sedative, hypnotic, antidepressant, and diuretic activity. People usually take 
it to improve stamina, concentration, vigilance, and well-being (Ernst, 
2002).   
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The active components in Asian ginseng are called ginsenosides (Kiefer & 
Pantuso, 2003; Ma et al., 2005).  These ginsenosides are divided into two 
major groups, panaxadiol (Rb1and Rc) and panaxatriol (Rg1 and Re) 
(Attele et al., 1995).  One study conducted on rat embryos showed 
embryotoxic effects of Rb1 on embryonic development (Chan et al., 2003).  
Another study conducted by Chan et al on rat embryos revealed the 
embryotoxic effects of Rc and Re as well (Chan et al., 2004).  
Developmental defects were also observed in mouse whole embryo 
cultures by Liu and his colleagues (Liu et al., 2005a; Liu et al., 2006).  
Although teratogenicity of different ginsenosides is confirmed in different 
animal models, there is very little knowledge available on human data to 
date. 
 5.2. Materials and Methods 
Chick cardiomyocytes were seeded in 24 well plates at a concentration of 3 
× 106 in each well in the form of 20µl droplets.  They were incubated for 2 
hours to allow cellular attachment.  Then 500µl of DMEM growth medium 
was added and the cultures were left for 24 hours (chapter 2 section 
2.1.4.5.2).  The DMEM medium was replaced by different concentrations 
of test chemicals after 24 hours.   
5.2.1. Test chemical preparation 
The test chemicals were serially diluted from their stock solutions in 
DMEM supplemented culture medium to give a desired concentration 
(chapter 2 table 2.1). All chemicals were prepared and applied to 
micromass cultures within 1 hour of preparation. 
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5.2.2. End points 
The differentiation assay, resazurin reduction assay and kenacid blue assay 
were performed as described in chapter 2 (section 2.1.5.1 and 2.1.5.2 
respectively).  The cultures were inspected morphologically for 
cardiomyocyte contractile activity at 24, 48 and 144 hours, while resazurin 
and kenacid blue assays was performed at 144 hours. 
5.2.3. Statistical analysis 
All statistical analysis for this chapter was performed using Prism 5 (Graph 
pad Software Inc. San Diego, USA).  All results with different dose 
FRQFHQWUDWLRQV ZHUH FRPSDUHG XVLQJ RQH ZD\ $129$ ZLWK 'XQQHW¶V
multiple comparison post hoc test, with p < 0.05 was considered 
statistically significant. 
5.3. Results 
5.3.1. Folic acid 
Exposure of chick cardiomyocytes to various concentrations of folic acid 
ranged from 1µM to 1mM tested over a period of 144 hours did not cause a 
reduction in cellular differentiation, cell number or resorufin production.  
The graphs for resorufin production show that the resorufin produced by 
cardiomyocytes treated with folic acid is not significantly different to 
controls at any concentrations used (fig 5.4 a and 5.4 b).  The protein 
content of cardiomyocytes treated with folic acid is also not significantly 
different from controls at all concentrations used, as shown in fig. 5.4 c and 
5.4 d.  Statistical analyses of 24 hours post culture scores were not 
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significant due to the fact that no drug was added prior to their scoring.   
Moreover statistical analyses of day 24 and 120 hours post exposure also 
showed no significant difference to control for folic acid treated cells 
(1µM-1mM) (fig 5.4 e and f). 
5.3.1.1. Conclusions 
The concentrations of folic acid tested did not show any effect on cell 
viability or protein content.  The cellular differentiation and rate of beating 
were also not effected at all concentration of folic acid. 
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Fig: 5.4 f 
Fig 5.4. Shows resorufin production (a & b), protein content (c & d), and 
contractile activity of cardiomyocytes (d & e) with different concentrations of 
folic acid 
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5.3.2. Vitamin E 
The effect of exposure of chick cardiomyocytes to various concentrations 
of vitamin E (trolox) ranging from 10µM to 100µM were tested over a 
period of 144 hours.  All of these concentrations did not affect cellular 
proteins or cell viability. The graph for resorufin production shows that the 
resorufin produced by cardiomyocytes treated with vitamin E is not 
significantly different to controls at any concentrations used (fig5.5 a).  The 
protein content of cardiomyocytes is also not significantly different from 
controls at all concentrations used as shown in fig. 5.5 b.  Statistical 
analyses of 24 hours post culture scores were not significant because of the 
reason mentioned earlier.   However statistical analyses of day 24 and 120 
hours post exposure also showed no significant difference to control for 
vitamin E treated cells (fig 5.5 c).   
5.3.2.1. Conclusions 
The doses of vitamin E tested did not show any effect on cell viability or 
protein content.  The cellular differentiation and rate of beating were also 
not effected at all concentration.  
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Fig: 5.5 a 
Fig: 5.5 c 
Fig: 5.5 b 
Fig 5.5. Shows resorufin production (a), protein content (b), and contractile 
activity of cardiomyocytes (c) with different concentrations of vitamin E. 
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5.3.3. Vitamin C 
Exposure of chick cardiomyocytes to different concentrations of vitamin C 
(10µM-100µM), over a period of 144 hours did not show any reduction in 
cellular differentiation, cell viability, or cellular protein level. The graphs 
for resorufin production show that the resorufin produced by 
cardiomyocytes treated with vitamin C is not significantly different to 
controls at any concentrations used (fig 5.6 a).  These concentrations of 
vitamin C did not produce any reduction in cell protein (fig 5.6 b).   
Statistical analyses of 24, 48 and 144 hours also showed no significant 
difference to the control for vitamin C treated cells (fig 5.6 c). 
5.3.3.1. Conclusions 
The concentrations of vitamin C tested did not show any effect on cell 
viability or protein content.  The cellular differentiation and rate of beating 
were also not affected at all concentration of vitamin C. 
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Fig 5.6. Shows resorufin production (a), protein content (b), and contractile 
activity of cardiomyocytes (c) with different concentrations of vitamin C. 
147 
 
5.3.4. All trans retinoic acid 
All-trans retinoic acid is a fat soluble vitamin, and needs a solvent (ethanol) 
to be soluble in aqueous solutions.  The concentration of solvent was kept 
as low as possible (0.01%).  At that concentration ethanol did not show any 
significant effects on cell viability, protein content and contractile activity 
of cardiomyocytes.  The resorufin produced by micromass cultures 
exposed to 1µM or above was significantly less as compared to control 
(p<0.05) (Fig 5.7, a, b, c).  The maximum concentration at which there was 
no significant difference between cell viability in the test chemical and the 
control was 0.8µM.  Protein content of cardiomyocytes is also decreased as 
the concentration of retinoic acid increased as shown in (fig 5.8, a b, c).  
Statistical analyses showed a significant difference to controls at and above 
1µM (p < 0.05).  The chick cardiomyocyte cultures were observed for 
contractile activity and rate of beating foci immediately prior to retinoic 
acid exposure and 24 hours and 120 hrs post exposure.  There was no 
significant difference observed for contractile activity prior to the addition 
of retinoic acid.  However observations at 24 hrs post exposure showed that 
the cultures exposed to 1µM or above had a significantly decreased 
contractile activity and beating rate (p<0.05) as compared to controls.  At 
120 hours, cultures with 50µM or more had no contractile activity as 
compare to controls (fig 5.9, a, b, c).   
5.3.4.1. Conclusions 
Retinoic acid affected cell viability from as low as 1µM concentrations 
while total protein was also affected at and above 1µM.  Cellular 
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differentiation was also affected at and above 1µM concentration with no 
signs of recovery with time. 
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post hoc test}.  
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5.3.5. Cadmium Chloride 
The cardiomyocytes were treated with various concentrations of cadmium 
chloride ranging from 1µM to 100 µM.  The resorufin produced by 
micromass cultures exposed to 2µM or above was significantly less as 
compared to the control (p<0.05) (fig 5.10, a, b).  Protein content of 
cardiomyocytes is also decreased in direct proportion to increasing 
concentrations of cadmium chloride as shown in (fig 5.10, c, d).  Statistical 
analyses showed a significant difference to controls at and above 5µM (p < 
0.05).  There was no significant difference observed for contractile activity 
and rate of beating prior to the addition of cadmium chloride.  However 
observations at 24 hrs post exposure showed that the cultures exposed to 
2µM or above had a significantly decreased contractile activity and beating 
rate as compare to controls.  At 120 hours cultures with 50µM or more 
showed no contractile activity as compare to controls (p<0.05) (fig 5.10 e, 
f).   
5.3.5.1. Conclusions 
The concentrations of cadmium chloride tested in this study affected cell 
viability from as low as 2µM concentrations while total protein was 
affected at and above 5µM.  The cellular differentiation was also affected 
at and above 2µM concentration.  
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Fig 5.10. Shows resorufin production (a & b), protein content (c & d), and 
contractile activity of cardiomyocytes (d & e) with different concentrations of 
cadmium chloride. {* SSIRU'XQQHWW¶VDQG'XQQ¶VSRVWKRF
tests applied to parametric and non parametric data respectively}.  
}.  
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5.3.6. Sodium fluoride 
Exposure of chick cardiomyocytes to 10µM to 100µM of sodium fluoride 
over a period of 144 hours did not cause a reduction in cellular 
differentiation or resorufin production.  The cell proteins were also 
unchanged when the cells were exposed to the above concentrations of 
sodium fluoride. 
The graphs for resorufin production show that the resorufin produced by 
cardiomyocytes treated with sodium fluoride is not significantly different 
to controls at any concentrations used (fig 5.11 a).  The protein content of 
cardiomyocytes is also not significantly different from controls at all 
concentrations used as shown in fig. 5.11 b.  Statistical analyses of 24 
hours post culture scores were not significant because of the reason 
mentioned earlier.   However statistical analyses of day 24 and 120 hours 
post exposure also showed no significant difference to control for sodium 
fluoride treated cells (fig 5.11 c).   
5.3.6.1. Conclusions 
The concentrations of sodium fluoride tested did not show any effect on 
cell viability or protein content.  The cellular differentiation and rate of 
beating were also not effected at all concentration of sodium fluoride. 
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Fig 5.11. Shows resorufin production (a), protein content (b), and contractile 
activity of cardiomyocytes (c) with different concentrations of sodium fluoride. 
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5.3.7. Ginseng 
Ginsenosides (Rb1) exposure to chick cardiomyocytes in the range 
between 10µM to 100µM showed no reduction in cellular differentiation or 
resorufin production during the entire duration of culture.  The cellular 
proteins were also unchanged when exposed to the above concentrations of 
Rb1.  The resazurin assay shows, that the resorufin produced by 
cardiomyocytes treated with Rb1 is not significantly different to controls at 
any concentrations used (fig 12 a).  Furthermore the protein content of 
cardiomyocytes is also not significantly different from controls as shown in 
fig. 5.12 b. Statistical analyses of 24 hours post culture scores were not 
significant because of the reason mentioned earlier.   However statistical 
analyses of day 24 and 120 hours post exposure also showed no significant 
difference to control for Rb1 treated cells (fig 5.12 c). 
5.3.7.1. Conclusions 
The concentrations of ginsenosides used in this study did not show any 
effect on all endpoints checked. 
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Fig 5.12. Shows resorufin production (a), protein content (b), and contractile 
activity of cardiomyocytes (c) with different concentrations of ginsenoside 
(Rb1). 
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5.3.8. Retinoic acid with folic acid and vitamin C 
After investigating different concentrations of retinoic acid with potential 
cytotoxicity, further experiments were performed where folic acid and 
vitamin C were added to cultures already flooded with retinoic acid (10µM 
and 20µM) in order to detect any protective effect offered by 
administration of folic acid and vitamin C. 
Fig 5.13 a and 5.13 b, show the resazurin reduction assay.  Here the graph 
shows that addition of folic acid and vitamin C to retinoic acid can protect 
the cultures from the teratogenic effects of retinoic acid.  Cellular protein 
levels, affected by retinoic acid were also rescued by addition of folic acid 
and vitamin C as shown in fig 5.13 c and 5.13 d.  Cells were scored at 24, 
48 and 144 hrs.  Results show that addition of folic acid and vitamin C to 
retinoic acid treated cells can protect the cells from embryotoxic effects of 
retinoic acid (Fig 5.13 e and 5.13 f).    
5.3.8.1. Conclusion 
Addition of folic acid and vitamin C to retinoic acid treated cultures has 
protective effects against retinoic acid induced developmental toxicity. 
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Fig 5.13. Shows resorufin production (a & b), protein content (c & d), and 
contractile activity of cardiomyocytes (d & e) with different concentrations of 
UHWLQRLFDFLGSOXVP0IROLFDFLG^SIRU'XQQHWW¶VDQG'XQQ¶VSRVW
hoc tests applied to parametric and non parametric data respectively}.  
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5.3.9. Cadmium chloride with folic acid and vitamin C 
Results show that addition of folic acid and vitamin C to cadmium chloride 
treated cells could not protect the cells from its embryotoxic effects.  Fig 
5.14 a, 5.14 b, 5.14 c show resorufin produced by cells.  Results shows that 
addition of folic acid and vitamin C to cadmium chloride treated cells 
could not reverse the cytotoxic effects of cadmium chloride. Cellular 
protein levels, affected by cadmium chloride were also not rescued by 
addition of folic acid and vitamin C as shown in (fig 5.15 a, b, c).  
Similarly addition of folic acid and vitamin C has no protective effects on 
contractile activity which is decreased with cadmium chloride as shown in 
fig 5.16 a, b, c. 
5.3.9.1. Conclusions 
Addition of folic acid and vitamin C has no protective effects against 
cadmium chloride induced teratogenicity. 
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Fig 5.14. Shows resorufin production by cardiomyocytes with different 
concentrations of cadmium chloride plus vitamin C and folic acid (a, b, c).   
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Fig 5.15. Shows protein content of cardiomyocytes with different concentrations 
of cadmium chloride plus vitamin C and folic acid (a, b, c).  {** (p<0.01) for 
'XQQHWW¶Vpost hoc test}.  
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Fig 5.16. Shows contractile activity of cardiomyocytes with different 
concentrations of cadmium chloride plus vitamin C and folic acid (a, b, c).   
^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5.4. Discussion 
5.4.1. Folic acid 
In this study chick heart cells were treated with different doses of folic acid 
ranging from 1µM to 1mM, in order to establish a maximum dose which 
itself has no any teratogenic effects on cardiomyocytes.  We found that 
even at 1mM folic acid did not show any toxic effects on chick 
cardiomyocytes, which is consistent with the amount of folinic acid used to 
treat the malformations of branchial arch derived structures in rats in whole 
embryo culture by (Zhang et al., 2006).   
The relation of folic acid intake during the periconceptional period and 
reduction of the risk of neural tube defects is very well recognized as 
evidenced by many studies (Pitkin, 2007).  Recently studies conducted on 
animals as well as on humans suggest that folic acid might also be useful in 
decreasing other birth defects; in particular congenital heart defects, the 
most common of all birth defects (Botto & Correa, 2003; Botto et al., 
2003; Huhta & Hernandez-Robles, 2005).  In an animal study conducted by 
Li and colleagues in 2005 it was found that in mouse embryos deficiency 
of maternal folic acid lead to congenital heart defects (Li et al., 2005).  
Folic acid exerted its effects by affecting proliferation of the embryonic 
hearts.  Several possible mechanisms could be involved in decreasing 
cellular proliferation, as folic acid is essential for many vital cellular 
processes including nucleotide synthesis, amino acid synthesis, and 
methylation reactions (Botto et al., 2004).  These processes are essential 
for rapid mitosis and differentiation of embryonic cardiomyocytes.  The 
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other possible mechanism could be the elevation of homocysteine and 
decrease in methionine, which in turn affect DNA methylation and thus 
cell proliferation (Jongbloet et al., 2008).  
5.4.2. Vitamin E 
In this study experiments were conducted on chick micromass culture to 
establish a dose of vitamin E a known antioxidant, which has no cytotoxic 
effect on its own on cardiomyocytes. Vitamin E is a biological antioxidant 
known to prevent lipid peroxidation of cellular membranes by quenching 
free radicals thus it functionally protects the cells and tissues from free 
radical derived damage.  It is also required by many animal species such as 
rats, sheep and chickens to maintain normal growth rate (Brigelius-Flohe et 
al., 2002).       
5.4.3. Vitamin C 
Vitamin C, an antioxidant molecule in aqueous environments was also 
tested in this study, and a desirable dose was established with no toxic 
effects on chick cardiomyocytes in culture, in order to conduct further 
experiments, where its protective effects as an antioxidant were checked by 
adding it with various other chemical teratogens.    
5.4.4. Retinoic acid 
Retinoids are known human teratogens and therefore have been extensively 
investigated.  The teratogenic potential of all-trans retinoic acid on chick 
micromass culture was confirmed by our present work.  The effects were 
consistent for any of the three end points measured.  The reliability of 
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chick MM culture was tested by (Wiger et al., 1988), with retinoic acid as 
one of the test chemicals used to treat the limb bud cells.  Results reflected 
those found in our study, with inhibition of cellular differentiation, cell 
viability and protein synthesis in chick cardiomyocytes MM cultures 
exposed to all-trans retinoic acid.  Many animal studies have focused the 
teratogenic effects of retinoids on developing heart cells. In an 
investigation on the effects of retinoic acid on early heart development by 
Osmond and colleagues (Osmond et al., 1991), he found that retinoic acid 
produced a wide range of heart malformation when applied either to the 
whole embryo culture or implanted in the form of beads to the precardiac 
mesoderm.  In both of these experiments the embryos were treated with 
concentrations of retinoic acid ranged from 1µM to 100µM.  Although 
supporting the current study in some ways, Osmond et al did not find any 
killing of cells even at higher concentrations of retinoic acid (Osmond et 
al., 1991).  In contrast our study showed cell death at concentrations 
ranging from 20µM to 100µM.  In another study conducted on mouse 
whole embryo culture Zhang et al (Zhang et al., 2006), found large number 
of malformation including cranial NTDs, and branchial arch abnormalities 
in 100% of embryos exposed to 0.4µM concentration of retinoic acid.  The 
reason of cell death in our study on micromass system could be due to high 
concentrations of retinoic acid used or increased sensitivity of the 
micromass to retinoic acid, because in micromass culture the cells are in 
direct contact with the retinoic acid whereas in whole embryo culture the 
embryo is protected by the surrounding membranes and yolk sac.   
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Two families of nuclear receptors, named as retinoic acid receptors (RARs) 
and retinoic X receptors (RXRs) are involved in retinoic acid induced 
malformations.  Both of these receptors bind to DNA motifs (Retinoic acid 
response elements RARE) in the form of RAR/RXR heterodimers to 
function as ligand dependent trans-UHJXODWRUV  5$55;5Į DUH WKH PDLQ
functional units for retinoid signalling during development and 
transcriptional activation of both of these partners is often required for 
most of the physiological effects of retinoic acid during organogenesis 
(Matt et al., 2003; Niederreither et al., 2003).  
5.4.5. Cadmium chloride 
Cadmium chloride is one of the environmental toxins; generated as a result 
of waste disposal, coal combustion, iron and steel production and 
phosphate fertilizers manufactures.  Cadmium is known to produce its 
teratogenic effects in many species.  It is used in this study in a range of 
1µM to 100µM, which is in line with other cell culture studies, which used 
cadmium in micro molar concentrations (Chan & Cheng, 2003b; Yano & 
Marcondes, 2005).  The chick cardiomyocytes exposed to these 
concentrations stopped beating and cell viability assays showed a reduction 
in viability and total proteins.  Chow and Cheng (Chow & Cheng, 2003) 
VWXGLHG FDGPLXP¶V HIIHFWV RQ ]HEUD fish embryos at early stages of 
development and their results showed that cadmium had toxic effects on 
early development and these effects are due to apoptosis induced by it.  In 
another study Chan and his colleagues found that zebra fish embryos when 
exposed to more than 100µM concentrations of cadmium chloride during 
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the period of gastrulation showed developmental defects in the head and 
neck region, heart malformations, and had altered axial curvatures (Chan & 
Cheng, 2003a).  Similar types of malformations were also observed in 
xenopus embryos as well (Sunderman et al., 1992).  In our study cadmium 
shows toxic effects at very low concentrations, and showed an inhibition of 
beating that might be due to the fact that cadmium possibly alters the 
intercellular junctions, which result in abnormal rhythm and cell 
proliferation , Previous work conducted on chick embryo shows that 
cadmium exposure of chick embryos resulted in epidermal and lateral plate 
mesoderm defects, possibly due to its interference with intercellular 
junctions and cadherin molecules (Thompson et al., 2005). 
5.4.6. Sodium fluoride 
Fluoride is a naturally occurring component of water and high levels of it 
are usually found in mountainous areas (Izquierdo-Vega et al., 2008).  
Sodium fluoride was used in a range of 10µM-100µM to detect any 
potential teratogenic effect on chick embryonic hearts using micromass 
culture.  It was observed that, the concentrations used in this study had no 
toxic effect on the developing chick heart.  Verma and Sherlin, showed in 
their study that when pregnant rats were administered with 40mg/kg/day of 
sodium fluoride, they had significant reduction in their weight and had 
small uterine volume.  Furthermore their embryos showed mostly skeletal 
abnormalities with some subcutaneous haemorrhages (Verma & Sherlin, 
2001).  In another study no embryonic defects were seen when female rats 
and rabbits were given 27mg/kg/day sodium fluoride in drinking water.  
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Effects were observed at higher concentrations due to the reason that 
concentrations higher than that dose were unpalatable and pregnant rats 
and rabbits were reluctant to take any food even beyond that dose (Heindel 
et al., 1996).  Our results are consistent with these results as low doses of 
sodium fluoride used in this study also showed no developmental defects.  
An in vitro study on frog embryos showed developmental abnormalities in 
frog embryos at higher doses but not at lower doses.  The effect of sodium 
fluoride on frog embryos when applied directly could be due to its actions 
as an enzyme inhibitor and it may interact with chromosomes to produce 
developmental defects.  It activates the G- protein which in turn initiates a 
series of reactions, resulting in developmental defects in different 
embryonic tissues particularly skeletal and neuromuscular (Goh & Neff, 
2003).  Also excess sodium fluoride in body tissues causes an abnormality 
in cellular calcium, and causes hypocalcaemia, that could be a reason that it 
particularly affects those organs which are rich in calcium and utilize that 
in order to grow and perform their biological activities.       
5.4.7. Ginseng 
Ginseng is one of the most well-known natural herbal medicines, used 
widely in the treatment of various diseases.  It is also used as a cooking 
supplement; daily nourishment and health building remedy (Kitts & Hu, 
2000; Fu & Ji, 2003).  In this study ginsenoside Rb1 was tested on chick 
cardiomyocytes for its toxicological effects on developing chicks.  No 
significant teratogenic effects were observed at the doses (10µM-100µM) 
used in this study.  However previous work with mouse and rat embryos 
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cultured in vitro, showed that both Rb1 and Rg1 (another ginsenoside) 
when used in the range of 10-50µg/ml, had toxic effects on developing 
embryos (Liu et al., 2005a; Liu et al., 2005b).  However the two species 
appeared to have toxic effects at different concentrations of ginsenosides.  
The rat embryos appeared to be more sensitive than mouse embryos.  
Furthermore heart defects were obvious in rats while mouse embryos did 
not show any defects in the cardiovascular system (Liu et al., 2006).  The 
inconsistency between our results and previous results on rat and mouse 
embryos could be due to the dose of ginsenoside used in this study or due 
to the species difference.  The mechanism of ginseng toxicity is still 
unclear but it might be due to alterations in calcium channels (Poindexter et 
al., 2006).    
5.4.8. Retinoic acid with folic acid and vitamin C 
The present study also demonstrates a protective effect of folic acid and 
vitamin C when added to retinoic acid treated cardiomyocytes.  The 
effective concentration shown to have protective effect is 1mM and 100µM 
respectively.  Epidemiologic evidence also supports the protective effects 
of folic acid on development of the cardiovascular system in humans.  A 
case control study, conducted in Atlanta suggested a direct relationship for 
prevention of cardiac defects, especially outflow tract and ventricular 
septal defects, with periconceptional use of multivitamins containing folic 
acid (Botto et al., 2003).  Similar results were also found in a randomized 
control trial in Hungary which showed a reduction of 50% in cardiac 
defects with supplemental folic acid during pregnancy (Gardiner, 2006).   
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Although folic acid and vitamin C when added to retinoic acid treated 
cardiomyocytes offered protection against retinoic acid induced 
cytotoxicity, results also demonstrate that supplemental folate and ascorbic 
acid do not completely overcome the effects of RA particularly at higher 
concentrations. This may be due to the fact that more than one mechanism 
of action of RA is involved, as at present mechanism underlying the effects 
of folic acid on RA teratogenicity remain unknown (Zhang et al., 2006). 
5.4.9. Cadmium chloride with folic acid and vitamin C  
In this study we tried to overcome the toxic effects of cadmium chloride by 
addition of vitamins such as folic acid and vitamin C.  The results in this 
study suggest no preventive effects of folic acid and ascorbic acid against 
cadmium chloride induced developmental toxicity even at lower 
concentrations (5µM).  There are many mechanisms involved in cadmium 
induced teratogenicity; one possible mechanism could be the generation of 
reactive oxygen species as studies conducted on mouse and human 
SURPRQRF\WLFFHOOVVKRZHGWKDWSULRUWUHDWPHQWZLWKĮ-tocopherols and N-
acetyle-L-cysteine could prevent these cells from cadmium induced 
toxicity (Galán et al., 2001).  Another possible mechanism could be due to 
activation of calcium dependant endonucleases, as cadmium cation may 
mimic calcium channels and treatment with a calcium channel blocker 
could protect the cells from cadmium induced cell death (Azzouzi et al., 
1994).  In our study antioxidants did not show any protection against 
cadmium toxicity in micromass culture, due to the possibility of other 
mechanisms involved in cadmium induced cardiovascular abnormalities. 
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Chapter 6 
Effect of social drugs on chick cardiomyocyte 
micromass culture and chick embryos cultured in 
ovo, and potential protective effects of vitamin 
supplementation 
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6.1. Introduction 
This chapter evaluates the effects of two social drugs (Ethanol and 
Nicotine), which have known potential to produce teratogenic effects when 
consumed in excess during pregnancy.  Also this chapter aims to evaluate 
the potential protective effects of vitamins particularly folic acid and 
vitamin C in prevention of developmental defects of the heart brought 
about by these drugs.  Two different techniques (chick heart micromass 
and in ovo culture), using chick embryos were employed to investigate the 
effects.  
6.1.1. Ethanol 
Alcohol or ethanol, one of the most common environmental teratogens, 
when consumed in excess during pregnancy is associated with a wide 
spectrum of embryonic and fetal malformations in humans as well as in 
various animal species (Wentzel & Eriksson, 2006). The effects, often 
called fetal alcohol syndrome, usually result in early embryo resorption, 
second trimester miscarriage, growth retardation of the embryo, 
craniofacial abnormalities, and malformations of the central nervous 
system.  Apart from affecting the brain it also involves other vital organs 
like the liver, kidney and heart.  The most common heart abnormalities 
LQFOXGH DWULDO DQG YHQWULFXODU VHSWDO GHIHFWV )DOORW¶V WHWUDORJ\ DQG
abnormalities of the great vessels (Cavieres & Smith, 2000).  The majority 
of ethanol embryotoxicity effects are dose dependant and more obvious 
when it is consumed during the period of organogenesis, which 
corresponds to the third to the eighth week post implantation in humans 
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(Parnell et al., 2006).  According to the UK department of Health 
guidelines, the recommended dose of alcohol for pregnant women, or for 
one who is trying to become pregnant, should not exceed 1 or 2 UK units 
once or twice a week (1 UK unit contain 8g of alcohol).  Despite all the 
guidelines regarding alcohol consumption, data shows that alcohol 
consumption has increased during the last two decades (Henderson et al., 
2007). 
The precise mechanism for ethanol induced embryonic dysmorphogenesis 
has not yet been completely clarified. However, various experimental 
studies suggest more then one factor is involved.  One possible mechanism 
could be the action of metabolic end products of ethanol such as 
acetaldehyde, which in turn produce excessive amounts of reactive oxygen 
radicals and generate oxidative stress and could result in abnormal 
development of the embryo (Aberle et al., 2003).  However some studies 
also argue that it is the ethanol itself which is responsible for the 
production of excessive amounts of free radicals, rather than its end 
products (Reimers et al., 2004).  Reactive oxygen radicals are produced as 
a by-product of many metabolic reactions and are regulated at 
physiological levels by antioxidant defence mechanisms of the body, as 
well as by antioxidants present in the diet, when consumed in the 
recommended range.  At physiological levels these reactive oxygen 
radicals participate in various cell processes especially in tissue 
remodelling, hormone signalling, steroidogenesis and germ cell function in 
adults as well as in embryos (Hossein et al., 2007). If antioxidants are not 
sufficient to maintain their physiological limits, these oxidative radicals 
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cause damage to lipids, DNA and proteins and result in malformations of 
the embryo (Jauniaux et al., 2004).  Studies have also suggested that fetal 
tissues have a more compromised or less active antioxidant system than 
adult tissue; thus embryos would be more sensitive to oxidative injury 
(Reimers et al., 2006).  
6.1.2.  Nicotine 
Maternal smoking is considered to be one of the leading causes of 
congenital malformations.  Active and passive smoking is an important risk 
factor for the developing fetus in every trimester of pregnancy (Jauniaux & 
Burton, 2007).  Smoking during the periconceptional period affects the 
development of major organs of the fetus including, the central nervous 
system, cardiovascular system and skeletal system.  Also it results in 
perinatal complications such as preterm delivery, stillbirth, low birth 
weight, and high perinatal mortality (Kallen, 1999).  Moreover, children of 
mothers who smoke during pregnancy have an increased risk of developing 
behavioural problems, attention deficits, hyperactivity and learning 
disabilities and nicotine dependence later in life (Morales-Suarez Varela et 
al., 2009).  Cigarette smoke introduces at least two thousand toxins into the 
blood stream, including cyanides, sulphides, cadmium, carcinogenic 
hydrocarbons and nicotine (Zhang & Ratcliffe, 1993).  Among all these 
toxins, nicotine is considered to be the major teratogenic constituent.  
Nicotine is a low molecular weight substance and is quickly absorbed into 
the blood stream from the lungs and oral cavity.  It can also easily cross the 
placenta, with resultant relatively higher concentration of nicotine and its 
metabolites in the fetus (Yildiz, 2004).  Nicotine exerts its effects by acting 
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on nicotinic acetylcholine receptors. These receptors in turn increase ion 
influx including Ca2+.  Increased concentrations of calcium ions, disturbs 
intracellular signalling and cell function.  As a result of disruption of 
cellular function, there is increased production of reactive oxygen species 
(ROS), leading to oxidative stress (Ermak & Davies, 2002).  Furthermore it 
has also been shown that increased concentrations of nicotine in the body 
compartments result in decreased activities of free radical scavenging 
enzymes.  As a consequence of these events, excessive free radicals exert 
their toxic effects on many cellular organelles in different tissues and cause 
deleterious injury.  In one study conducted on rat brain, Gumustekin, K. 
and his colleagues found a protective effect of vitamin E on nicotine 
induced damage (Gumustekin et al., 2003).  Similarly, protective effects of 
vitamin C, another antioxidant, were also observed on nicotine induced 
oxidative stress (Kelly, 2003).   
This study is aimed at detecting any toxic effects of ethanol and nicotine on 
chick cardiomyocytes cultured in vitro and chick embryos in ovo.  Also to 
investigate any possible protective effects of antioxidants vitamin C and 
folic acid on ethanol and nicotine induced toxicity.                                      
6.2. Materials and Methods 
6.2.1. Micromass Culture 
Chick heart cells were seeded in 24 well plates at a concentration of 3 × 106 
in each well in the form of 20µl droplets.  They were incubated for 2 hours 
to allow cellular attachment.  Then 500µl of DMEM growth medium was 
added and the cultures were left for 24 hours (Chapter 2, section; 
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2.1.4.5.2).  The DMEM medium was replaced by different concentrations 
of test chemicals after 24 hours.  
6.2.1.1. Test chemical preparation 
The test chemicals were serially diluted from their stock solutions (Chapter 
2 table 2.1) in DMEM supplemented culture medium to give a desired 
concentration (Ethanol 10µl/ml, 20µl/ml, 50µl/ml, 100µl/ml; Nicotine 
2µM, 5µM, 10µM, 20µM; vitamin C 100µM; folic acid 1mM; superoxide 
dismutase (SOD) 2µM.  All chemicals were prepared and applied to 
micromass cultures within 1 hour of preparation. 
6.2.1.2. End points 
The differentiation assay, resazurin reduction assay and kenacid blue assay 
were performed as described in (Chapter 2, sections2.1.5.1 and 2.1.5.2).  
The cultures were inspected morphologically for cardiomyocyte contractile 
activity at 24, 48 and 144 hours, while resazurin and kenacid blue assays 
was performed at 144 hours. 
6.2.2. In Ovo culture 
White leghorn fertilized chicken eggs were incubated as described in 
(Chapter 2, section 2.2.3.1.  At day 3 of incubation, eggs with viable 
embryos were either kept untouched or injected with 100µl of ethanol or 
nicotine (100µl/ml or 10µM respectively), vitamin C (100µM), folic acid 
(1mM), ethanol plus vitamin C or folic acid, nicotine plus vitamin C or 
folic acid or PBS, by making a hole on their blunt end.  Eggs were then 
sealed, labelled and re-incubated with the blunt end up till day 9 of 
incubation.  On day 9, embryos were taken out under sterile conditions and 
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examined under a dissecting microscope for any gross malformations and 
scored according to the criteria shown in table 4.1 (Chapter 4). 
6.2.2.1. Test chemical preparation 
The test chemicals were serially diluted from their stock solutions (Chapter 
2 table 2.1) in PBS to give a desired concentration (ethanol 100µl/ml, 
nicotine 10µM, folic acid 1mM, and vitamin C 100µM.  All chemicals 
were prepared and applied to chick embryos in ovo within 1 hour of 
preparation. 
6.2.3. Statistical analysis 
All statistical analysis for this chapter was performed using Prism 5 
(Graphpad Software Inc. San Diego, USA).  All results were compared 
using one way ANOVA with Dunnett¶V DQG'XQQ¶V multiple comparison 
post hoc tests, where p < 0.05 was considered statistically significant. 
6.3. Results 
6.3.1. Results of micromass culture  
6.3.1.1. Results of ethanol treatment 
The aim of this part of the study was to detect the developmental toxicity 
of ethanol in chick cardiomyocytes cultured in the micromass system and 
also to see any protective effects of antioxidant vitamin C and folic acid.  
Furthermore to confirm antioxidant activity of folic acid and vitamin C, 
SOD (an antioxidant enzyme) was added to ethanol treated cultures. 
Cells were scored at 24, 48 and 144 hours and results are shown in fig 6.1 
(a).  The graph shows a clear trend of decreased cardiomyocytes beating at 
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all concentrations of ethanol.  Statistical analyses were performed on 
results for all the days on which the cells were scored.  At 24 hours there 
was no significant difference between cell scores but this was to be 
expected as scoring was performed just before addition of chemicals.  
However this does confirm the reliability of results as all the wells were 
starting at the same level of differentiation prior to treatment with 
chemical. 
Statistical analyses of cell scores on day 2 showed a significant difference 
(p< 0.05) between cell scores of ethanol treatment and controls.  Results 
also show that addition of folic acid and vitamin C to ethanol treated cells 
can protect the cells from the embryotoxic effects of ethanol (fig 6.2 a and 
6.2 b).  Results also show that addition of SOD to ethanol treated cultures 
had protective effects against ethanol induced toxicity (fig 6.3 a).  
Fig 6.1 (b) shows the results of the resazurin reduction assay.  Here again 
the graph shows a highly significant difference (p<0.05) in the amount of 
resorufin being produced, and hence the cell viability, at 50 and 100µl/ml 
ethanol.  This would suggest that ethanol is cytotoxic to cells. The results 
also show that addition of 100µM vitamin C or 1mM folic acid to 100µl/ml 
ethanol (the highest concentration of ethanol used in this study) can protect 
the cultures from the toxic effects of ethanol, as the results with addition of 
folic acid and vitamin C were comparable to the control respectively (fig 
6.2 c and 6.2 d).  Moreover addition of SOD to ethanol treated 
cardiomyocytes has the same effects as folic acid and vitamin C (fig 6.3 b). 
The protein content of cardiomyocytes is also decreased at 50 and 
100µl/ml ethanol as shown in fig 6.1 c.  Statistical analyses showed a 
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significant difference to controls (p < 0.05).  The results also show that 
addition of 100µM folic acid and vitamin C to ethanol can protect the 
cultures from the cytotoxic effects of ethanol as the values were 
comparable to controls (fig 6.2 e and 6.2 f).  Here again addition of SOD to 
ethanol has protective effects and proteins were comparable to the control 
(fig 6.3 c). 
6.3.1.1.1. Conclusion 
The micromass results indicate that addition of vitamin C and folic acid 
could protect the heart cells from toxic effects of ethanol. 
  
182 
 
 
  
Figure 6.1: Shows cell scoring (a), resazurin assay (b), and protein assay (c) with 
different concentrations of ethanol.  ^SSIRU'XQQHWW¶VDQG
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6.2 a 
6.2 e 
6.2 b 
6.2 d 
Figure 6.2: Shows cell scoring (a,b), resazurin assay (c,d), and protein assay 
(e,f) with ethanol plus folic acid and vitamin C.  {* (p<0.05); ** (p<0.01) for 
'XQQHWW¶VDQG'XQQ¶VSRVWKRFWHVWVDSSOLHGIRUSDUDPHWULFDQG non 
parametric data respectively}. 
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6.3 c 
Figure 6.3: Shows cell scoring (a), resazurin assay (b), and protein assay 
(c) with ethanol plus SOD.  ^SIRU'XQQHWW¶VDQG'XQQ¶VSRVW
hoc tests applied for parametric and non parametric data respectively}. 
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6.3.1.2. Results of Nicotine treatment 
The aim of this part of the study was to detect the developmental toxicity 
of nicotine in chick cardiomyocytes cultured in the micromass system and 
also to see any protective effects of antioxidant vitamin C and folic acid. 
Cells were scored at 24, 48 and 144 hours and results are shown in fig 6.4 
a.  The graph shows that at 10µM nicotine, cardiomyocytes showed less 
contractile activity on day 2 and had no any beating on day 6.  Statistical 
analyses showed that at 24 hours there was no significant difference 
between cell scores but this was to be expected as scoring was tested just 
before addition of chemicals.    Statistical analyses of cell scores on day 2 
and 6 showed a significant difference (p< 0.05) between cell scores at 
nicotine (10µM) and controls.  Results also show that addition of folic acid 
and vitamin C to nicotine treated cells can protect the cells from the 
embryotoxic effects of nicotine (fig 6.5 a and 6.6 a). 
The graph for the resazurin reduction assay shows a decrease in the amount 
of resorufin produced by nicotine treated cells (10µM), but that is not 
significantly different to controls (fig 6.4 b).  The results also show that the 
cells treated with addition of 1mM folic acid or 100µM vitamin C to 
nicotine are comparable to controls (fig 6.5 b and 6.6 b). The protein 
content of cardiomyocytes is also decreased at 10µM nicotine as shown in 
fig 6.4 (c).  However statistical analyses showed no significant difference 
to controls. The results also show that the cells treated with addition folic 
acid and vitamin C in addition to nicotine were comparable to controls (fig. 
6.5 c and 6.6 c). 
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Figure 6.4: Shows cell scoring (a), resazurin assay (b), and protein assay (c) 
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SIRU'XQQ¶VSRVWKRFWHVW` 
188 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell Scoring
C
o
n
tr
o
l
M
 
N
ic
o
tin
e
P
10
M
 
Vi
ta
m
in
 
C
P
10
0
N
ic
o
tin
e+
 
VC
0
1
2
3
24hrs
48hrs
144hrs
C
on
tr
a
c
til
e
 
a
c
tiv
ity
 
o
f
c
a
rd
io
m
yo
c
yt
e
s
**
Cell Viability
Co
n
tr
o
l
M
 
Ni
co
tin
e
P
10
M
 
Vi
ta
m
in
 
C
P
10
0
Ni
co
tin
e+
VC
0
250
500
750
1000
1250
1500
1750
2000
2250
2500
Re
so
ru
fin
 
Pr
o
du
ct
io
n
6.6 a 
6.6 b 
Protein Determination
Co
nt
ro
l
M
 
Ni
co
tin
e
P
10
M
 
Vi
ta
m
in
 
C
P
10
0
Ni
co
tin
e+
VC
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
Pr
ot
ei
n 
Co
nt
en
t
6.6 c 
Figure 6.6: Shows cell scoring (a), resazurin assay (b), and protein assay 
(c) with nicotine plus vitamin C.  ^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6.3.2. Results of In Ovo culture 
6.3.2.1. Results of Ethanol 
Ethanol significantly reduced overall survival of embryos to less than 60%, 
while the survival rate of the remaining groups was more than 90%.  Also 
embryos which were treated with PBS, showed no gross abnormalities (fig 
6.7 a), while embryos cultured with ethanol were growth retarded and 
showed obvious gross malformations of the face, anterior thoracic and 
abdominal wall and limbs as compared to controls (fig 6.7 b). However 
embryos treated with vitamin C and folic acid in addition to ethanol 
showed no gross malformations and none of them was growth retarded as 
shown in fig 6.7 c and d respectively.  Histological examination of the 
hearts clearly shows that whereas in the control there are clearly three 
chambers visible (fig 6.8 a), in the ethanol treated embryo the heart has 
failed to develop correctly and only one chamber is visible (fig 6.8 b).  
Treatment with additional vitamin C (fig 6.8 c) or folate (fig 6.8 d) restores 
normal development.  Statistical analyses of crown rump length of embryos 
showed a decrease in length of ethanol treated embryos (p<0.05), while 
embryos with vitamin C and folic acid in addition grew normally and were 
comparable to control, as shown in fig 6.9. Moreover Statistical analyses of 
other parameters including vitelline circulation (fig 6.10 a), flexion of the 
embryo (fig 6.10 b), heart development (fig 6.10 c), craniofacial structures 
(fig 6.11 a), brain development (6.11 b) and limb development (6.11 c) 
show a significant difference between ethanol treated embryos and control 
(p<0.05). Here again addition of vitamin C and folic acid restored normal 
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development of all organ systems such that the embryos were comparable 
to control.  
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Figure 6.7: Shows control embryos (a), embryos treated with ethanol (b), ethanol plus 
vitamin C (c) and folic acid (d).  The figure clearly demonstrates the abnormal development 
of eyes (E), midbrain (MB), and limb buds (LB) with ethanol treatment, however addition of 
folic acid and vitamin C rescued the embryos and they are comparable to control. Original 
magnification 200x. 
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Figure 6.8: Shows H&E staining of control hearts (a), treated with ethanol (b), 
ethanol plus vitamin C (c) and folic acid (d).  Black arrows indicate 
interventricular septum which is not developed in ethanol treated hearts and 
white arrows indicate ventricular muscular wall which is also very thin in 
ethanol treated hearts as compared to controls and the hearts treated with vitamin 
C and folic acid in addition to ethanol.  Original magnification 200x. 
a 
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Figure 6.9: Shows crown rump length of embryos treated with ethanol, 
plus vitamin C and folic acid.  ^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Figure 6.10: Shows vitelline circulation (a) flexion of embryo (b) and heart 
malformations (c) of embryos treated with ethanol, plus vitamin C and 
folic acid.  ^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Figure 6.11: Shows facial malformations (a) and brain development (b) and limb 
development (c) of embryos treated with ethanol, plus vitamin C and folic acid.  
^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Figure 6.11: Shows facial malformations (a) and brain development (b) and limb 
development (c) of embryos treated with ethanol, plus vitamin C and folic acid.  
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6.3.2.2. Results of Nicotine treatment 
The embryos treated with nicotine were growth retarded (fig 6.12 b) as 
compared to embryos treated with PBS, which showed no gross 
abnormalities (Fig 6.12 a),  However treatment of embryos with vitamin C 
and folic acid in addition to nicotine showed no gross malformations and 
none of them was growth retarded as shown in fig 6.12 c & d respectively.  
Histological examination of the hearts  shows that hearts of nicotine treated 
embryos (fig 6.13 b) show no abnormalities and were comparable to 
controls (fig 6.13 a).  Also histological examination of hearts treated with 
additional vitamin C or folate were comparable to controls (fig 6.13 c & d 
respectively).   Statistical analyses of the crown rump length of embryos 
showed a decrease in length of nicotine treated embryos (p<0.05), while 
embryos with vitamin C and folic acid in addition grew normally and were 
comparable to control, as shown in fig 6.14.  Moreover Statistical analyses 
of other parameters including vitelline circulation (fig 6.15 a), flexion of 
the embryo (fig 6.15 b), heart development (fig 6.15 c), cranio facial 
structures (fig 6.16 a), brain development (fig 6.16 b) and limb 
development (fig 6.16 c) show no significant difference between nicotine 
treated embryos, control and vitamin C and folic acid treated embryos.  
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Figure 6.12: Shows control embryos (a), embryos treated with nicotine (b), nicotine 
plus vitamin C (c) and folic acid (d).  This figure demonstrates that the development of 
the eyes (E), midbrain (MB) and limb buds (LB) is not affected by nicotine treatment 
as these features are comparable in nicotine treated embryos and rest of the groups, 
however nicotine treated embryos are smaller in size as compare to other groups.  
Original magnification 200x. 
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Figure 6.13: Shows H&E staining of control hearts (a), treated with 
nicotine (b), nicotine plus vitamin C (c) and folic acid (d).  Black arrows 
indicate interventricular septum and white arrows indicate ventricular 
muscular wall.  The figure shows that there are no histological 
abnormalities observed in nicotine treated embryonic hearts as compare to 
other groups.  Original magnification 200x. 
a b 
c d 
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Figure 6.14: Shows crown rump of embryos treated with ethanol, plus vitamin C 
and folic acid.  {** (p < 0.0IRU'XQQHWW¶VSRVWKRFWHVW` 
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6.4. Discussion 
Ethanol and nicotine are known human teratogens and therefore have been 
extensively investigated.  This study was conducted to study ethanol and 
nicotine induced developmental toxicity and also to investigate any 
protective effects of vitamin C and folic acid in preventing teratogenic 
effects brought about by ethanol and nicotine, both in vitro and in ovo 
using chick embryos.  Avian embryos were chosen as a model system for 
these studies as these are cost effective, easy to handle, less time 
consuming, involve no maternal sacrifice and provide reliable results. The 
teratogenic potential of ethanol on chick micromass culture, as well as in 
ovo culture, was confirmed by our present work.  The effects were 
consistent for both culture systems used.  While teratogenic effects of 
nicotine on chick micromass was confirmed in this study, the dose of 
nicotine which showed toxic effects on cardiomyocytes in culture had not 
shown toxic effects on chick embryos cultured in ovo, except growth 
retardation. 
Using the chick micromass system the effects observed were consistent for 
any of the three end points measured.  The reliability of chick micromass 
culture was tested by Wiger et al (Wiger et al., 1988) with many toxic 
chemicals used to treat the limb bud cells.  The main finding of our in ovo 
study for ethanol was that ethanol when injected caused a destruction of 
many organ systems of chick embryos.  With ethanol about half of the 
embryos were dead and almost all remaining embryos were 
underdeveloped and showed features of fetal alcohol syndrome including 
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gross craniofacial malformations. These findings are consistent with 
previous studies performed on different animal species including rats, 
mouse and zebra fish, which showed similar types of abnormalities when 
treated with ethanol (Reimers et al., 2006; Wentzel & Eriksson, 2006; 
Wentzel et al., 2006).  Our findings also suggest that most embryos had 
optic defects, which are similar to those found by Yelin et al (Yelin et al., 
2007), when he applied ethanol to Xenopus embryos.  It is not possible to 
relate our findings of developmentally toxic levels of ethanol precisely 
with humans; however, studies conducted on humans showed a direct 
relationship of ethanol consumption in excess of the recommended dose 
and potential malformations in the offspring (Jones & Smith, 1973).  
Ethanol consumption is also one of the major risk factors for non-inherited 
causes of congenital heart disease especially ventricular and septal heart 
defects.  However two case control studies conducted in Atlanta and 
Finland showed no significant difference in fetal cardiac malformation 
between alcoholic and non alcoholic mothers (Jenkins et al., 2007).  This 
could be due to the smaller study size or the dose of alcohol consumed.   
 Nicotine administration has teratogenic effects on many animal species.  
In one study conducted by Zhao and Reece on mouse embryos, nicotine 
was shown to have teratogenic effects in a dose dependant manner.  The 
mouse embryos treated with nicotine were growth retarded (Zhao & Reece, 
2005).  These findings are consistent with this study as the majority of 
embryos treated with nicotine were growth retarded.  However in another 
study conducted on rat embryos show that carbon monoxide was the major 
contributing factor for low fetal birth weight   (Carmines & Rajendran, 
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2008).  The epidemiological studies conducted on humans also showed a 
relationship between tobacco smoking and congenital malformations. The 
results of one study conducted in the Baltimore±Washington area, show an 
association between maternal cigarette smoking of more than one pack per 
day and cardiovascular malformations, including: transposition of great 
vessels with ventricular septal defect and pulmonary stenosis.  Similarly a 
relationship between maternal smoking and increased risk of neonates born 
with congenital heart diseases was observed in a case-control study 
conducted in Lithuania .XþLHQơ 	 'XOVNLHQơ . However some 
epidemiological studies also show no association between smoking and 
congenital malformations (Kallen, 1999; Scherbak Y. et al., 2007). 
The present study also demonstrates a protective effect of Vitamin C and 
folic acid on ethanol and nicotine treated cardiomyocytes in vitro as well as 
in ovo.  The effective concentration of vitamin C shown to have a 
protective effect is 100µM which is consistent with the amount of vitamin 
C used by Peng et al (Peng et al., 2005) to treat ethanol induced growth 
retardation and microcephaly in Xenopus laevis embryos.  The 
concentration of folic acid with protective effect is 1mM which is similar 
to the amount of folinic acid used to treat the malformations of branchial 
arch derived structures in rats in whole embryo culture by Zhang et al by 
(Zhang et al., 2006).  In a case control study, conducted in Atlanta a direct 
relationship of prevention of cardiac defects, especially outflow tract and 
ventricular septal defects, with periconceptional use of multivitamins 
containing folic acid and vitamin C was suggested (Botto et al., 2003; 
Botto et al., 2004; Willcox et al., 2008).  Similar results were also found in 
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a randomized control trial in Hungary which showed a reduction of 50% in 
cardiac defects with supplemental folic acid during pregnancy (Gardinar, 
2006).   
The present study also confirmed this as results with addition of the potent 
antioxidant enzyme SOD were similar to those with addition of these two 
vitamins. The observations that supplemental vitamin C and folic acid 
offered a remarkable protection against the effects of ethanol and nicotine 
might be due to their antioxidant properties, as has been shown by animal 
studies conducted on chick and rat embryos (Henderson et al., 1995; Nasha 
et al., 2007).  These studies proposed an involvement of oxidative stress 
produced by the generation of free oxygen radicals when embryos were 
exposed to ethanol, and suggest a critical role for reactive oxygen species 
in the teratogenic actions of ethanol.  Under these conditions, reactive 
oxygen species may be continuously formed as a by product of metabolic 
reactions.  Furthermore such reactive oxygen species have also been linked 
with embryonic heart defects (Hobbs et al., 2005) caused by a variety of 
environmental toxins and maternal diseases.  However the extent of 
reactive oxygen species production and the subsequent likelihood of a 
developmentally toxic effect depend on the time and dose of exposure.  
Therefore, in order for normal development of embryos to be achieved 
under conditions where free radicals or reactive oxygen species are 
generated at abnormally high levels, there must be a balance between free 
radical generation and Vitamin C, which may be useful in promoting 
degradation of free radicals (Barrow et al., 2000).  In fact embryos have 
less protective mechanisms against free radicals compared to adults 
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(Reimers et al., 2006), therefore antioxidant supplements, like folic acid 
and Vitamin C, may be useful in protecting embryos against damage.  
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Chapter 7 
Effect of diabetic condition on chick cardiomyocyte 
micromass culture and chick embryos cultured in 
ovo, and potential protective effects of vitamin 
supplementation 
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7.1. Introduction 
Diabetes mellitus (DM) is characterized by abnormalities in carbohydrate, 
protein and lipid metabolism, caused by the complete or relative 
inadequacy of insulin secretion and/or insulin action. Diabetes in 
pregnancy is associated with an increased risk of maternal and fetal 
morbidity and mortality, and remains a significant medical challenge. 
Diabetes in pregnant women may be divided into clinical diabetes or 
pregestational diabetes (women previously diagnosed with type 1 or type 2 
diabetes) and gestational diabetes (GDM), which is defined as any degree 
of glucose intolerance with onset or first recognition during pregnancy 
(Forsbach-Sanchez et al., 2005; AmericanDiabetesAssociation, 2009).  
GDM represents nearly 90% of all pregnancies complicated by diabetes 
(AmericanDiabetesAssociation, 2006), and it affects 2-5% of all 
pregnancies (Crowther et al., 2005).  Both type 1 and type 2 pregestational 
diabetic conditions are associated with early and late complications of 
pregnancy, while gestational diabetes is associated with complications in 
the second-half of pregnancy.  However all types of diabetes are related to 
metabolic complications in the newborn (Hanson & Persson, 1993; Kjos & 
Buchanan, 1999; Platt et al., 2002).  Maternal diabetes significantly 
increases the risk for embryonic malformations (Vercheval et al., 1990).   
These malformations arise at the early stages of organogenesis, 
approximately the first 8 weeks of pregnancy (Evers et al., 2004).  The 
most frequently observed malformations are congenital heart and central 
nervous system defects (Macintosh et al., 2006).   The cardiac 
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malformations include endocardial cushion (EC) defects, persistent truncus 
arteriosus (PTA) and ventricular septal defects (VSD) (Loffredo et al., 
2001).  Despite all clinical interventions to achieve a good glycemic 
control during and before pregnancy, the rate of congenital malformations 
is still higher in the offspring of diabetic mothers than non-diabetic 
mothers.  The underlying mechanisms of these defects are not known, 
several teratological pathways are involved in diabetic induced 
malformations (Zhiyong, 2010).  These teratogenic pathways include 
alterations of metabolic and signalling pathways such as metabolism of 
arachidonic acid, inositol, sorbitol, folic acid, reactive oxygen species and 
alterations in the activation of protein kinase C (PKC).  Many experimental 
studies suggest a partial role for reactive oxygen species (ROS) in diabetes 
induced congenital defects (Eriksson & Borg, 1991).  Accumulation of 
reactive oxygen species is a result of either excessive free oxygen radical 
formation or decreased ability of scavenging enzymes or both.  Excessive 
glucose metabolism in embryonic and fetal cells, exposed to increased 
levels of glucose could be a triggering factor behind diabetic induced 
oxidative stress.  Another possibility of diabetic embryopathy is 
accumulation of excessive ketone bodies.  One primary source of 
production of ROS is mitochondria which receive excessive amounts of 
pyruvate and oxygen and produce a large quantity of free radicals in 
electron transport chain reactions (Yang et al., 1997).  These ROS, 
particularly superoxide, leak from the mitochondria and initiate a cascade 
of events, which result in the formation of other radicals including 
hydrogen peroxide hydroxyl radicals.  This oxidative stress may induce 
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DNA damage by either altering expression of key genes or enhancing 
apoptosis (Lee et al., 1999).  These events result in dysmorphogenesis of 
different organ systems in diabetic embryopathy.   
This chapter aims to investigate the effects of high glucose and ketone 
ERG\ ȕ K\GUR[\EXW\ULF DFLG FRQFHQWUDWLRQV RQ FKLFN FDUGLRP\RF\WHV
cultured in vitro, and chick embryos in ovo.  This chapter also investigates 
the protective effects of antioxidants (folic acid and Vitamin C) on diabetic 
induced heart defects in chick embryos. 
7.2. Materials and Methods 
7.2.1. Micromass Culture 
Chick heart cells were seeded in 24 well plates at a concentration of 3 × 106 
in each well in the form of 20µl droplets.  They were incubated for 2 hours 
to allow cellular attachment.  Then 500µl of DMEM growth medium was 
added and the cultures were left for 24 hours (chapter 2 section 2.1.4.5.2).  
The DMEM medium was replaced by different concentrations of test 
chemicals after 24 hours.  
7.2.1.1. Test chemical preparation 
The test chemicals were serially diluted from their stock solutions (Chapter 
2 table 2.1) in DMEM supplemented culture medium to give a desired 
concentration JOXFRVHP0ȕK\GUR[\EXW\ULF DFLGP0 IROLFDFLG
mM and vitamin C 100µM. All chemicals were prepared and applied to 
micromass cultures within 1 hour of preparation. 
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7.2.1.2. End points 
The differentiation assay, resazurin reduction assay and kenacid blue assay 
were performed as described in chapter 2 sections 2.1.5.1 and 2.1.5.2.  The 
cultures were inspected morphologically for cardiomyocyte contractile 
activity at 24, 48 and 144 hours, while resazurin and kenacid blue assays 
was performed at 144 hours. 
7.2.2. In Ovo culture 
White leghorn fertilized chicken eggs were incubated as described in 
chapter 2 section 2.2.3.1. At day 3 of incubation, eggs with viable embryos 
were either kept untouched or injected with 100µl of JOXFRVH ȕ
hydroxybutyric acid (20mM+10mM respectively), vitamin C (100µM), 
IROLFDFLGP0JOXFRVHȕK\GUR[\EXW\ULFDcid plus vitamin C or folic 
acid, or PBS, by making a hole on their blunt end.  Eggs were then sealed, 
labelled and re-incubated with the blunt end up till day 9 of incubation.  On 
day 9, embryos were taken out under sterile conditions and examined under 
a dissecting microscope for any gross malformations and scored according 
to the criteria shown in table 4.1 Chapter 4.  
7.2.2.1. Test chemical preparation 
The test chemicals were serially diluted from their stock solutions (Chapter 
2 table 2.1) in PBS to give a desired concentration (glucose 20 mM ȕ
hydroxybutyric acid 10mM, folic acid 1 mM and vitamin C 100µM). All 
chemicals were prepared and applied to chick embryos in ovo within 1 
hour of preparation. 
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7.2.3. Statistical analysis 
All statistical analysis for this chapter was performed using Prism 5 
(Graphpad Software Inc. San Diego, USA).  All results were compared 
using one way ANOVA with Dunnett¶V DQG'XQQ¶Vmultiple comparison 
post hoc tests, with p < 0.05 was considered statistically significant. 
 
7.3. Results 
7.3.1. Micromass culture 
7.3.1.1. Effects of high glucose and ȕ-hydroxybutyric acid 
concentrations 
The aim of this in vitro study was to detect the teratogenicity of high 
FRQFHQWUDWLRQV RI JOXFRVH DQG ȕ-hydroxybutyric acid (ketone body) on 
chick heart cells cultured in the micromass system.  
A range of different concHQWUDWLRQVRIJOXFRVHDQGȕ-hydroxybutyric acid 
was investigated, with the potential to produce teratogenic effects on 
FDUGLRP\RF\WHV LQ PLFURPDVV FXOWXUH  &RQFHQWUDWLRQV RI JOXFRVH DQG ȕ-
hydroxybutyric acid tested ranged between 5mM to 20mM for both 
chemicals.   
Cells were scored at 24, 48 and 144 hours.  Statistical analyses were 
performed on results for all the days on which the cells were scored.   At 24 
hours there was no significant difference between cell scores but this was 
to be expected as scoring was tested just before addition of chemicals.  
This does confirm the reliability of results as all the wells were starting at 
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the same level of differentiation prior to treatment with chemical.  
Statistical analysis of 48 hrs and 122 hrs post exposure shows that glucose 
has no effect on contractile activity of cardiomyocytes at all concentrations 
XVHG  D ZKLOH FHOOV H[SRVHG WR KLJKHU FRQFHQWUDWLRQ P0 RI ȕ
hydroxybutyric acid showed minimal or no beating at 122 hours post 
exposure (fig 7.2 a).  However when cells were exposed to both of them 
WRJHWKHU LQ FXOWXUH DW FRQFHQWUDWLRQV P0  JOXFRVH DQG P0 ȕ-
hydroxybutyric acid) which have no effect independently, a clear trend of 
decreased cardiomyocytes beating is observed at 122 hours post exposure 
(fig 7.3 a).    
Fig 7.1 (b) 7.2 (b) and 7.3 (b) show the results of the resazurin reduction 
assay.  Here again the graph shows no significant difference in the amount 
of resorufin being produced, and hence the cell viability, with glucose 
treatment (7.1 b  :LWK P0 ȕ- hydroxybutyric acid treatment, a 
reduction in resorufin production and hence cell viability was observed (fig 
7.2 b).  The results also show that synergistic effects of combined glucose 
DQGȕ-hydroxybutyric acid result in decrease cell viability (fig 7.3b).  The 
FHOOV H[SRVHG WR FRPELQHG JOXFRVH DQG ȕ-hydroxybutyric acid treatment 
were significantly different to controls (p < 0.05).  
The protein content of cardiomyocytes was also decreased with synergistic 
HIIHFWV RI JOXFRVH DQG ȕ-hydroxybutyric acid (fig 7.3 c), which was not 
observed with individual treatment at any concentration as shown in fig 7.1 
c and 7.2 c respectively.  Statistical analyses of cells treated with glucose 
DQGȕ-hydroxybutyric acid showed a significant difference to controls (p < 
0.05).  
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(IIHFWVRIIROLFDFLGDQGYLWDPLQ&RQKLJKJOXFRVHDQGȕ-
hydroxybutyric acid treated chick cardiomyocytes. 
The aim of this part of study was to investigate any protective effects of 
antioxidant vitamin C and folic acid on chick cardiomyocytes, cultured in 
KLJK JOXFRVH DQG ȕ-hydroxybutyric acid concentrations, in micromass 
system.  
Cells were scored as described in the previous section at 24, 48 and 144 
hrs.  Results show that addition of vitamin C and folic acid to cells, treated 
ZLWK FRPELQHG JOXFRVH DQG ȕ K\GUR[\EXW\ULF DFLG FDQ SURWHFW WKH FHOOV
IURP WKH HPEU\RWR[LF HIIHFWV RI FRPELQHG JOXFRVH DQG ȕ K\GUR[\EXW\ULF
acid treatment (fig 7.4 a and 7.5 a).  Statistical analysis showed that 
contractile activity of cells exposed to FRPELQHG JOXFRVH DQG ȕ
hydroxybutyric acid treatment was significantly different to controls (p 
<0.05).  However cells treated with folic acid and vitamin C in addition to 
FRPELQHGJOXFRVHDQGȕK\GUR[\EXW\ULFDFLGWUHDWPHQWZHUHFRPSDUDEOHWR
controls (fig 7.4 a and 7.5 a).  
Results of resazurin assay also show that addition of folic acid and vitamin 
C can protect the cultures from the toxic effects of diabetic conditions, as 
the results with addition of folic acid or vitamin C and were comparable to 
the control (fig 7.4 b and 7.5 b). 
The kenacid blue protein assay results also show that addition of folic acid 
DQG YLWDPLQ & WR FXOWXUHV WUHDWHG ZLWK FRPELQHG JOXFRVH DQG ȕ
hydroxybutyric acid can protect the cultures from their cytotoxic effects as 
the values were comparable to controls (fig 7.4 c and 7.5 c).  
7.3.1.2.1. Conclusion 
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It is concluded from these results that diabetic conditions (high glucose and 
ȕ-hydroxybutyric acid) result in cardiovascular malformations.  Moreover 
results also showed that addition of antioxidants such as folic acid and 
vitamin C reversed toxic effects of diabetic environment.  
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Figure 7.1: Shows cell scoring (a), resazurin assay (b), and protein assay 
(c) with different concentrations of glucose 
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Figure 7.2: Shows cell scoring (a), resazurin assay (b), and protein assay 
(c) with GLIIHUHQWFRQFHQWUDWLRQVRIȕ-hydroxybutyric acid.  {* (p<0.01); 
SIRU'XQQHWW¶VDQG'XQQ¶VSRVWKRFWHVWDSSOLHGWRSDUDPHWULF
and non parametric data respectively}.  
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Figure 7.3: Shows cell scoring (a), resazurin assay (b), and protein assay 
FZLWKGLIIHUHQWFRQFHQWUDWLRQVRIȕ-hydroxybutyric acid and glucose.  
^SIRU'XQQHWW¶VDQG'XQQ¶VSRVWKRFWHVWDSSOLHGWR
parametric and non parametric data respectively}. 
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Figure 7.4: Shows cell scoring (a), resazurin assay (b), and protein assay 
(c) with combined ȕ-hydroxybutyric acid and glucose, plus folic acid.  
^SIRU'XQQHWW¶VDQG'XQQ¶VSRVWKRFWHVWDSSOLHGWR
parametric and non parametric data respectively}. 
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Figure 7.5: Shows cell scoring (a), resazurin assay (b), and protein assay 
FZLWKFRPELQHGȕ-hydroxybutyric acid and glucose, plus vitamin C.  
^SIRU'XQQHWW¶VDQG'XQQ¶VSRVWKRFWHVWDSSOLHGWR
parametric and non parametric data respectively}. 
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7.3.2. Results of In Ovo Culture 
'LDEHWLF FRQGLWLRQ JOXFRVH DQG ȕ K\GUR[\EXW\ULF DFLG VLJQLILFDQWO\
reduced overall survival of embryos.  Control embryos showed no gross 
abnormalities, while embryos with diabetic condition were growth retarded 
and showed obvious external malformations as compared to controls (fig 7. 
6 a, 7.6 b).  However treatment of embryos with vitamin C and folic acid in 
addition to diabetic conditions showed no gross malformations and none of 
them was growth retarded as shown in fig 7.6 c and 7.6 d respectively.   
H& E staining of the hearts (Fig 7.7 a) shows that in control embryos the 
heart chambers are clearly visible, while in embryos treated with glucose 
DQG ȕ K\GUR[\EXW\ULF DFLG ILJ  E WKH KHDUW KDV IDLOHG WR GHYHORS
correctly.  Treatment with additional folate or vitamin C restores normal 
development (fig 7.7 c and 7.7 d).  Statistical analyses of crown rump 
length RI HPEU\RV VKRZHG D GHFUHDVH LQ OHQJWK RI JOXFRVH DQG ȕ
hydroxybutyric acid treated embryos (p<0.05), while embryos with folic 
acid and vitamin C in addition grew normally as shown in fig 7.8.  
Moreover Statistical analyses of other parameters including vitelline 
circulation (fig 7.9 a), flexion of the embryo (fig 7.9 b), heart development 
(7.9 c), gross facial abnormalities (fig 7.10 a), brain development (fig 7.10 
b), and limb development (fig 7.10 c), show a significant difference 
EHWZHHQ JOXFRVH DQG ȕ hydroxybutyric acid treated embryos and control 
(p<0.05).  Here again addition of folic acid and vitamin C restored normal 
development of all organ systems such that the embryos were comparable 
to the control. 
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Figure 7.6: Shows control embryos (a), embryos treated with glucose and 
ȕ-K\GUR[\EXW\ULFDFLGEJOXFRVHDQGȕ-hydroxybutyric acid plus vitamin 
C (c), JOXFRVH DQG ȕ-hydroxybutyric acid plus folic acid (d).  The figure 
clearly demonstrates the abnormal development of eyes (E), midbrain 
(MB), and limb buds (LB) with glucose plus ȕ-hydroxybutyric acid 
treatment, however addition of folic acid and vitamin C rescued the 
embryos and they are comparable to control. Original magnification 200x. 
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Figure 7.7: Shows H&E staining of control hearts (a), treated with glucose 
DQG ȕ-K\GUR[\EXW\ULF DFLG E JOXFRVH DQG ȕ-hydroxybutyric acid plus 
vitamin C (c) and folic acid (d).  Black arrows show interventricular 
VHSWXPZKLFKLVQRWGHYHORSHGQRUPDOO\LQJOXFRVHSOXVȕK\GUR[\EXW\ULF
acid treated embryonic hearts as compare to other groups while white 
arrows indicate ventricular muscle which is also very thin in  glucose plus 
ȕ K\GUR[\EXW\ULF DFLG WUHDWHG HPEU\RQLF KHDUWV DV FRPSDUH WR RWKHU
groups.  Original magnification 200x. 
a 
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Figure 7.8: Shows crown rump length of embryos treated with glucose and 
ȕ-hydroxybutyric acid, plus vitamin C and folic acid.  {** (p <0.01) for 
'XQQHWW¶VSRVWKRFWHVW` 
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Figure 7.9: Shows vitelline circulation (a) flexion of embryo (b) heart 
morphology F WUHDWHG ZLWK JOXFRVH DQG ȕ-hydroxybutyric acid, plus 
vitamin C and folic acid.  ^SIRU'XQQHWW¶VSRVWKRFWHVW` 
 
227 
 
 
Gross Fascial Malformations
Co
n
tr
o
l
PB
S 
 
hy
dr
o
E
G
lu
c
o
s
e
+
Vi
t C
 
hy
dr
o
+
VC
E
G
+
0
1
2
3
4
**
M
o
rp
ho
lo
gi
ca
l s
co
rin
g
Gross Fascial Malformations
Co
n
tr
o
l
PB
S 
 
hy
dr
o
E
G
lu
c
o
s
e
+ Fo
lic
 
a
c
id
 
hy
dr
o
+
FA
E
G
+
0
1
2
3
4
**
M
o
rp
ho
lo
gi
ca
l s
co
rin
g
Brain Development
Co
n
tr
o
l
PB
S 
 
hy
dr
o
E
G
lu
c
o
s
e
+
Vi
t C
 
hy
dr
o
+
VC
E
G
+
0
1
2
3
4
**
M
o
rp
ho
lo
gi
ca
l s
co
rin
g
Brain Development
Co
n
tr
o
l
PB
S 
 
hy
dr
o
E
G
lu
c
o
s
e
+ Fo
lic
 
a
c
id
 
hy
dr
o
+
FA
E
G
+
0
1
2
3
4
**
M
o
rp
ho
lo
gi
ca
l s
co
rin
g
Limb Development
Co
n
tr
o
l
PB
S 
 
hy
dr
o
E
G
lu
c
o
s
e
+ Fo
lic
 
a
c
id
 
hy
dr
o
+
FA
E
G
+
0
1
2
3
4
**
M
o
rp
ho
lo
gi
ca
l s
co
ri
n
g
Limb Development
Co
n
tr
o
l
PB
S 
 
hy
dr
o
E
G
lu
c
o
s
e
+
Vi
t C
 
hy
dr
o
+
VC
E
G
+
0
1
2
3
4
**
M
o
rp
ho
lo
gi
ca
l s
co
rin
g
Figure 7.10: Shows gross facial malformations (a) brain development (b) 
limb development F WUHDWHGZLWKJOXFRVHDQGȕ-hydroxybutyric acid, plus 
vitamin C and folic acid.  ^SIRU'XQQHWW¶VSRVWKRFWHVW` 
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7.4. Discussion 
Diabetes mellitus is one of the frequent metabolic pregnancy complications 
associated with an increased risk of maternal and neonatal morbidities.  In 
fact, uncontrolled diabetes during pregnancy is associated with serious 
medical conditions in the fetus.  If it remains uncontrolled during the 
period of organogenesis, it leads to severe congenital malformations of 
major organ systems including the central nervous system and 
cardiovascular system.  Late pregnancy complications of uncontrolled 
diabetes result in neonatal morbidity and mortality.  Several 
epidemiological studies show that despite good glycemic control, the 
number of congenital malformations in diabetic mothers is still higher than 
in non-diabetics (Evers et al., 2004; Macintosh et al., 2006).   
This study was carried out to investigate possible teratogenic effects of 
diabetic environment on development of the cardiovascular system of chick 
embryos.  Also to evaluate potential preventive effects of two antioxidant 
vitamins; vitamin C and folic acid.  Two different techniques (micromass 
culture and in ovo culture) were employed to detect the possible toxicity of 
diabetes.  Results of micromass culture show that experimental diabetic 
conditions (high glucose and ketone body) result in a decreased contractile 
activity and viability of heart cells.  Moreover results of in ovo culture also 
show that with experimental diabetic conditions survival of embryos was 
affected.  Also embryos show gross abnormalities of the central nervous 
system and facial structures.  The findings of this study indicate that 
glucose treatment even at higher concentrations (20mM) has no toxic effect 
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on heart cells; this could be due to the fact that cells rely on glucose for 
their nourishment and use it as an energy source.  However, previous 
studies on animal models show that a high glucose concentration is a sole 
teratogenic factor for the development of congenital malformations (Datar 
& Bhonde, 2005; Gäreskog et al., 2007).   Some studies suggested that 
other metabolic factors may also be responsible for the higher 
malformation rates. The diabetic state is characterized by elevated levels of 
glucose as well as ketones, amino acids, lipids, glycerol and lactate, all of 
which might also contribute to the development of anomalies and early 
fetal loss (Shum & Sadler, 1988).  In fact, some experimental studies have 
shown higher number of teratogenic effects when embryos (mouse, rats) 
were cultured in high concentrations of ketones (Moley et al., 1994; 
Fujimoto et al., 1997; Eriksson, 2009).   
The mechanism of teratogenicity of high levels of glucose and ketone 
bodies in diabetes involves many factors.  One of the key factors is 
oxidative stress, which is proved in many experimental studies.  The effects 
of free radicals are normally controlled by administration of wide range of 
antioxidants (Viana et al., 2000; Zhiyong, 2010).  In this study chick heart 
cells and chick embryos were also treated with antioxidants vitamin C and 
folic acid.  Our results show that addition of both of these vitamins to chick 
heart cells and chick embryos treated with diabetic conditions reversed the 
WR[LF HIIHFWV RI KLJK JOXFRVH DQG ȕ-hydroxybutyric acid.  Our results are 
consistent with previous studies conducted on rat embryos (Cederberg & 
Eriksson, 2005; Wentzel & Eriksson, 2005).  Supplementation by 
antioxidants in diabetic mothers during pregnancy may be helpful in 
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preventing diabetes induced malformations, and thus reduce overall 
mortality and morbidity in the offspring.      
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Chapter 8 
Effect of various teratogens and vitamin supplementation on 
expression and distribution of Cx43 
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8.1. Introduction 
8.1.1. Gap junctions and connexins 
Gap junction channels form conduits between adjacent cells and thus they 
allow the transfer of small molecules of less than 1000Da (Söhl & 
Willecke, 2004).  They also allow intercellular propagation of current 
carrying ions between excitable cells, including cardiac muscle, smooth 
muscle and nerves. Gap junction mediated communication between cells is 
vital for many cellular processes, such as cellular differentiation, 
embryonic development and growth (Musil & Goodenough, 1991).   
Gap junctions are made up of a family of integral membrane proteins 
called connexins (Cx).  The first gene of this family of proteins was cloned 
and sequenced from rat hepatocytes, in 1986 by Paul and his colleagues 
(Paul, 1986).  Since then, at least 21 members in humans and 19 members 
in mouse have been cloned (Willecke et al., 2002; Willecke et al., 2005).  
It is well known that almost all cells in vertebrates contain gap junctions.  
Some connexins are expressed in specific tissues while some connexions, 
like connexion 43, are expressed in a variety of tissues (Solan & Lampe, 
2005). 
The most widely used nomenclature for connexins is according to their 
molecular weight in kilo Daltons preceded by the suffix Cx.  There are 
some other ways of denoting connexins and these depend on connexin 
VXEIDPLOLHVHJĮDQGȕHWF (Dbouk et al., 2009). 
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8.1.1.1. Structure of Connexins 
The connexin polypeptide contains four transmembrane domains (M1, M2, 
M3 and M4), separated by a cytoplasmic loop between M2 and M3, and 
two extra cellular loops (E1 and E2) between M1 and M2, M3 and M4 
respectively (Veen et al., 2001).  It also has a short cytoplasmic amino 
terminal (NT) and a carboxyl cytoplasmic terminal (CT) as shown in fig 
8.1.   The two extracellular loops are joined together by disulfide bonds and 
are involved in docking and functional assembly of gap junction channels.  
While most connexins exhibit similarities in their transmembrane domain, 
extracellular loop and amino terminal, they differ considerably in terms of 
the size of their cytoplasmic loop and the length of carboxyl terminal 
(Beyer et al., 1995; Laird, 2005).  
  
Fig 8.1. Structure and arrangement of connexins at gap junction plaques. 
http://en.wikipedia.org/wiki/Connexin 
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8.1.1.2. Formation and degradation of Connexins and Gap junctions 
Once translated by ribosomes, connexins are incorporated in endoplasmic 
reticulum where they are aligned and folded properly to be used in the 
formation of hemichannels (Huang et al., 2009).  All misfolded connexins 
are degraded by proteosomes.  Once correctly folded, these proteins follow 
a classic secretory pathway, which involves transport through the Golgi 
apparatus.  Most of the connexins, in particular Cx 43, oligomerize in to 
connexons, while in the trans-Golgi network rather than in the endoplasmic 
reticulum.  Oligomerization of six connexin monomers in to half an 
intercellular channel (a connexon) is necessary for gap junction formation 
(Musil & Goodenough, 1991).  However, some studies also suggest that 
oligomerization of some connexins e.g. Cx 32 and 26 takes place within 
the endoplasmic reticulum or in the Golgi apparatus.  Newly formed 
connexons are transported in a closed state, via vesicles or tubules towards 
plasma membranes, where they appear as hemichannels.  These 
hemichannels would pair with connexons from the neighbouring cell and 
form gap junction channels (Sosinksky, 1995).  Some of the adhesion 
molecules particularly Ca2+ dependant cadherins play a crucial role in the 
formation of gap junction channels.  Gap junction channels cluster to form 
gap junction plaques, which are the functioning units of gap junctions. Gap 
junction channels typically form between the same type of cells and are 
called homocellular gap junctions.  But there is some evidence of gap 
junction channels between different cell types and these are termed 
heterocellular gap junctions (Sandow et al., 2003).  In vitro and in vivo 
studies also show evidence of homomeric (composed of same connexin) 
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and heteromeric (composed of more then one connexin) connexons within 
the same cells due to the presence of more than one connexin type in the 
same cell.   
          
Fig. 8.2. Arrangement of homomeric and heteromeric connexons. 
Intercellular communication via gap junctions is regulated by connexin 
synthesis and degradation.  Connexins are very dynamic structures with a 
very short half life.  These proteins follow two major pathways for their 
degradation; the lysosomal pathway and the proteosomal pathway.  Most of 
the studies on degradation pathways utilized connexin 43 due to the fact 
that it is the most abundant.  Degradation by the proteosomal pathway is 
used for those proteins which are either misfolded or not properly 
oligomerized and unable to take part in the formation of gap junctions.  
Degradation by the lysosomal pathway usually involves connexons from 
the centre of gap junction plaques, which detach and are internalized to 
form membrane bounded structures called annular gap junctions.  These 
annular gap junctions are also a substrate for endosomes and are degraded 
by lysosomes.   
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8.1.1.3. Phosphorylation of connexin43 
All connexins studied until now are phosphoproteins except Cx26.  
Phosphorylation is involved in regulation of intercellular communication 
via a number of mechanisms; including connexin synthesis, transport, 
assembly, channel gating, internalization and degradation (Lamp & Lau, 
2004).  Cx43 is the most extensively studied protein amongst the connexin 
family, in terms of phosphorylation.  Initial work done by Musil and 
Goodenough, has shown that Cx 43 is differentially phosphorylated 
throughout its life cycle in homeostatic cells (Musil & Goodenough, 1991).  
When analysed by polyacrylamide gel electrophoresis (SDS-PAGE), Cx43 
shows different electrophoretic forms, including a non phosphorylated or 
faster migrating form (NP or P0) with MW ~42 kd, and two slower 
migrating forms (P1 and P2) with MW ranged from 44 to 46 kd 
respectively (Pahuja et al., 2007).  The majority of phosphorylation events 
occur on serine residues as evidenced by phosphor amino acid analysis 
(Solan et al., 2003).  The primary site for Cx43 to be phosphorylated is the 
C-terminal.     
8.1.1.4. Role of connexin 43 during embryonic heart development 
The connexins also play an important role during development of the heart 
(Willecke et al., 2002; Houghton, 2005).  Out of the 20 connexins 
identified thus far in vertebrates, four (Cx37, Cx40, Cx43, and Cx45) have 
been detected in the developing and mature heart (Gros & Jongsma, 1996). 
Connexin 43 is expressed throughout the development of the heart (Alcolea 
et al., 1999), and is essential for normal development. Cx43 knock down 
237 
 
mice die at birth due to conotruncal malformations and pulmonary outflow 
obstruction (Reaume et al., 1995; Ya et al., 1998). 
Since connexins play an important role during embryogenesis, this could 
raise the possibility that teratogens affect embryonic development and 
growth through disruption of connexins.  Therefore effects of different 
teratogens on connexin expression were examined in order to detect 
possible mechanism of action of these teratogens.        
8.2. Materials and methods 
8.2.1. Immunohistochemistry 
Chick cardiac cells were cultured in 8 well chamber slides at a 
concentration of 3 × 106 in each well in the form of 20µl droplets.  They 
were incubated for 2 hours to allow cellular attachment.  The supplemented 
culture medium (DMEM) was added to the cultures and cultures were left 
for 24 hours (Chapter 2, section 2.1.4.5.2).  The different concentrations of 
test chemicals were added after 24 hours in culture.  The cultures were 
fixed in paraformaldehyde solution (2% w/v in PBS) for 1 hour at room 
temperature on day 6 of incubation. The cells were washed three times with 
PBS each for 5 minutes, before being permeabilised with 0.2% Triton X-
100 in PBS (v/v) for 10 minutes.  The cells were incubated in 5% goat 
serum in PBS for 1 hour to block nonspecific bindings of secondary 
antibody.  The cells were incubated with 200 µl of the primary antibody 
(connexin 43 Cx43) (Table2.2) overnight at 4oC.  The secondary antibody 
(Table 2.3) diluted in 0.1% BSA in PBS was applied and incubated for 1 
hour in the dark.  Cells were washed in PBS (3 x 5 minutes) to remove 
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excess unbound secondary antibody before mounted ZLWK 9HFWRUVKLHOG
containing DAPI (Chapter 2, section 2.3.5.1).  Sections were viewed under 
a Leica confocal microscope. 
8.2.2. Western blotting 
The samples were cultured as described in (chapter 2 section 2.1.4.5.2).  
Cell lysates were prepared as described in chapter 2 section 2.4.3.1.  The 
proteins were denatured by heating the samples to 95oC for 5 minutes in a 
heating block.  Then 20µl of sample (20mg protein) was loaded in to the 
precast gels, along with 1µl of marker.  The electrophoresis was performed 
by running the gel in 1X electrode buffer for approximately 45 minutes at 
200V.  The gel was then transferred to nitrocellulose membrane.  The 
transfer was done in cold transfer buffer for 60 minutes at 100V.  Once 
transfer was complete nitrocellulose was blocked in 1.5% fish skin gelatine 
in TBST (v/v) using Snap i.d.  The primary antibody (connexin 43 and 
GAPDH) was added for 10 minutes, which was followed by three quick 
washes in TBST.  The secondary antibodies were applied for ten minutes in 
the dark.  The blot was analysed using the Odyssey scanner after quick 
washes with TBST and distilled water (chapter 2 section 2.4.5).   
8.2.3. Controls  
8.2.3.1. Positive controls 
Day 9 in ovo chick hearts were used as positive control, as the expression 
of Cx43 is increased with advancing embryonic age (Kirchhoff et al., 
2000).  TPA treatment was used as a negative control.  TPA is a protein 
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kinase activator and through PKC it causes an increase in connexin 
phosphorylation and thus decreases gap junction intercellular 
communication.  A stock solution of 50µM of TPA was formed by diluting 
it into DMSO.  The stock solution was then further diluted to final test 
concentration (50nM) in complete culture medium.  The final 
concentration of DMSO as a solvent was less than 0.01%.  A positive 
control, cyclic AMP treatment, was used in this study as well.  The cyclic 
AMP acts through Protein kinase A and increases the number of gap 
junctions and Connexins.  
8.2.3.2. Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) 
Glyceraldehyde 3-phosphate dehydrogenase is one of the key enzymes 
involved in glycolysis.  It serves to break down glucose for energy and 
carbon molecules by catalyzing the conversion of glyceraldehyde 3-
phosphate.  In addition to its metabolic function, GAPDH has also been 
implicated in several non-metabolic processes, such as transcription, 
apoptosis, and ER to Golgi vesicle shuttling.  The GAPDH is stably and 
constitutively expressed at high levels in almost all tissues and cells of the 
body, and because of this reason this gene is used as a house keeping gene.  
The house keeping genes are commonly used as a loading control for 
protein normalization and as a loading control in western blotting and 
many other molecular assays such as RT-PCR.  The GAPDH is detected as 
a band of approximately 36-40 kDa on western blots.  
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8.3. Results 
8.3.1. Day 9 controls, Day 5 controls, TPA, vitamin C, folic 
acid and cyclic AMP  
8.3.1.1. Immunohistochemistry  
The day 9 chick hearts stained with anti-Cx43 show a bright green staining 
as shown in fig 8.3 and figure 8.4 shows negative control stained with 
secondary antibody in absence of Cx43 antibody.  Figure 8.5 shows day 5 
chick cardiomyocyte controls. The day 5 chick heart micromass cultures 
treated with TPA show a decreased expression of Cx43 (fig 8.6), while 
cultures treated with cyclic AMP show brighter staining with more bright 
spots on the surface of the cells (fig 8.7). The results also illustrate that in 
the cells treated with folic acid (1mM) and vitamin C (100µM), brighter 
staining is observed on the surface of the cells (fig 8.8 and 8.9 
respectively).  
8.3.1.2. Western blotting 
The protein analyses with western blotting shows that the ratio of Cx43 to 
GAPDH  in day 9 chick embryonic hearts and day 5 chick cardiomyocytes 
is comparable.  Also chick micromass cultures treated with vitamin C and 
folic acid showed same ratio as day 5 controls.  However cyclic AMP 
caused an increase in Cx43 to GAPDH ratio.  TPA treatment results show a 
decrease in Cx43 to GAPDH ratio as compare to day 9 and day 5 controls 
(fig 8.10 a & b).  The expression of GAPDH remained constant in all 
culture groups (fig 8.10 c).  
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Fig 8.3: Day 9 heart expressing 
Cx43 (200x magnification) 
Fig 8.4: Day 9 heart, ±ve control 
Alexa 488 (200x magnification) 
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Fig 8.6: Day 5 cardiomyocytes 
treated with TPA expressing Cx43 
(600x magnification oil immersion) 
Fig 8.7: Day 5 cardiomyocytes 
treated with cAMP expressing Cx43 
(600x magnification oil immersion) 
Fig 8.8: Day 5 cardiomyocytes 
treated with VC expressing Cx43 
(600x magnification oil immersion) 
Fig 8.9: Day 5 cardiomyocytes 
treated with FA expressing Cx43 
(600x magnification oil immersion) 
{TPA (12-O-tetradecanoylphorbol 13-acetate); VC (vitamin C); FA (folic acid); cAMP 
(cyclic AMP)}. White arrows indicate expression of Cx43 on cell surface; 
Yellow arrows indicate Cx43 expression inside the cells 
 
Fig 8.5: Day 5 control cardiomyocytes 
expressing Cx43 (600x magnification 
oil immersion) 
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8.3.2. Ethanol plus folic acid and vitamin C 
8.3.2.1. Immunohistochemistry 
In cultures treated with ethanol, the overall expression of Cx43 is less as 
compared to controls (fig 8.11 b).  The addition of folic acid and vitamin C 
in addition to ethanol significantly increased the expression of Cx 43 as 
shown in fig 8.11 c and 8.11d and are comparable to controls (fig 8.11 a). 
8.3.2.2. Western blotting 
Ethanol at a concentration of 100µl/ml significantly reduced the ratio of Cx 
43 to GAPDH (<0.05) at 96 hrs post exposure in micromass cultures (fig 
8.12 a & b) and day 9 chick hearts (fig 8.13 a & b).  While the cell cultures 
as well as day 9 hearts treated with vitamin C (100µM) and folic acid 
(1mM) the ratio of connexin 43 to GAPDH is not significantly different to 
that of controls.   
Addition of vitamin C and folic acid to ethanol treated cells and day 9 
hearts improved the ratio of Cx43 to GAPDH and were also comparable to 
controls (fig 8.12 a & b) and (8.13 a & b) respectively.  
Treatment of cells with TPA (50nM) showed significant difference in the 
expression of Cx 43 (<0.05) to that of control cultures. While expression of 
Cx 43 to GAPDH in the cells which were treated with 100µM of cyclic 
AMP waVFRPSDUDEOHWRFRQWUROVDQGGLGQ¶WVKRZDQ\GHFUHDVHILJD
& b).   
The expression of GAPDH (house keeping gene) remained constant in all 
culture groups (fig 8.12 c and 8.13 c). 
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8.3.2.3. Conclusion 
Immunohistochemistry and western blotting results showed that the 
expression of Cx 43 was significantly decreased by ethanol administration.  
However addition of multivitamins folic acid and vitamin C reversed the 
effects of ethanol, and the expression of Cx 43 in cultures treated with folic 
acid and vitamin C in addition to ethanol was comparable to control.  
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Fig 8.11 a: Day 5 control, 
showing expression of Cx43 
(600x magnification oil 
immersion) 
Fig 8.11 b: Day 5 ethanol treated 
cells, showing expression of 
Cx43 (600x magnification oil 
immersion) 
 
Fig 8.11 c: Day 5 ethanol plus 
vitamin C treated cells, showing 
expression of Cx43 (600x 
magnification oil immersion) 
 
Fig 8.11 d: Day 5 ethanol plus 
folic acid treated cells, showing 
expression of Cx43 (600x 
magnification oil immersion) 
 
Fig 8.11: Shows expression of connexin 43 (Cx43) in day 5 controls (a), 
ethanol treated (b), ethanol and vitamin C treated, (d) ethanol and folic 
acid treated.  
White arrows indicate expression of Cx43 on cell surface; Yellow arrows 
indicate Cx43 expression inside the cells 
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8.3.3. Nicotine plus folic acid and vitamin C 
8.3.3.1. Immunohistochemistry 
The expression of Cx 43 is less on the surface as well as inside the 
cytoplasm of cells treated with nicotine (fig 8.14 b), as compare to controls 
(fig 8.14 a).  The addition of folic acid and vitamin C in addition to 
nicotine increased the expression of Cx 43 as shown in fig 8.14 c & d 
respectively and are comparable to controls.  
8.3.3.2. Western blotting 
The Cx 43 to GAPDH ratio is significant reduced with nicotine (10µM) 
treatment at 96 hrs post exposure in micromass cultures (p < 0.05) (fig 8.15 
a & b).  However, in cultures treated with folic acid (1mM) and vitamin C 
(100µM), the ratio of Cx 43 to GAPDH is not significantly different to that 
of controls.   
Moreover the cells treated with folic acid and vitamin C, in addition to 
nicotine expression of Cx43 was comparable to controls (fig 8.15 a & b).  
The cells treated with TPA showed significant difference in the ratio of Cx 
43 to GAPDH (<0.05) to that of control cultures. While an increased ratio 
of Cx 43 to GAPDH was observed in the cells which were treated with 
100µM of cyclic AMP and are comparable to controls.  The GAPDH 
remained constant in all culture groups (fig 8.15 c). 
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8.3.3.3. Conclusion 
The ratio of Cx 43 to GAPDH which was significantly decreased by 
nicotine, was reversed with addition of folic acid and vitamin C and 
cultures are comparable to controls.    
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  Fig 8.14 a: Day 5 control, 
showing expression of Cx43 
(600x magnification oil 
immersion) 
Fig 8.14 b: Day 5 nicotine treated 
cells, showing expression of 
Cx43 (600x magnification oil 
immersion) 
 
Fig 8.14 c: Day 5 nicotine plus 
vitamin C treated cells, showing 
expression of Cx43 (600x 
magnification oil immersion) 
 
Fig 8.14 d: Day 5 nicotine plus 
folic acid treated cells, showing 
expression of Cx43 (600x 
magnification oil immersion) 
 
Fig 8.14: Shows expression of connexin 43 (Cx43) in day 5 controls (a), 
nicotine treated (b), nicotine and vitamin C treated, (d) nicotine and folic 
acid treated.  
White arrows indicate expression of Cx43 on cell surface; Yellow arrows 
indicate Cx43 expression inside the cells 
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Fig. 8.15: Shows protein analysis in day 5 chick cardiomyocytes micromass 
cultures by Western blot (a), graphical representation of ratio of Cx43 to 
GAPDH (b) and GAPDH (housekeeping gene) only (c).  {** (p<0.01) for 
'XQQHWW¶VSRVWKRFWHVW`  
 
Fig 8.15 a 
Fig 8.15 b Fig 8.15 c 
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8.3.4. Retinoic acid plus folic acid and vitamin C 
8.3.4.1. Immunohistochemistry 
In cultures treated with retinoic acid (20µM), the expression of Cx 43 is 
less on the surface as well as inside the cytoplasm of cells (fig 8.16 b) as 
compare to controls (fig 8.16 a).  The addition of folic acid and vitamin C 
in addition to retinoic acid significantly increased the expression of 
connexin 43 as shown in fig 8.16 c & d respectively and are comparable to 
controls. 
8.3.4.2. Western blotting 
Retinoic acid at a concentration of 20µM significantly reduced the ratio of 
Cx 43 to GAPDH (<0.05) at 96 hrs post exposure in micromass cultures 
(fig 8.17 a & b).  While in cultures treated with vitamin C (100µM) and 
folic acid (1mM) the ratio of Cx 43 to GAPDH is not significantly different 
to that of controls.   
The cells treated with vitamin C and folic acid, in addition to retinoic acid 
were also comparable to controls (fig 8.17 a & b).  
Treatment of cells with TPA (50nM) showed significant difference in the 
expression of Cx 43 (<0.05) to that of control cultures. While an increased 
expression of Cx 43 was observed in the cells which were treated with 
100µM of cyclic AMP (fig 8.17 a & b).   
The expression of GAPDH (house keeping gene) remained constant in all 
culture groups (fig 8.17 c). 
 
254 
 
 
8.3.4.3. Conclusion 
Immunohistochemistry and western blotting results showed that the 
expression of connexin 43 was significantly decreased by retinoic acid.  
However addition of multivitamins folic acid and vitamin C reversed the 
effects of retinoic acid, and the expression of Cx43 in cultures treated with 
folic acid and vitamin C in addition to retinoic acid was comparable to 
control. 
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Fig 8.16 a: Day 5 control, 
showing expression of Cx43 
(600x magnification oil 
immersion) 
Fig 8.16 b: Day 5 retinoic acid 
treated cells, showing expression 
of Cx43 (600x magnification oil 
immersion) 
 
Fig 8.16 c: Day 5 retinoic acid 
plus vitamin C treated cells, 
showing expression of Cx43 
(600x magnification oil 
immersion) 
 
Fig 8.16 d: Day 5 retinoic acid 
plus folic acid treated cells, 
showing expression of Cx43 
(600x magnification oil 
immersion) 
 
Fig 8.16: Shows expression of connexin 43 (Cx43) in day 5 controls (a), 
retinoic acid treated (b), retinoic acid and vitamin C treated, (d) retinoic 
acid and folic acid treated.  
White arrows indicate expression of Cx43 on cell surface; Yellow arrows 
indicate Cx43 expression inside the cells 
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Fig. 8.17: Shows protein analysis in day 5 chick cardiomyocytes micromass 
cultures by Western blot (a), graphical representation of ratio of Cx43 to 
GAPDH (b) and GAPDH (housekeeping gene) only (c).  {** (p<0.01) for 
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8.3.5. Diabetic conditions plus folic acid and vitamin C 
8.3.5.1. Immunohistochemistry  
In cultures treated with diabetic conditions P0 JOXFRVH P0 ȕ- 
hydroxybutyric acid), the expression of Cx 43 is less on the surface as well 
as inside the cytoplasm of cells (fig 8.18 b) as compared to controls (fig 
8.18 a).  The addition of folic acid and vitamin C in addition to diabetic 
conditions significantly increased the expression of Cx 43 as shown in fig 
8.18 c and 8.18 d respectively and are comparable to controls. 
8.3.5.2. Western blotting  
There was a synergistic acWLRQ RI P0 JOXFRVH DQG P0 ȕ
hydroxybutyric acid when added to chick heart micromass cultures which 
results in a significantly reduced Cx43 to GAPDH ratio in comparison to 
controls (fig 8.19 a & b).  The effect of diabetic condition on Cx 43 to 
GAPDH ratio is reversed with addition of folic acid and vitamin C (fig 
8.19 a & b).  These two vitamins themselves produce no significant 
changes in Cx43 to GAPDH ratio to controls (fig 8.19 a & b).  The cells 
treated with TPA (50nM), showed significant difference in the ratio of 
connexin 43 to GAPDH (<0.05) compared to that of control cultures. An 
increased expression of Cx 43 to GAPDH was observed in the cells which 
were treated with 100µM of cyclic AMP (fig 8.19 a & b).  The GAPDH 
remained constant in all culture groups (fig 8.19 c). 
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8.3.5.3. Conclusion 
The ratio of Cx 43 to GAPDH was significantly reduced by the diabetic 
condition.  However addition of vitamins folic acid and vitamin C reversed 
the effects of diabetic condition, and the expression of Cx 43 in cultures 
treated with folic acid and vitamin C in addition to diabetes was 
comparable to control.  
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Fig 8.18 a: Day 5 control, 
showing expression of Cx43 
(600x magnification oil 
immersion) 
Fig 8.18 b: Day 5 DM treated 
cells, showing expression of 
Cx43 (600x magnification oil 
immersion) 
 
Fig 8.18 c: Day 5 DM plus 
vitamin C treated cells, showing 
expression of Cx43 (600x 
magnification oil immersion) 
 
Fig 8.18 d: Day 5 DM plus folic 
acid treated cells, showing 
expression of Cx43 (600x 
magnification oil immersion) 
 
Fig 8.18: Shows expression of connexin 43 (Cx43) in day 5 controls (a), 
DM treated (b), DM and vitamin C treated, (d) DM and folic acid treated. 
 DM (diabetic conditions); white arrows indicate expression of Cx43 on 
cell surface, yellow arrows indicate Cx43 expression inside the cells 
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Fig. 8.19: Shows protein analysis in day 5 chick cardiomyocytes micromass 
cultures by Western blot (a), graphical representation of ratio of Cx43 to 
GAPDH (b) and GAPDH (housekeeping gene) only (c).  {** (p<0.01) for 
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Fig 8.19 a 
Fig 8.19 b Fig 8.19 c 
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8.4. Discussion 
This chapter aimed to detect a possible role of connexin 43 (Cx43), in the 
etiology of defective contractile activity and less viability of chick 
cardiomyocytes when exposed to different environmental teratogens, using 
two molecular techniques; immunohistochemistry and western blotting.  
Development of the heart involves a series of molecular and cellular events 
including transformation of cardiogenic precursors initially into a linear 
heart tube, followed by a looped structure, and finally into a mature four-
chambered heart. Many genetic and transgenic approaches have shown 
crucial roles for transcription factors, signalling molecules, cell adhesion 
molecules, and ion channels in development of the heart (Olson & 
Srivastava, 1996; Simon et al., 2004a).  Gap junctions are made up of a 
family of proteins called connexins and are responsible for coordination of 
intercellular communications, and maintenance of metabolic continuity 
between adjacent cells (Berthoud et al., 2004; Zhang et al., 2007).  The 
major connexins present in the heart are Cx43, Cx40, and Cx45.  Cx43 is 
one of the key proteins involved in embryonic heart development and is 
essential for normal growth and synchronous beating of the fetal heart.  
While Cx40 is predominately expressed in the atrium and Cx45 expressed 
in the ventricular conduction system, Cx43 is expressed in both atria and 
ventricles (Leaf et al., 2008; Saito et al., 2009; von Maltzahn et al., 2009).  
The results of this chapter showed that common environmental teratogens 
including ethanol, nicotine and retinoic acid and diabetic conditions 
showed an overall decrease in the expression of Cx43 in chick 
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cardiomyocytes in micromass cultures.  In one study conducted to detect 
the role of Cx43 in mouse heart, Cx43 null homozygous mice, replaced by 
Cx26, showed slower ventricular contractions and reproductive disorders 
(Winterhager et al., 2007).  Previous work on animals also demonstrated a 
vital role of Cx 43 in development of the heart and coronary vessels 
(Simon et al., 1998; Simon et al., 2004b; Liu et al., 2006; Shasha et al., 
2006).  All the teratogens also caused a decrease in contractile activity of 
cardiomyocytes (Chapter 5, 6, 7).  The two effects can be related to each 
other, due to the fact that the heart cells behave as an electrical syncytium 
and their action potential, composed of rapid excitation followed by a 
delay, corresponds to intracellular transfer of current.  This process occurs 
at gap junctions and is facilitated by connexins.  Any disruption of these 
molecules results in asynchronous and decreased beating of excitable 
cardiac cells (Haussig et al., 2008).   
The results of immunohistochemistry illustrate that there was less 
expression of Cx43 on the cell surface when treated with these teratogens.  
However addition of vitamin C and folic acid diminished the effects of 
these toxins, and Cx43 was more obviously expressed at the surface rather 
than inside the cells and was comparable to control.  These results suggest 
that micronutrients consumed either in the diet or as supplements might be 
helpful in protecting against teratogen induced insults on cardiomyocytes.   
In the light of previous data which show a role of TPA and cyclic AMP 
(cAMP) in connexin regulation, (Rivedal & Opsahl, 2001; Faucheux et al., 
2002), these two chemicals were used as positive and negative controls in 
this study. Treatment of cardiomyocytes with TPA showed a reduced 
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overall expression of Cx43.  These findings are in line with studies that 
show a decrease in production and expression of Cx 43 when treated with 
TPA (Rivedal & Opsahl, 2001).  There is a growing body of evidence that 
TPA increases the phosphorylation of connexins through activation of 
protein kinase C pathway (PKC).  On the other hand cAMP increased its 
expression particularly on the cell surface.  The crowding of Cx channels is 
controlled by many factors, including hormones, which activate the 
production of cAMP.  The activation of cAMP results in an increase in the 
number of membrane gap junctions in various cell types.  The cAMP 
causes this increase via the protein kinase A pathway (Faucheux et al., 
2002).  It is possible that teratogens used in this study utilized the protein 
kinase C pathway to down regulate the expression of connexin 43.  
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Chapter 9 
Effect of various teratogens and vitamin 
supplementation on expression and distribution of 
ET-1 
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9.1. Introduction 
Endothelins comprise a family of conserved 21-amino acid peptides that 
consist of three members encoded by different genes (ET1, ET2, and ET3) 
and a role has been suggested for them in heart development.  The 
endothelin-1 (ET-1) isoform contains free carboxyl and amino termini with 
two intra molecular disulfide bonds.  It is expressed in humans as well as 
many animal species. It is formed in many cell types including vascular 
endothelial cells, renal tubular endothelium, cardiac myocytes, cells in the 
pituitary, macrophages, mast cells etc (Inoue et al., 1989).  ET-1 is 
synthesised to its active form from its precursor pre-proendothelin by the 
converting enzyme ECE (Xu et al., 1994).  Two types of endothelin 
converting enzymes have been identified (ECE-1 and ECE-2).   ECE-1 is 
membrane bound and cleaves both intra and extra cellular proendothelin-1 
to endothelin-1.  The ECE-2 is involved in intra cellular cleavage of 
endogenously synthesized proendothelin-1 to endothelin-1 at the trans-
Golgi apparatus.  The endothelins are secreted via the rough endoplasmic 
reticulum, Golgi cisternae, Golgi vesicles, and small exocytic vesicles.  
The secretion of endothelin can be inhibited by atrial natriuretic factor and 
protein kinase (Remiss et al., 1993; Rubanyi et al., 1994).  The endothelins 
exert their different biological actions via the G coupled-protein endothelin 
receptors type A and B (ETA and ETB) (Yanagisawa, 1994; Yokota et al., 
2001).  These receptors are classified according to their binding affinities 
to different endothelins.  The first receptor shows maximum binding to ET-
1 while the ETB receptor has equal binding affinity to all types of 
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endothelins (Sakurai et al., 1992).  Endothelins seem to act mostly as local 
paracrine/autocrine peptides, but circulating levels of Endothelins, 
especially in pathological states of increased serum concentration, have 
great biological importance (Sakurai et al., 1992). 
Endothelins and their receptors were initially known for their involvement 
in the regulation of blood pressure (Yanagisawa et al., 1988).  Afterwards 
an unanticipated role as growth factors during embryonic development was 
discovered.  Experimental studies on mouse embryos reveal that mice 
which carry homozygos mutations for Endothelin receptor type A (ETA), 
ET-1 or ECE-1 were viable to term but die shortly after due to severe 
defects in the formation of neural crest derivatives (Clouthier et al., 1998; 
Clouthier et al., 2003).  The expression and function of ET-1/ ETA 
signalling appears to be crucial in all species.  The pharmacological 
changes of either ET-1 or endothelin receptors also resulted in altered 
development in chick (Kempf et al., 1998) and rat (Spence et al., 1999) 
embryos.  Further more mutations of ET-1 gene resulted in multiple 
deformities in zebra fish (Kimmel et al., 2003; Miller et al., 2001; Miller et 
al., 2003). These studies have showed that the Ednra signaling is essential 
for late neural crest development in mice, chick and fish embryos (Bonano 
M. et al., 2008). 
 9.2. Materials and Methods 
Chick cardiomyocytes were seeded in 8 well chamber slides at a 
concentration of 3 × 106 in each well in the form of 20µl droplets.  They 
were incubated for 2 hours to allow cellular attachment.  Then 500µl of 
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DMEM growth medium was added and the cultures were left for 24 hours 
(Chapter 2, section 2.1.4.5.2).  The DMEM medium was replaced by 
different concentrations of test chemicals after 24 hours.  On day 6 cultures 
were fixed in paraformaldehyde solution (2% w/v in PBS) for 1 hour at 
room temperature. The cells were washed washed thrice with PBS each for 
5 minutes, before being permeabilised with 0.2% Triton X-100 in PBS 
(v/v) for 10 minutes.  The cells were incubated in 5% goat serum in PBS 
for 1 hour to block nonspecific bindings of secondary antibody.  The cells 
were incubated with the primary antibody (ET-1) (200µl) (Table2.2) 
overnight at 4oC.  The secondary antibody (Table 2.3) diluted in 0.1% BSA 
in PBS was applied and incubated for 1 hour in the dark.  Cells were 
washed in PBS (3 x 5 minutes) to remove excess unbound secondary 
DQWLERG\EHIRUHPRXQWLQJZLWK9HFWRUVKLHOGFRQWDLQLQJ'$3,6HFWLRQV
were viewed under a confocal microscope (Chapter 2, section 2.3.5.1). 
9.3. Results 
The results of experiments performed on day 9 hearts stained for ET-1 
show a bright staining (Fig 9.1), while Fig 9.2 shows negative staining with 
Alexa 488 in the absence of primary antibody which confirms the reactivity 
of ET-1 in chick hearts.  Day 5 chick micromass control hearts similarly 
show a bright staining with ET-1 as shown in Fig 9.3, also cultures treated 
with folic acid and vitamin C show the same bright staining as controls 
(Fig 9.4 and Fig 9.5 respectively).  The micromass cultures treated with 
ethanol 100µl/ml (Fig 9.6 b), nicotine 10µM (Fig 9.7 b), retinoic acid 
20µM (FLJ  E DQG 'LDEHWLF FRQGLWLRQ JOXFRVH P0  ȕ-
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hydroxybutyric acid 15mM) (9.9 b), showed a decreased overall expression 
of ET-1 inside the cells.  The addition of folic acid (1mM) and vitamin C 
(100µM), to cultures treated with ethanol show that the expression of ET-1 
is comparable to controls (Fig 9.6 c and d respectively).  Similarly 
treatment of cardiomyocytes with folic acid and vitamin C in addition to 
nicotine (fig 9.6 a) shows that the level of ET-1 is comparable to controls 
(Fig 9.7 c and d). The same effect of folic acid and vitamin C was observed 
when added to retinoic acid treated cultures (Fig 9.8 c and d).  Fig 9.8 c and 
d also illustrate the protective effects of folic acid and vitamin C on 
diabetic condition and no difference in ET-1 expression as compared to 
controls was observed. 
Conclusion 
The teratogenic agents used in this study cause a decrease in expression of 
ET-1 in chick cardiomyocytes micromass cultures.  However addition of 
vitamin C and folic acid rescued the cells and expression of ET-1. 
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Fig 9.1: Day 9 heart expressing ET-
1. 200x magnification 
Fig 9.2:  Day 9 heart ±ve control 
Alexa 488. 200x magnification 
Fig 9.3: Day 5 control, showing 
expression of ET-1. 600x 
magnification (oil immersion) 
Fig 9.4:  Day 5 chick heart cells 
treated with folic acid expressing 
ET-1.  600x  magnification (oil 
immersion) 
 
Fig 9.5:  Day 5 chick heart cells 
treated with vitamin C expressing 
ET-1.  600x  magnification (oil 
immersion) 
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Fig 9.6 a: Day 5 control, showing 
expression of ET-1.  600x 
magnification (oil immersion) 
 
Fig 9.6 b: Day 5 ethanol  treated cells, 
showing expression of ET-1.  600x 
magnification (oil immersion) 
 
Fig 9.6 c: Day 5 ethanol + folic acid 
treated cells, showing expression of 
ET-1.  600x magnification (oil 
immersion) 
 
Fig 9.6 d: Day 5 ethanol +vitamin C 
treated cells, showing expression of 
ET-1.  600x magnification (oil 
immersion) 
 
Fig 9.6: Shows expression of ET-1 in day 5 controls (a), ethanol treated 
(b), ethanol and folic acid treated (c) ethanol and vitamin C (d).  White 
arrows indicate a brighter staining of ET-1, while yellow arrows indicate 
less expression of ET-1 in ethanol treated cells.    
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Fig 9.7 a: Day 5 control, showing 
expression of ET-1.  600x 
magnification (oil immersion) 
 
 
Fig 9.7 c: Day 5 nicotine + folic acid 
treated cells, showing expression of 
ET-1.  600x magnification (oil 
immersion) 
 
Fig 9.7 b: Day 5 nicotine treated 
cells, showing expression of ET-1.  
600x magnification (oil immersion) 
 
 
Fig 9.7 d: Day 5 nicotine + vitamin 
C treated cells, showing expression 
of ET-1.  600x magnification (oil 
immersion) 
 
Fig 9.7: Shows expression of ET-1 in day 5 controls (a), nicotine treated 
(b), nicotine and folic acid treated (c), nicotine and vitamin C (d).  White 
arrows indicate a brighter staining of ET-1, while yellow arrows indicate 
less expression of ET-1 in nicotine treated cells.    
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Fig 9.8 a: Day 5 control, showing 
expression of ET-1.  600x 
magnification (oil immersion) 
 
Fig 9.8 b: Day 5 retinoic acid treated 
cells, showing expression of ET-1.  
600x magnification (oil immersion) 
 
 
Fig 9.8: Shows expression of ET-1 in day 5 controls (a), retinoic acid (RA) 
treated (b), RA and folic acid treated (c), RA and vitamin C (d).   White 
arrows indicate a brighter staining of ET-1, while yellow arrows indicate 
less expression of ET-1 in RA treated cells.    
 
Fig 9.8 c: Day 5 retinoic acid + folic 
acid treated cells, showing expression 
of ET-1.  600x magnification (oil 
immersion) 
 
Fig 9.8 d: Day 5 retinoic acid + 
vitamin C acid treated cells, showing 
expression of Et-1.  600x 
magnification (oil immersion) 
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Fig 9.9 a: Day 5 control, showing 
expression of ET-1.  600x 
magnification (oil immersion) 
 
 
Fig 9.9 b: Day 5 Diabetic condition 
P0JOXFRVHP0ȕK\GUR[\EXW\ULF
acid) treated cells, showing expression of 
ET-1.  600x  magnification (oil 
immersion) 
 
 
Fig 9.9: Shows expression of ET-1 in day 5 controls (a), Diabetic 
conditions (2P0JOXFRVHP0ȕK\GUR[\EXW\ULFDFLG treated (b), 
Diabetic condition and folic acid treated (c), diabetic condition and 
vitamin C (d).   White arrows indicate a brighter staining of ET-1, while 
yellow arrows indicate less expression of ET-1 in diabetic conditions.  
 
 
Fig 9.9 c: Day 5 Diabetic condition 
+ folic acid treated cells, showing 
expression of ET-1.  600x 
magnification (oil immersion) 
 
Fig 9.0 d: Day 5 Diabetic condition + 
Vitamin C treated cells, showing 
expression of ET-1.  600x 
magnification (oil immersion) 
 
274 
 
9.4. Discussion 
The aim of this chapter was to determine the possibility for different 
teratogens {ethanol, retinoic acid, nicotine and diabetic conditions 
JOXFRVH ȕ K\GUR[\EXW\ULF DFLG` WR DIIHFW QRUPDO GHYHORSPHQW RI WKH
heart, by interfering with ET-1.   Almost all of teratogens tested, cause a 
decrease in immuno expression of endothelin 1 in chick cardiomyocytes.  
ET-1 is a 21 amino acid peptide, shown to be involved in many 
developmental processes including development of the heart.  One study 
conducted on mouse embryos show that null homozygous mice for ET- 
exhibit cardiovascular malformations.  The most affected parts were the 
outflow tract and endocardial cushion, and great vessels (Clouthier et al., 
1998; Kuriharam et al., 1995).  It is obvious from many animal studies that 
cardiac neural crest cells are involved in the formation of the outflow tract 
and the endothelium of the great vessels (Thomas et al., 1998).  In another 
study on mouse embryos, retinoic acid was shown to decrease the 
expression of ET-1 in branchial arch structures.  The mice treated with 
retinoic acid showed craniofacial abnormalities, suggesting a role of ET-1 
in retinoic acid induced malformations (Zhang et al., 2006).  Similar types 
of developmental defects were also observed in ET-1 deficient zebra fish 
and chickens (Groenendijk BC. et al., 2008; Miller Craig T. et al., 2007; 
Walker et al., 2007).  The chemicals tested in this study also show decrease 
in contractile activity and cell viability of chick cardiomyocytes.  Ethanol 
and diabetic conditions also revealed developmental defects in the chick 
heart.  It might be possible that these teratogens target ET-1 expression in 
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the heart and neural crest cells with a resultant decrease in cellular 
differentiation and heart defects.  
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Chapter 10 
General Discussion 
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10.1. Introduction 
This study was conducted to detect the possible role of environmental 
teratogens in the etiology of congenital heart defects.  Also to find out the 
function of nutrition particularly micronutrients in the prevention of 
environmentally induced cardiovascular anomalies.  The chick embryo was 
chosen as the experimental model due to the fact that chick eggs are easily 
available at low cost, the embryonic tissues are easy to dissect out for 
different micromass cultures, and no licence is necessary to conduct 
experiments on early embryos.  Moreover the stages of chick development 
are very well recognized (Hamburger & Hamilton, 1951) and there are 
many similarities discovered between the chicken genome and human 
genome.   
Congenital malformations are the principal cause of poor pregnancy 
outcome.  Approximately 50% of all human concepti are lost before 
implantation, and of those that implant, further 15±20% are lost before 
term delivery.  Of the fetuses which reach the end of term pregnancy, an 
estimated 3% are born with one or more severe congenital defects (Moore 
& Persaud, 1998).  These figures show that errors which result in prenatal 
death or postnatal abnormalities are frighteningly common. Although 
rigorous research has been conducted on underlying mechanisms of many 
developmental defects, still many mechanisms are poorly understood.   
Some lifestyle factors such as a diet low in nutrients, alcohol consumption, 
cigarette smoking, misuse of drugs available over the counter and some 
maternal diseases like diabetes mellitus might play a crucial role in the 
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etiology of congenital anomalies.  Therefore identifying and adjusting 
these life style factors would be a step forward in detecting and preventing 
environmentally induced defects.  Alcohol, one of two social drugs 
investigated in this study was shown to have direct impact on the 
development of chick heart cells and chick embryos cultured in ovo.  The 
chick heart micromass cultures showed decreased cellular differentiation, 
cell viability and protein content.  Chick embryos cultured in ovo showed 
other gross malformations as well, along with heart defects.  However, 
nicotine, an active component in maternal smoking, revealed its teratogenic 
effects on the chick heart cells only.  A decrease in contractile activity of 
chick cardiomyocytes was observed, but it had no cytotoxic effects on the 
cells.  The chick embryos showed no developmental defects.  This might 
be due to the fact that the dose used in this study was not sufficient to 
produce any effects on whole chick embryos.  It is obvious from previous 
data that these social drugs are most commonly consumed by women of 
child bearing age from low socioeconomic status, less educated, younger 
age and usually jobless (Mehta, 2008).  Alcohol when consumed in excess 
of the recommended range produces a spectrum of defects.  However mild 
to moderate drinking might produce congenital anomalies (Henderson et 
al., 2007).  Therefore some other factors apart from these drugs, 
particularly diet, may also be involved in the causation of developmental 
defects.  The results of this study also demonstrate the protective effects of 
folic acid and vitamin C on ethanol and nicotine induced malformations.  
Moreover these micronutrients were also shown to have preventive effects 
on teratogenesis brought about by excessive retinoic acid intake and 
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diabetic conditions.  However these vitamins when added to cadmium 
chloride treated cells did not show any protective effect.  This could be due 
to the fact that cadmium chloride exerts its effects by a different 
mechanism.  The mechanisms involved in cadmium induced cell damage 
are very complex.  It has been suggested that cadmium induces 
mitochondrial and lysosomal damage, which leads to lipid peroxidation, 
DNA damage (Fotakis et al., 2005; Fotakis & Timbrell, 2006), 
chromosomal aberrations and apoptosis (Biesalski et al., 1998).  Some data 
reveals the production of reactive oxygen species in cadmium induced 
damage but our study shows no role for antioxidants in the prevention of 
cadmium induced cytotoxicity (Lampe et al., 2008; Panjehpour & 
Bayesteh, 2008).  The recognised relationship between deficiency of the 
micronutrient folic acid and neural tube defects is of very long standing.  
Low social status with poor dietary conditions are well known risk 
indicators for a variety of unfavourable perinatal and infant outcomes, for 
instance low birth weight and perinatal, neonatal and postnatal mortality. 
Poor maternal nutrition may not only be responsible for congenital 
anomalies including heart defects, orofacial defects, cleft lip etc, but also 
have several long term effects on the offspring.  Animal studies have 
proved a relationship between a low nutritious maternal diet during the 
SHULFRQFHSWLRQDOSHULRGDQGORQJWHUPFRQVHTXHQFHVRQWKHFKLOG¶VKHDOWK.  
A diet which is deficient in proteins exerts several effects on the offspring.  
Studies on mice, and rats for detection of a possible role for a low protein 
diet in the periconceptional period showed behavioural and cardiovascular 
problems in the offspring and they were also growth retarded (Kwong et 
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al., 2000; Kwong et al., 2006; Watkins et al., 2008; Watkins et al., 2010). 
$OVR SRRU PDWHUQDO QXWULWLRQ DIIHFWV WKH IHWXV¶V KHSDWLF H[SUHVVLRQ RI
certain genes involved in glucose metabolism and blood pressure 
UHJXODWLRQDQGWKXVWKHERG\¶VKRPHRVWDVLVWKHVHHIIHFWVZHUHREVHUYHGLQ
a gender specific manner (Kwong et al., 2007).   
Low nutritious diet does not only denote low caloric diet but also a diet 
which is low in many micronutrients, for example folic acid, vitamin A, 
vitamin C, E, zinc iodine, copper, and manganese etc.  Deficiencies of 
these micronutrients result in a wide range of malformations (Shah & 
Ohlsson, 2009).  Not only deficiency but also excess intake of some 
micronutrients e.g. retinoic acid can also produce craniofacial and heart 
defects (Zhang et al., 2006).  
Although the concept of suboptimal maternal nutrition is not new, still 
there are certain groups of people who are not fully aware of the 
importance of micronutrients for healthy pregnancy outcomes.  Primary 
deficiency of nutrition is not very common in developed countries, as 
compared to developing countries, but there are a number of life style 
factors (alcohol abuse, smoking, recreational drugs, genetic defects and 
maternal illness), which result in secondary deficiencies.   
10.1.1.  Experimental Techniques used to detect possible 
teratogenic effects of different environmental teratogens 
This study was designed to detect developmental toxicity of certain 
environmental teratogens in a system which was cost effective, 
reproducible, reduced animal killing and avoided any maternal metabolism.  
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Two culture techniques were employed; chick heart micromass culture and 
in ovo culture.  The rat limb bud micromass culture has been validated for 
the detection of potential developmental teratogens by the ECVAM 
validation study which took place from 1997 to 2000 (Spielmann et al., 
2001).  The chick cardiomyocyte culture was evaluated to detect teratogens 
that affect cardiomyocyte differentiation and viability and hence cardiac 
development. The chick micromass culture was based on a limb bud and 
midbrain system developed by (Atterwill et al., 1992), and later used with 
cardiomyocytes by (L'Huillier et al., 2002; Hurst et al., 2007; Ahir, 2009).  
In a blind study conducted on paired chemicals with known embryotoxicity 
and non toxicity, chick cardiomyocyte micromass culture detected potential 
toxicity of embryotoxic chemicals while their counterparts showed no 
developmental toxicity (Hurst et al., 2009), and results of micromass 
culture were compared with D3 embryonic stem cells an already validated 
toxicity screening method by ECVAM.  Similarly in another blind study 
with different paired chemicals Ahir also found similar results (Ahir, 
2009).  These results confirm the reliability of the chick heart micromass 
culture for teratogenicity screening tests.  For the micromass cultures used 
in this study it was necessary to confirm the presence of cardiomyocytes as 
the majority of cells, before the evaluation of teratogenic potential of 
different chemicals.  During explantation cardiomyocytes are not the only 
cells which are dissected out; some other cells like fibroblasts and smooth 
muscle cells are also likely to be present. Conventional histological 
WHFKQLTXHV+	(VWDLQLQJDQG0DVVRQ¶VWULFKURPHVWDLQLQJZHUHXVHGWR
detect cardiomyocytes in cultures on the basis of their morphological 
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characteristics.  Although the results confirmed the presence of cells it did 
not confirm the nature of the cells in the cultures.  To further confirm the 
presence of cardiomyocytes immunohistochemical methods were applied 
with some molecular markers (CH1, MF20, 12/101) which are only 
expressed by heart cells and not fibroblasts.  The results confirmed that the 
majority of cells in chick cardiomyocyte micromass cultures were heart 
cells. 
Once the presence and number of cardiomyocytes was confirmed, 
preliminary experiments were performed to select the optimal cell density 
and day for heart explantations.  The cell density of 3 x 106 was considered 
optimal and employed in further experiments due to satisfactory attachment 
and differentiation of micromass cultures.  Beating was observed after 24 
hrs of seeding initially in individual cardiomyocytes, (Hewitt et al., 2005; 
Hurst et al., 2007) but later a synchronous beating was observed as 
cardiomyocytes in cultures make connections with each other.  Day 5 was 
selected for explantation due to the fact that day 5 embryonic hearts are 
still in the period of organogenesis; an important point when detecting 
teratogenic potential of toxic substances (Sadler et al., 1982).  Three end 
points; cell viability, protein content and cellular differentiation, were used 
to detect teratogenicity of chemicals.  Cell viability was assessed by the 
resazurin reduction assay. The resazurin assay was initially designed to 
assess bacterial and yeast contaminations in biological fluids (Erbs & 
Ehlers, 1950).  Later it was used in cytotoxicity assays to detect the 
viability of cells due to the fact that it has the ability to enter the cells and 
itself it is not toxic, therefore the same cells can further be used for other 
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endpoints (Clothier, 1992; Hurst et al., 2007).  The other cytotoxicity assay 
employed was the Kenacid blue assay.  This assay provides a good 
association in detecting the toxicity of different chemicals and is 
advantageous in getting repeat measures on the same cells as compared to 
other cytotoxicity assays (Clothier & Samson, 1996; O' Brien et al., 2000).  
The in ovo culture technique was evaluated to detect gross and histological 
defects in chick embryos when teratogenic agents were injected in ovo 
through the air sac region.  Pilot experiments were conducted to ensure that 
the volume of test chemical injected was enough to produce effects, PBS, 
neutral red dye and Parafilm had themselves no teratogenic or toxic effects 
on chick embryos. The results confirmed that none of above vehicles 
showed any toxicity. 
This study was further extended to examine some of the potential 
molecular mechanisms involved in cardiovascular defects when cultures 
were exposed to different teratogens and their protection brought about by 
multivitamins. 
Development of the heart is a complex process and involves a series of 
molecular events.  The two genes used in this study were Cx43 and ET-1.  
Cx43 is abundantly expressed in adult and embryonic hearts and data 
regarding heterozygous null animals show a wide range of cardiac defects 
(Shasha et al., 2006).  It is required in the formation of the myocardium of 
atria, ventricles, ventricular septum, atrioventricular junction, outflow tract, 
and the conduction system of the heart (Christoffels et al., 2004).  Apart 
from Cx43, other members of the connexin family (Cx40 and Cx45) are 
also involved in the formation of the heart (Alcolea et al., 1999).  ET-1 was 
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initially recognized for its vasoconstrictor functions but later on it was also 
proved to be a growth factor involved in the development and growth of 
many embryonic organs (Bonano M. et al., 2008).  Its role in the formation 
of the heart is very well recognized.  Many studies reveal a direct relation 
of ET-1 and development of neural crest cell-derived parts of the heart.  
Furthermore this molecule also plays an important role in the formation 
and growth of the interventricular septum, conduction system and 
ventricular myocardium (Zhang et al., 2006). 
The heart is composed of cardiomyocytes which act as an electrical 
syncytium.  Efficient and well orchestrated impulse propagation and 
synchronized beating is achieved through cell-cell communication gap 
junction organization (Smyth et al., 2010).  The gap junctions are 
specialized clusters of hexameric arrays, composed of hundreds of 
connexins.  In the heart, gap junctions are located at intercalated discs 
which are distinct zones of cardiomyocyte-cardiomyocyte coupling in the 
heart (Saez et al., 2003).  To date approximately 20 connexins have been 
discovered in the human genome.  The most abundant connexin found in 
the adult and embryonic heart is Cx43.  Alterations in the organization and 
expression of Cx43 are considered to be key contributors involved in 
arrhythmias and contractile malfunctions (Severs et al., 2008).  Also there 
is a growing body of evidence from animal studies that remodelling of gap 
junctions, particularly disturbances in Cx43 expression, is related to 
congenital defects of the heart (Ya et al., 1998).  The results of this study 
suggest that exposure of cardiomyocytes to ethanol, nicotine, retinoic acid 
and diabetic conditions, resulted in decrease in the expression of Cx43 both 
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in immunohistochemical analyses and western blotting (chapter 8).  The 
addition of vitamins was shown to have substantial effects on the above 
mentioned teratogens and Cx43 was expressed as with control embryos.  
The mechanism by which these teratogens affect the expression of Cx43 
and thus the gap junctions might be related to oxidative stress.  One recent 
study showed a direct relation of oxidative stress and a decrease in the 
expression of Cx43 (Smyth et al., 2010).  The oxidative stress was shown 
to decrease the amount of Cx43 at gap junctions plaques by two means; 
first excessive production of reactive oxygen radicals caused an increase in 
Cx43 phosphorylation, which in turn resulted in excessive turnover, 
internalization and lateralization of Cx43 at gap junctions plaques with 
decreased cell-cell communication (Beardslee et al., 2000).  The oxidative 
stress induced increased phosphorylation is via the protein kinase C 
pathway; secondly, oxidative stress also affects forward trafficking of 
Cx43 to gap junction plaques by creating defects in post Golgi microtubule 
transfer.  The microtubules are responsible for the transfer of correctly 
aligned connexins to the cell surface and gap junction plaques.  
Disturbances to this pathway result in transport of less Cx43 to the cell 
surface, such that there is not enough to be functional and there is a 
resultant decrease in intercellular communication (Smyth et al., 2010).  
This study confirmed the role of reactive oxygen species cardiac 
malformations involving Cx43 distribution in both cardiac cells and chick 
cardiomyocytes cultured in ovo, due to the fact that addition of 
antioxidants folic acid and vitamin C could reverse the effects of the above 
teratogens.  Also, connexin 43 expression was restored with the addition of 
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antioxidants.  Furthermore this study also confirmed one possible 
mechanism of oxidative stress induced damage to Cx43 levels.  It is well 
known that TPA increased phosphorylation of Cx43 and decreased the 
levels of Cx43 at gap junction plaques and thus reduced cell-cell 
communications (Rivedal & Opsahl, 2001).   The teratogens used in this 
study produced an excessive amount of reactive oxygen species which 
have deleterious effects on Cx43 phosphorylation with resultantly less 
available Cx43 at the cell surface.   
Immunohistochemical analysis showed that expression of cytoplasmic ET-
1 was less in teratogen-treated cultures as compare to controls and also 
addition of folic acid and vitamin C restored its cytoplasmic concentration.  
The possible mechanism of decreased levels of active ET-1 in the cell 
cytoplasm could also be related to oxidative stress produced by 
environmental teratogens used in this study, as oxidative stress has been 
shown to be involved in regulation of ET-1 in other systems.  A study 
conducted on rat pulmonary endothelial cells showed that the level of ET-1 
is decreased with addition of H2O2 and glucose oxidase in a dose dependant 
manner and is increased by addition of antioxidants (Michael et al., 1997).  
Other studies conducted on bovine carotid arteries also demonstrated the 
same response (Saito et al., 1998 ; Masatsugu et al., 2003).   However there 
is evidence that oxidative stress produced by hypertensive and diabetic 
conditions also enhances the production of ET-1 from endothelial cells.  
The possibility that other factors including pro-inflammatory markers 
might be involved along with oxidative stress in the generation of higher 
levels of ET-1 has been suggested (Saito et al., 2001; Pollock, 2005; 
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Manea et al., 2010).  However the question of how oxidative stress affects 
the levels of ET-1 in chick hearts has yet to be fully answered.   
10.2. Conclusions         
To conclude, this study has demonstrated the toxic effects of ethanol, 
nicotine, retinoic acid, cadmium chloride and diabetic conditions in chick 
heart micromass culture.  The micromass culture also revealed that sodium 
fluoride and the traditional medicine ginseng had no teratogenic potential 
in chick hearts, at least at the concentrations employed.  Also 
micronutrients used in this study were shown to have no cytotoxic effect, 
except retinoic acid as already mentioned.  Furthermore the protective role 
of micronutrients, particularly vitamins, against environmental teratogen 
induced cardiovascular malformations was also observed for the majority 
of chemicals tested, except cadmium chloride.  The developmental defects 
brought about by ethanol were also observed in chick embryos cultured in 
ovo.  However nicotine showed no developmental defects in in ovo culture.  
The diabetic condition also revealed developmental defects in chick 
embryos.  The teratogenic effects of ethanol and diabetic conditions were 
abrogated by supplemental vitamins.  The expression of both Cx 43 and 
ET-1 was affected by these environmental toxins, but addition of vitamins 
proved to be helpful in restoring the expression of both molecules 
comparable with controls.  In summary the present work confirmed a 
protective role of healthy nutrition particularly micronutrients against 
environmentally induced congenital anomalies. 
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10.3. Future Work 
Future work may be extended in two different directions.  Firstly, as 
described in fig 10.1, aggressive public awareness programmes should be 
started in a more wide ranging way.  Although the notion of a 
periconceptional healthy diet, especially in micronutrient intake, and 
healthy pregnancy outcome is not new, still many pregnancies are 
unplanned, particularly in low socioeconomic groups and these are the 
groups where binge drinking, cigarette smoking and misuse of over the 
counter drugs are very common.  There should be some longitudinal 
studies conducted at the GP surgery level, where more and more women 
should be studied.  Also, another approach should be pre-pregnancy 
counselling regarding planned pregnancies and encouragement about a 
healthy diet and avoidance of social and recreational drugs.  Public health 
seminars are another good approach to create awareness about intake of 
multivitamins among women of child bearing age.  
Secondly, future work may be to further extend the experimental work to 
detect the role of other connexins particularly Cx40 and Cx45 in 
developmental defects.  Also it would be worthwhile to detect the 
expression of Cx43 in chick heart sections and to see whether it plays a 
role in migration of cardiac neural crest cells, which are essential 
components of the secondary heart field and play a vital role in the 
development of many parts of the heart.  Also investigations concerning 
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the possible role of oxidative stress in affecting the post Golgi microtubule 
network and forward trafficking of Cx43 to be available for gap junction 
plaques would be of interest.   
As the chick micromass provided reliable and reproducible results it would 
be useful to extend the work to other organs, in particular chick brain 
development and to detect possible beneficial role of nutrition for its 
development (fig 10.1). 
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